<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pulp treatment for extensive decay in primary teeth - Smaïl‐Faugeron, V - 2018 | Cochrane Library</title> <meta content="Pulp treatment for extensive decay in primary teeth - Smaïl‐Faugeron, V - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003220.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pulp treatment for extensive decay in primary teeth - Smaïl‐Faugeron, V - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003220.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003220.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Pulp treatment for extensive decay in primary teeth" name="citation_title"/> <meta content="Violaine Smaïl‐Faugeron" name="citation_author"/> <meta content="Université Paris Descartes ‐ Sorbonne Paris Cité" name="citation_author_institution"/> <meta content="viosmail@orange.fr" name="citation_author_email"/> <meta content="Anne‐Marie Glenny" name="citation_author"/> <meta content="The University of Manchester" name="citation_author_institution"/> <meta content="Frédéric Courson" name="citation_author"/> <meta content="Université Paris Descartes ‐ Sorbonne Paris Cité" name="citation_author_institution"/> <meta content="Pierre Durieux" name="citation_author"/> <meta content="Georges Pompidou European Hospital" name="citation_author_institution"/> <meta content="Michele Muller‐Bolla" name="citation_author"/> <meta content="UFR Odontology, University of the Côte d’Azur" name="citation_author_institution"/> <meta content="Helene Fron Chabouis" name="citation_author"/> <meta content="Université Paris Descartes ‐ Sorbonne Paris Cité" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD003220.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003220.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003220.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003220.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Molar; *Tooth, Deciduous; Aluminum Compounds [therapeutic use]; Calcium Compounds [therapeutic use]; Calcium Hydroxide [therapeutic use]; Controlled Clinical Trials as Topic; Dental Caries [*therapy]; Dental Cements [therapeutic use]; Dental Materials [therapeutic use]; Drug Combinations; Electric Stimulation Therapy; Ferric Compounds [therapeutic use]; Formocresols [therapeutic use]; Oxides [therapeutic use]; Pulpectomy [*methods]; Pulpotomy [*methods]; Randomized Controlled Trials as Topic; Silicates [therapeutic use]; Treatment Failure; Zinc Oxide‐Eugenol Cement [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003220.pub3&amp;doi=10.1002/14651858.CD003220.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WcPhDegp";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003220\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003220\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ru","ms","pl","fr","fa","hr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003220.pub3",title:"Pulp treatment for extensive decay in primary teeth",firstPublishedDate:"May 31, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Oral Health Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003220.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003220.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003220.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003220.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003220.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003220.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003220.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003220.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003220.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003220.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>18450 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003220.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0374"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0062"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-sec-0358"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/appendices#CD003220-sec-0379"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/table_n/CD003220StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/table_n/CD003220StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pulp treatment for extensive decay in primary teeth</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#CD003220-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Violaine Smaïl‐Faugeron</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#CD003220-cr-0003">Anne‐Marie Glenny</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#CD003220-cr-0004">Frédéric Courson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#CD003220-cr-0005">Pierre Durieux</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#CD003220-cr-0006">Michele Muller‐Bolla</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information#CD003220-cr-0007">Helene Fron Chabouis</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information/en#CD003220-sec-0396">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003220.pub3">https://doi.org/10.1002/14651858.CD003220.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003220-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003220-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003220-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003220-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003220-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003220-abs-0001" lang="en"> <section id="CD003220-sec-0001"> <h3 class="title" id="CD003220-sec-0001">Background</h3> <p>In children, dental caries (tooth decay) is among the most prevalent chronic diseases worldwide. Pulp interventions are indicated for extensive tooth decay. Depending on the severity of the disease, three pulp treatment techniques are available: direct pulp capping, pulpotomy and pulpectomy. After treatment, the cavity is filled with a medicament. Materials commonly used include mineral trioxide aggregate (MTA), calcium hydroxide, formocresol or ferric sulphate. </p> <p>This is an update of a Cochrane Review published in 2014 when insufficient evidence was found to clearly identify one superior pulpotomy medicament and technique. </p> </section> <section id="CD003220-sec-0002"> <h3 class="title" id="CD003220-sec-0002">Objectives</h3> <p>To assess the effects of different pulp treatment techniques and associated medicaments for the treatment of extensive decay in primary teeth. </p> </section> <section id="CD003220-sec-0003"> <h3 class="title" id="CD003220-sec-0003">Search methods</h3> <p>Cochrane Oral Health's Information Specialist searched the Cochrane Oral Health Group's Trials Register (to 10 August 2017), the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2017, Issue 7), MEDLINE Ovid (1946 to 10 August 2017), Embase Ovid (1980 to 10 August 2017) and the Web of Science (1945 to 10 August 2017). OpenGrey was searched for grey literature. The US National Institutes of Health Trials Registry (<a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>) and the <a href="http://apps.who.int/trialsearch/" target="_blank">World Health Organization International Clinical Trials Registry Platform</a> were searched for ongoing trials. No restrictions were placed on the language or date of publication when searching the electronic databases. </p> </section> <section id="CD003220-sec-0004"> <h3 class="title" id="CD003220-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) comparing interventions that combined a pulp treatment technique with a medicament or device in children with extensive decay in the dental pulp of their primary teeth. </p> </section> <section id="CD003220-sec-0005"> <h3 class="title" id="CD003220-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed 'Risk of bias'. We contacted authors of RCTs for additional information when necessary. The primary outcomes were clinical failure and radiological failure, as defined in trials, at six, 12 and 24 months. We performed data synthesis with pair‐wise meta‐analyses using fixed‐effect models. We assessed statistical heterogeneity by using I² coefficients. </p> </section> <section id="CD003220-sec-0006"> <h3 class="title" id="CD003220-sec-0006">Main results</h3> <p>We included 40 new trials bringing the total to 87 included trials (7140 randomised teeth) for this update. All were small, single‐centre trials (median number of randomised teeth = 68). All trials were assessed at unclear or high risk of bias. </p> <p>The 87 trials examined 125 different comparisons: 75 comparisons of different medicaments or techniques for pulpotomy; 25 comparisons of different medicaments for pulpectomy; four comparisons of pulpotomy and pulpectomy; and 21 comparisons of different medicaments for direct pulp capping. </p> <p>The proportion of clinical failures and radiological failures was low in all trials. In many trials, there were either no clinical failures or no radiographic failures in either study arm. </p> <p>For pulpotomy, we assessed three comparisons as providing moderate‐quality evidence. Compared with formocresol, MTA reduced both clinical and radiological failures, with a statistically significant difference at 12 months for clinical failure and at six, 12 and 24 months for radiological failure (12 trials, 740 participants). Compared with calcium hydroxide, MTA reduced both clinical and radiological failures, with statistically significant differences for clinical failure at 12 and 24 months. MTA also appeared to reduce radiological failure at six, 12 and 24 months (four trials, 150 participants) (low‐quality evidence). When comparing calcium hydroxide with formocresol, there was a statistically significant difference in favour of formocresol for clinical failure at six and 12 months and radiological failure at six, 12 and 24 months (six trials (one with no failures), 332 participants). </p> <p>Regarding pulpectomy, we found moderate‐quality evidence for two comparisons. The comparison between Metapex and zinc oxide and eugenol (ZOE) paste was inconclusive, with no clear evidence of a difference between the interventions for failure at 6 or 12 months (two trials, 62 participants). Similarly inconclusive, there was no clear evidence of a difference in failure between Endoflas and ZOE (outcomes measured at 6 months; two trials, 80 participants). There was low‐quality evidence of a difference in failure at 12 months that suggested ZOE paste may be better than Vitapex (calcium hydroxide/iodoform) paste (two trials, 161 participants). </p> <p>Regarding direct pulp capping, the small number of studies undertaking the same comparison limits any interpretation. We assessed the quality of the evidence as low or very low for all comparisons. One trial appeared to favour formocresol over calcium hydroxide; however, there are safety concerns about formocresol. </p> </section> <section id="CD003220-sec-0007"> <h3 class="title" id="CD003220-sec-0007">Authors' conclusions</h3> <p>Pulp treatment for extensive decay in primary teeth is generally successful. Many included trials had no clinical or radiological failures in either trial arm, and the overall proportion of failures was low. Any future trials in this area would require a very large sample size and follow up of a minimum of one year. </p> <p>The evidence suggests MTA may be the most efficacious medicament to heal the root pulp after pulpotomy of a deciduous tooth. As MTA is relatively expensive, future research could be undertaken to confirm if Biodentine, enamel matrix derivative, laser treatment or Ankaferd Blood Stopper are acceptable second choices, and whether, where none of these treatments can be used, application of sodium hypochlorite is the safest option. Formocresol, though effective, has known concerns about toxicity. </p> <p>Regarding pulpectomy, there is no conclusive evidence that one medicament or technique is superior to another, and so the choice of medicament remains at the clinician's discretion. Research could be undertaken to confirm if ZOE paste is more effective than Vitapex and to evaluate other alternatives. </p> <p>Regarding direct pulp capping, the small number of studies and low quality of the evidence limited interpretation. Formocresol may be more successful than calcium hydroxide; however, given its toxicity, any future research should focus on alternatives. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003220-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003220-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003220-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003220-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003220-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD003220-abs-0013">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003220-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD003220-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003220-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD003220-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003220-abs-0004" lang="en"> <h3>Pulp treatment for extensive decay in primary teeth</h3> <p><b>Review question</b> </p> <p>How effective are different options for treating extensive tooth decay in children's primary (milk) teeth to resolve the child's symptoms (typically pain, swelling, abnormal movement) and tooth signs (as shown on an x‐ray)? </p> <p><b>Background</b> </p> <p>In children, tooth decay is among the most common diseases. Tooth decay in the primary teeth tends to progress rapidly, often reaching the pulp ‐ the nerves, tiny blood vessels and connective tissue that make up the centre of a tooth. Dentists often have to perform one of three pulp treatment techniques: direct pulp capping (where a healing agent is placed directly over the exposed pulp), pulpotomy (removal of a portion of the pulp) or pulpectomy (removal of all of the pulp in the pulp chamber and root canal of a tooth). </p> <p>The most common materials used for direct pulp capping are calcium hydroxide, the more recent but more expensive mineral trioxide aggregate, formocresol or an adhesive resin (placed directly over the tooth's nerve). </p> <p>After a pulpotomy, one of four materials is generally used: ferric sulphate, formocresol, calcium hydroxide or mineral trioxide aggregate. </p> <p>After a pulpectomy, a material is put into the space created by pulp removal. This material should not prevent the resorption of the primary tooth's root, to let the permanent tooth to grow in. </p> <p><b>Study characteristics</b> </p> <p>Review authors working with Cochrane Oral Health carried out this review of randomised controlled trials. The evidence is current up to August 2017. </p> <p>We included 87 trials that investigated the success of pulp treatment of milk teeth. The trials were published between 1989 and 2017 and provided 125 comparisons of different treatment options. </p> <p><b>Key results</b> </p> <p>Pulp treatment for extensive decay in primary teeth is generally successful. The proportion of treatment failures was low, with many of the included trials having no failures with either of the treatments being compared. </p> <p>After a pulpotomy, mineral trioxide aggregate (MTA) seems to be the best material (in terms of biocompatibility and efficacy) to put into contact with the remaining root dental nerve. The evidence showed it to be less likely to fail than either calcium hydroxide or formocresol. </p> <p>After pulpectomy, it is not clear whether any medicament is superior to another. ZOE paste may give better results than Vitapex (calcium hydroxide/iodoform) paste, but more studies are needed to confirm this and to explore other treatment options. </p> <p>Regarding direct pulp capping, the small number of studies undertaking the same comparison limits any interpretation. Formocresol may be superior to calcium hydroxide in terms of clinical and radiological failure, but because of toxic effects associated with formocresol, safer alternatives should be evaluated. </p> <p><b>Quality of the evidence</b> </p> <p>We judged the quality of the evidence suggesting the superiority of MTA over calcium hydroxide or formocresol after pulpotomy to be moderate. For other comparisons, the quality of the evidence is low or very low, which means we cannot be certain about the findings. The low quality is due to shortcomings in the methods used within the individual trials, the small number of children included in the trials and the short‐term follow‐up after treatment. </p> <p>Future trials to evaluate which healing agents are best for the three pulp treatments would require a very large sample size and should follow up the participants of a minimum of one year. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003220-sec-0374" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003220-sec-0374"></div> <h3 class="title" id="CD003220-sec-0375">Implications for practice</h3> <section id="CD003220-sec-0375"> <p>Many of the included trials had no clinical or radiological failures in either arm, and the proportion of failures in other trials was small. </p> <p>Mineral trioxide aggregate (MTA) may be the best medicament to apply on the pulp stumps after pulpotomy of a deciduous tooth. Formocresol is effective, but there are known concerns about toxicity. Where MTA is not accessible, Biodentine, enamel matrix derivatives (EMD), laser treatment or maybe Ankaferd Blood Stopper seem to be the second choices. Where none of these treatments can be used, application of sodium hypochlorite (NaOCl) could be the safest option. </p> <p>Concerning pulpectomy of primary teeth, the evidence was inconclusive. Zinc‐oxide eugenol (ZOE) paste, which is cheap and considered relatively safe, may be more effective than Vitapex, but data were insufficient to draw conclusions about its relative efficacy compared to Endoflas and Metapex, or other alternatives. </p> <p>For direct pulp capping in primary teeth, formocresol appeared to be more successful than calcium hydroxide, but should not be used in children due to its toxicity. Tricalcium silicates (MTA in particular), calcium sulphate hemihydrate (DentoGen) and EMD may be the best alternatives, but the quality of the evidence is low to very low and all comparisons were based on only one trial. </p> <p>The overall quality of the evidence ranged from was moderate to very low and so it should be noted that future research could change our findings. </p> </section> <h3 class="title" id="CD003220-sec-0376">Implications for research</h3> <section id="CD003220-sec-0376"> <p>Future trials in this area should take into consideration the high success rate, which means that very large trials would be needed and should follow up children for at least one year, ideally longer. Trials should use the criteria we proposed for the evaluation of pulp treatment techniques to facilitate future systematic reviews and meta‐analyses (<a href="./references#CD003220-bbs2-0187" title="Smaïl‐FaugeronV , Fron ChabouisH , DurieuxP , AttalJ P , Muller‐BollaM , CoursonF . Development of a core set of outcomes for randomized controlled trials with multiple outcomes ‐ example of pulp treatments of primary teeth for extensive decay in children. PLoS One2013;8(1):e51908. ">Smaïl‐Faugeron 2013</a>). </p> <p>Concerning pulpotomy in primary teeth, well designed long‐term trials could compare MTA with Biodentine, laser therapy (diode or Er:Yag), EMD, Ankaferd Blood Stopper and maybe simple NaOCl application in terms of efficacy and cost‐effectiveness. Cost‐effectiveness trials from different countries could be useful to determine which medicament should be advocated in which economic setting. Laboratory research could also be encouraged to elaborate a calcium silicate or inorganic material as safe and effective as MTA for primary tooth pulpotomy, but with a shorter setting time. We suggest that researchers choose MTA as the reference treatment. </p> <p>Concerning pulpectomy, well designed long‐term trials could compare ZOE paste with Endoflas, 3Mix and Metapex. </p> <p>Concerning direct pulp capping of primary teeth, a trial (or trials) comparing MTA, EMD, calcium sulphate hemihydrate (DentoGen) and maybe other tricalcium silicates (such as Biodentine) or laser therapy could help in defining which is the most effective treatment. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003220-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003220-sec-0029"></div> <div class="table" id="CD003220-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pulpotomy compared with pulpotomy using alternative medicament/technique for extensive decay in primary teeth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Pulpotomy compared with pulpotomy using alternative medicament/technique for extensive decay in primary teeth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> children with extensive decay in primary teeth </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> pulpotomy with one type of medicament </p> <p><b>Comparison:</b> pulpotomy using alternative medicament or different technique </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Experimental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>MTA versus formocresol</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure</b> </p> <p><b>(12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>28 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>8.6 per 1000 (2.8 per 1000 to 26.0 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.31 (0.10 to 0.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740</p> <p>(12 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure rate less than 3% across both the MTA and formocresol treatment groups. Seven of the 12 studies had no failures at 12 months. </p> <p>No evidence of a difference in clinical failure at 6 months or 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure</b> </p> <p><b>(12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>50 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>20.5 per 1000 (9.5 per 1000 to 44.5 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.41 (0.19 to 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740 (12 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure rate 5% across formocresol treatment groups and 2.1% across MTA treatment groups. Five of the 12 studies had no failures at 12 months. </p> <p>Results similar at 6 and 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>MTA versus calcium hydroxide</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>14 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>2.2 per 1000 (0.02 per 1000 to 9.8 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.16 (0.04 to 0.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 24 months.</p> <p>No evidence of a difference in clinical failure at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure</b> </p> <p><b>(12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>351 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>42.1 per 1000 (14 per 1000 to 126.4 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.12 (0.04 to 0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 and 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Calcium hydroxide versus formocresol</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>115 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>215 per 1000 (140.3 per 1000 to 332.4 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.87 (1.22 to 2.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>332 (6 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 months</p> <p>No evidence of a difference in clinical failure at 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>253 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>470.6 per 1000 (359.3 per 1000 to 617.3 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.86 (1.42 to 2.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>332 (6 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 and 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Other comparisons assessed in more than one trial that had treatment failures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was<b>low</b> for 4 comparisons<sup>3</sup>: laser versus ferric sulphate; Biodentine versus MTA; ferric sulphate versus formocresol; electrosurgery versus ferric sulphate; calcium hydroxide versus ferric sulphate. </p> <p>The quality of the evidence was <b>very low</b> for 5 comparisons: NaOCl versus ferric sulphate<sup>4</sup>; laser versus electrosurgery<sup>4</sup>; MTA versus ferric sulphate<sup>5</sup>; ABS versus ferric sulphate<sup>6</sup>; EMD versus formocresol<sup>7</sup>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was<b>low</b> for 8 comparisons: NaOCl versus ferric sulphate<sup>2</sup>; MTA versus ferric sulphate<sup>3</sup>; Biodentine versus MTA<sup>3</sup>; ferric sulphate versus formocresol<sup>3</sup>; laser versus ferric sulphate<sup>3</sup>; electrosurgery versus ferric sulphate<sup>3</sup>; ABS versus ferric sulphate<sup>3</sup>; laser versus electrosurgery<sup>3</sup>; calcium hydroxide versus ferric sulphate (favouring ferric sulphate)<sup>3</sup>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Downgraded 1 level due to high risk of bias<br/> <sup>2.</sup> Downgraded 1 level due to high risk of bias and 1 level due to substantial inconsistency<br/> <sup>3.</sup> Downgraded 1 level due to high risk of bias and 1 level due to imprecision<br/> <sup>4.</sup> Downgraded 1 level due to high risk of bias and 2 levels due to imprecision<br/> <sup>5.</sup> Downgraded 1 level due to high risk of bias, 1 level due to moderate inconsistency and 1 level due to imprecision<br/> <sup>6.</sup> Downgraded 1 level due to high risk of bias and 2 levels due to very serious imprecision<br/> <sup>7.</sup> Downgraded 1 level due to high risk of bias, 1 level due to substantial inconsistency and 1 level due to imprecision </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003220-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Pulpectomy compared with pulpectomy using alternative medicament for extensive decay in primary teeth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Pulpectomy compared with pulpectomy using alternative medicament for extensive decay in primary teeth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> children with extensive decay in primary teeth </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> pulpectomy with 1 type of medicament </p> <p><b>Comparison:</b> pulpectomy using alternative medicament </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Experimental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Endoflas versus ZOE</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (6 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>128 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>33.3 per 1000 (6.4 per 1000 to 192 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.26 (0.05 to 1.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>One trial assessed failure at 12 months: RR 1.00, 95% 0.07 to 14.55</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (6 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>128 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>33.3 per 1000 (6.4 per 1000 to 192 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.26 (0.05 to 1.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Metapex versus ZOE</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>97 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>68.9 per 1000 (14.6 per 1000 to 323 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.71 (0.15 to 3.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>129 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>129 per 1000 (40 per 1000 to 421.8 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.00 (0.31 to 3.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Other comparisons assessed in more than one trial that had treatment failures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was rated as <b>low</b> for 1 comparison: Vitapex versus ZOE (favouring ZOE)<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was rated as <b>low</b> for 2 comparisons: Vitapex versus ZOE<sup>2</sup> (favouring ZOE); calcium hydroxide versus ZOE<sup>3</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Downgraded 1 level due to imprecision<br/> <sup>2.</sup> Downgraded 2 levels due to very substantial inconsistency<br/> <sup>3.</sup> Downgraded 1 level due to substantial inconsistency and 1 level due to imprecision </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003220-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Direct pulp capping compared with direct pulp capping using alternative medicament for extensive decay in primary teeth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Direct pulp capping compared with direct pulp capping using alternative medicament for extensive decay in primary teeth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> children with extensive decay in primary teeth </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> direct pulp capping with 1 type of medicament </p> <p><b>Comparison:</b> direct pulp capping using alternative medicament </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Experimental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Seven trials evaluated 22 comparisons of different medicaments for direct pulp capping. Each comparison was assessed by a single trial. </p> <p>There were no clinical or radiological failures in two comparisons: acetone‐based total‐etch adhesive versus calcium hydroxide; MTA versus calcium hydroxide. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was assessed as <b>low</b> for 5 comparisons<sup>1</sup>: calcium hydroxide versus formocresol (favouring formocrescol), MTA versus 3Mix and MTA versus simvastatin (favouring MTA), 3Mix versus 3Mixtatin and 3Mixtatin versus simvastatin (favouring 3Mixtatin). </p> <p>The quality of the evidence was rated as <b>very low</b> for all other comparisons.<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was rated as <b>low</b> for 1 comparison: calcium hydroxide versus formocresol<sup>1</sup> (favouring formocresol). </p> <p>The quality of the evidence was rated as <b>very low</b> for all other comparisons.<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Downgraded 1 level due to risk of bias and 1 level due to imprecision<br/> <sup>2.</sup> Downgraded 1 level due to risk of bias and 2 levels due to severe imprecision </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003220-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003220-sec-0030"></div> <section id="CD003220-sec-0031"> <h3 class="title" id="CD003220-sec-0031">Description of the condition</h3> <p>Dental caries (tooth decay) is a bacterial infection that causes demineralisation and destruction of tooth tissues. The severity ranges from the early clinically visible changes in enamel caused by demineralisation to extensive cavitation. If the cavitation exposes dentine, then the caries has progressed to a 'distinct cavitation'. In more severe cases, there is obvious loss of tooth structure, the cavity is both deep and wide, and the dentine is clearly visible; a cavity that involves at least half of a tooth surface or possibly reaches the pulp is referred to as 'extensive' (<a href="./references#CD003220-bbs2-0169" title="International Caries Detection and Assessment System Coordinating Committee. Rationale and Evidence for the International Caries Detection and Assessment System (ICDAS II), 2011. Available from www.icdas.org/downloads (accessed 5 June 2014). ">ICDAS II 2011</a>). In children, dental caries is among the most prevalent chronic diseases worldwide. Extensive tooth decay is the most common disease of primary teeth; 42% of children aged from two to 11 years have dental caries in their primary teeth, with a mean of 1.6 decayed teeth for each child (<a href="./references#CD003220-bbs2-0178" title="National Health and Nutrition Examination Survey (NHANES). National Health and Nutrition Examination Survey Data (1999‐2004). Available from www.cdc.gov/nchs/data/datalinkage/nh99+_mort_file_layout_public_2010.pdf (accessed 5 June 2014). ">NHANES 2010</a>; <a href="./references#CD003220-bbs2-0184" title="SelwitzRH , IsmailAI , PittsNB . Dental caries. Lancet2007;369(9555):51‐9. ">Selwitz 2007</a>). Most dental caries in children are left untreated (<a href="./references#CD003220-bbs2-0159" title="USA National Center for Health Statistics, Centers for Disease Control and Prevention. CDC Data &amp; Statistics. Feature: Untreated Dental Caries (Cavities) in Children Ages 2‐19, United States, 2011. Available from www.cdc.gov/Features/dsUntreatedCavitiesKids/ (accessed 5 June 2014). ">CDC 2011</a>). Decay in primary teeth is a risk factor for decay in permanent teeth (<a href="./references#CD003220-bbs2-0157" title="Al‐ShalanTA , EricksonPR , HardieNA . Primary incisor decay before age 4 as a risk factor for future dental caries. Pediatric Dentistry1997;19(1):37‐41. [PUBMED: 9048412] ">Al‐Shalan 1997</a>; <a href="./references#CD003220-bbs2-0164" title="FinucaneD . Rationale for restoration of carious primary teeth: a review. European Archives of Paediatric Dentistry2012;13(6):281‐92. [PUBMED: 23235127] ">Finucane 2012</a>; <a href="./references#CD003220-bbs2-0170" title="KasteLM , MarianosD , ChangR , PhippsKR . The assessment of nursing caries and its relationship to high caries in the permanent dentition. Journal of Public Health Dentistry1992;52(2):64‐8. [PUBMED: 1564693] ">Kaste 1992</a>). </p> </section> <section id="CD003220-sec-0032"> <h3 class="title" id="CD003220-sec-0032">Description of the intervention</h3> <p>Pulp interventions combine a pulp treatment technique and a medicament. The primary objective of pulp interventions is to maintain the integrity of the tooth and the health of its supporting tissues. Depending on the severity of the disease, three pulp treatment techniques are available: direct pulp capping, pulpotomy and pulpectomy (<a href="./references#CD003220-bbs2-0165" title="Clinical Affairs Committee ‐ Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. American Academy of Pediatric Dentistry2014:244‐52. ">Guideline Pulp Therapy 2014</a>; <a href="./references#CD003220-bbs2-0166" title="Clinical Affairs Committee ‐ Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. Pediatric Dentistry2016;38(6):280‐8. [PUBMED: 27931467] ">Guideline Pulp Therapy 2016</a>). These treatments consist of the eviction of caries, followed by the eviction of a part of the pulp tissue and then setting in place medicaments. This treatment keeps the temporary tooth on the arch until it is replaced by the permanent tooth. </p> <p>Direct pulp capping is usually indicated in a primary tooth with normal pulp (accidentally) exposed 1 mm or less. The exposed pulp is capped with a medicament before placing a restoration that seals the tooth. A pulpotomy is performed in a primary tooth with extensive caries but without evidence of radicular pathology. The coronal pulp is removed, and the remaining vital radicular pulp tissue is covered with a medicament. A pulpectomy is performed in a primary tooth with irreversible pulpitis. The radicular pulp is removed, and then a medicament is used to fill the canals. The tooth is restored with a restoration. </p> <p>These treatments are combined with a variety of medicaments, to protect the pulp or the periradicular tissues, or to fill the substance loss, or both. </p> </section> <section id="CD003220-sec-0033"> <h3 class="title" id="CD003220-sec-0033">How the intervention might work</h3> <p>Pulp interventions involve the elimination of the infection and protection of the decontaminated tooth from future microbial invasion. Several medicaments are available for the obturation of the decontaminated surfaces or canals, the most frequently used are mineral trioxide aggregate (MTA), calcium hydroxide, formocresol or ferric sulphate. </p> <p>Formocresol is a solution of cresol 35% and formaldehyde 19% in a vehicle of glycerine 15% and water (Buckley's formocresol). One part of this formula is normally mixed with three parts glycerine and one part water. This mixture prevents tissue autolysis by bonding to protein. Cresol is locally destructive to vital tissues but presents negligible potential for systemic distribution following the pulp treatment technique. However, formaldehyde is distributed systemically after pulp treatment technique and is classified by the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) as a known human carcinogen (<a href="./references#CD003220-bbs2-0168" title="World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. monographs.iarc.fr/ENG/Classification/latest_classif.php (accessed 8 January 2018). ">IARC 2017</a>). Although a 1:5 or 1:25 dilution of formocresol is generally advocated, many dentists use a more concentrated formula. </p> <p>Ferric sulphate is a haemostatic compound that forms a metal‐protein clot at the surface of the pulp stumps, which seals blood capillaries and acts as a barrier to irritating components of the materials applied after. No concerns about toxic or harmful effects of ferric sulphate have been published in the dental or medical literature. </p> <p>Calcium hydroxide was the first agent used in pulpotomies that demonstrated a capacity to induce dentine regeneration by becoming very alkaline when mixed with water. However, calcium hydroxide may possibly wound the primary tooth pulp to permit internal resorption or dystrophic calcification. </p> <p>MTA is a recent mineral material that results ‐ when mixed with water ‐ in a hydrated calcium silicate gel containing calcium hydroxide. It is also very alkaline and promotes tissue regeneration when placed in contact with the pulp or periradicular tissues. It is biocompatible, non‐toxic and non‐resorbable and leads to minimal leakage around the margins. </p> </section> <section id="CD003220-sec-0034"> <h3 class="title" id="CD003220-sec-0034">Why it is important to do this review</h3> <p>Cochrane Oral Health undertook an extensive prioritisation exercise in 2014 to identify a core portfolio of titles that were the most clinically important to maintain on the Cochrane Library (<a href="./references#CD003220-bbs2-0190" title="WorthingtonH , ClarksonJ , WeldonJ . Priority oral health research identification for clinical decision‐making. Evidence‐based Dentistry2015;16(3):69‐71. ">Worthington 2015</a>). Consequently, this review was identified as a priority title by the paediatric expert panel (<a href="http://ohg.cochrane.org/priority-reviews" target="_blank">Cochrane Oral Health priority review portfolio</a>). </p> <p>Because formocresol contains a known human carcinogen and is widely used for direct pulp capping and pulpotomy in children, finding a biocompatible and efficient alternative is a priority. </p> <p>This is an update of a Cochrane Review first published in 2003 (<a href="./references#CD003220-bbs2-0191" title="NadinG , GoelBR , YeungCA , GlennyAM . Pulp treatment for extensive decay in primary teeth. Cochrane Database of Systematic Reviews2003, Issue 1. [DOI: 10.1002/14651858.CD003220] ">Nadin 2003</a>) and updated in October 2014 (<a href="./references#CD003220-bbs2-0192" title="Smaïl‐FaugeronV , CoursonF , DurieuxP , Muller‐BollaM , GlennyAM , Fron ChabouisH . Pulp treatment for extensive decay in primary teeth. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD003220.pub2] ">Smaïl‐Faugeron 2014a</a>). The 2003 version review included three randomised controlled trials (RCTs). We wrote a new protocol and searched for up‐to‐date evidence for an update in 2014. The 2014 update included 47 RCTs, on the basis of which the review authors concluded there was insufficient evidence supporting the superiority of one type of treatment over another. Since the 2014 version, results of new trials have been published and new medicaments have been introduced, and so we considered it important to synthesise new findings with existing evidence. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003220-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003220-sec-0035"></div> <p>To assess the effects of different pulp treatment techniques and associated medicaments for the treatment of extensive decay in primary teeth. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003220-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003220-sec-0036"></div> <section id="CD003220-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003220-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing different pulp interventions combining a pulp treatment technique and a medicament in primary teeth. We included trials that compared different medicaments for the same pulp treatment technique or different pulp treatment techniques with each other. </p> </section> <section id="CD003220-sec-0039"> <h4 class="title">Types of participants</h4> <p>Children with extensive decay involving dental pulp in primary teeth.</p> </section> <section id="CD003220-sec-0040"> <h4 class="title">Types of interventions</h4> <p>All pulp interventions combining a pulp treatment technique (pulpotomy, pulpectomy or direct pulp capping) and a medicament (any medication or device). </p> </section> <section id="CD003220-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD003220-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>We defined two primary outcomes: clinical failure and radiological failure as defined in primary studies, at six, 12 and 24 months. </p> </section> <section id="CD003220-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p>According to our classification of outcomes (<a href="./references#CD003220-bbs2-0187" title="Smaïl‐FaugeronV , Fron ChabouisH , DurieuxP , AttalJ P , Muller‐BollaM , CoursonF . Development of a core set of outcomes for randomized controlled trials with multiple outcomes ‐ example of pulp treatments of primary teeth for extensive decay in children. PLoS One2013;8(1):e51908. ">Smaïl‐Faugeron 2013</a>), we considered the following secondary outcomes to be relevant: </p> <p> <ul id="CD003220-list-0001"> <li> <p>overall failure;</p> </li> <li> <p>secondary clinical outcomes: pain, soft tissue pathology, pathological mobility, adjacent tissue inflammation, defective restoration (clinically), secondary caries at the margin (clinically), periodontal pocket formation, dental anxiety/phobia, premature tooth loss, signs of exfoliation, smell; and </p> </li> <li> <p>secondary radiological outcomes: pathological radiolucency, pathological root resorption, pulp canal obliteration, dentin bridge formation, physiological root resorption, defective restoration (radiographically), secondary caries (radiographically), and filling material anomaly. </p> </li> </ul> </p> </section> </section> </section> <section id="CD003220-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003220-sec-0045"> <h4 class="title">Electronic searches</h4> <p>Cochrane Oral Health’s Information Specialist conducted systematic searches in the following databases for RCTs and controlled clinical trials. There were no language, publication year or publication status restrictions: </p> <p> <ul id="CD003220-list-0002"> <li> <p>Cochrane Oral Health's Trials Register (to 10 August 2017) (<a href="./appendices#CD003220-sec-0380">Appendix 1</a>); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 7) in the Cochrane Library (searched 10 August 2017) (<a href="./appendices#CD003220-sec-0381">Appendix 2</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to 10 August 2017) (<a href="./appendices#CD003220-sec-0382">Appendix 3</a>); </p> </li> <li> <p>Embase Ovid (1980 to 10 August 2017) (<a href="./appendices#CD003220-sec-0383">Appendix 4</a>); </p> </li> <li> <p>Web of Science (1945 to 10 August 2017) (<a href="./appendices#CD003220-sec-0384">Appendix 5</a>); and </p> </li> <li> <p>OpenGrey (to 10 August 2017) (<a href="./appendices#CD003220-sec-0385">Appendix 6</a>). </p> </li> </ul> </p> <p>There were no restrictions on the language or date of publication when searching the electronic databases. We identified and translated references in German, Serbian, Spanish, Japanese, Chinese, Danish, Italian, Arabic and Iranian. </p> <p>Subject strategies were modelled on the search strategy designed for MEDLINE Ovid. Where appropriate, they were combined with subject strategy adaptations of the highly sensitive search strategy designed by Cochrane for identifying RCTs and controlled clinical trials as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 6 (<a href="./references#CD003220-bbs2-0171" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration. ">Lefebvre 2011</a>). </p> </section> <section id="CD003220-sec-0046"> <h4 class="title">Searching other resources</h4> <section id="CD003220-sec-0047"> <h5 class="title">Handsearching and identification of unpublished studies</h5> <p>The following databases were searched for ongoing trials, <i>see</i><a href="./appendices#CD003220-sec-0386">Appendix 7</a> for the search strategy: </p> <p> <ul id="CD003220-list-0003"> <li> <p>US National Institutes of Health Ongoing Trials Register (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 10 August 2017); and </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>; searched 10 August 2017). </p> </li> </ul> </p> <p>We handsearched the following journals:</p> <p> <ul id="CD003220-list-0004"> <li> <p><i>Pediatric Dentistry</i> (1995 to 2001); </p> </li> <li> <p><i>European Journal of Paediatric Dentistry</i> (2000 to 2002); </p> </li> <li> <p><i>Journal of Clinical Pediatric Dentistry</i> (1996 to 2002); </p> </li> <li> <p><i>Journal of Endodontics</i> (1996 to 2002); and </p> </li> <li> <p><i>International Journal of Paediatric Dentistry</i> (1991 to 2002). </p> </li> </ul> </p> </section> <section id="CD003220-sec-0048"> <h5 class="title">Reference searching</h5> <p>We checked the references of all eligible trials for relevant studies. We scanned reference lists from review articles identified in the searches for further studies and consulted reference lists from paediatric dentistry textbooks. </p> <p>We contacted experts in the field to help identify unpublished literature.</p> </section> </section> </section> <section id="CD003220-sec-0049"> <h3 class="title" id="CD003220-sec-0049">Data collection and analysis</h3> <section id="CD003220-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently scanned the titles of all records identified by the search to determine whether the studies were relevant. We resolved disagreements by discussion. Two review authors independently scanned selected abstracts to determine whether the study was relevant. If necessary, we obtained the full article. We resolved disagreements by discussion. We obtained the full report for all relevant articles. Two review authors independently scanned the full reports and completed the data extraction form to determine whether the article should be included or excluded. Disagreements were resolved by discussion. Finally, we included studies after checking for multiple publications of a given study (<a href="./references#CD003220-sec-0402" title="">Characteristics of included studies</a>). We recorded excluded studies, with reasons for exclusion (<a href="./references#CD003220-sec-0403" title="">Characteristics of excluded studies</a>). </p> </section> <section id="CD003220-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently collected data using a specially designed data extraction form. Two review authors had pilot‐tested the data extraction form with 10 articles and modified it as required before use. We extracted data presented in graphs and figures whenever possible but included data only if both review authors independently had the same result or the authors could provide clarification of data. We resolved disagreements by discussion. We attempted to contact all study authors for clarification or missing information. We excluded data until further clarification was available, if we could not reach agreement. For each trial, we recorded the following data: year of publication and country of origin, inclusion/exclusion criteria specified, detailed description of interventions, sample size, mean age of participants, duration of follow‐up and outcome data. We tabulated all outcomes as reported in trials at six, 12, and 24 months. </p> </section> <section id="CD003220-sec-0052"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently graded all relevant articles in duplicate. This process followed the domain‐based evaluation described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> 5.1.0 (updated March 2011) (<a href="./references#CD003220-bbs2-0167" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org. ">Higgins 2011</a>). The two review authors compared evaluations and resolved any disagreements by discussion. The two review authors assessed the following domains in terms of 'low', 'unclear' or 'high' risk of bias: generation of sequence allocation, allocation concealment, blinding of participants and personnel, blinding of clinical outcome assessors, blinding of radiological outcome assessors and complete outcome data (both intention‐to‐treat and missing data). We tried to assess selective outcome reporting by looking for the trials in the clinicaltrials.gov register and comparing the 'Methods' and 'Results' sections of the publication. </p> <p>Assessment of overall risk of bias considered the importance of different domains and studies and was classified as follows: low risk of bias (plausible bias unlikely to seriously alter the results) if all criteria were met; unclear risk of bias (plausible bias that raises some doubt about the results) if one or more criteria were assessed as unclear; or high risk of bias (plausible bias that seriously weakens confidence in the results) if one or more criteria were not met. </p> </section> <section id="CD003220-sec-0053"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes, we expressed the estimate of treatment effect as risk ratios together with 95% confidence intervals (CIs). </p> <p>For continuous outcomes (such as mean participant satisfaction scores), where studies used the same scale to measure the outcome, we used the mean difference with 95% CIs. Where different scales were used, we expressed the treatment effect as a standardised mean difference and 95% CI. </p> </section> <section id="CD003220-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the tooth, because teeth were randomly assigned to interventions. Some trials had a split‐mouth design, whereby one tooth was randomly allocated to the experimental treatment and another tooth in the same child was allocated to the control treatment. Pairing of data needed to be taken into account in the analysis. Split‐mouth trials that ignore the pairing show a unit‐of‐analysis error. Failure to account for correlation is likely to underestimate the precision of the trial (i.e. a CI that is too wide). We reported such errors, but could not re‐analyse data appropriately. </p> </section> <section id="CD003220-sec-0055"> <h4 class="title">Dealing with missing data</h4> <p>To allow for an intention‐to‐treat analysis, we imputed missing outcome data as treatment success. </p> </section> <section id="CD003220-sec-0056"> <h4 class="title">Assessment of heterogeneity</h4> <p>To investigate statistical heterogeneity, we examined forest plots, as well as Cochran's homogeneity tests, I² co‐efficients and between‐trial variances. We used the I² statistic with an approximate guide for interpretation as follows: 0% to 40% might not be important; 30% to 60% may represent moderate heterogeneity; 50% to 90% may represent substantial heterogeneity; 75% to 100% represents considerable heterogeneity. </p> </section> <section id="CD003220-sec-0057"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not assess within‐study selective outcome reporting because we did not have access to study protocols. We planned to assess a possible between‐study reporting bias by producing a funnel plot of effect estimates against their standard errors if at least 10 trials were included in a meta‐analysis. If asymmetry of the funnel plot was found by inspection and confirmed by statistical tests, possible explanations were planned to be taken into account in the interpretation of the overall estimate of treatment effects. </p> </section> <section id="CD003220-sec-0058"> <h4 class="title">Data synthesis</h4> <p>When two or more similar outcomes were reported in the same trial (e.g. spontaneous pain and pain on palpation), we considered only the most frequently reported outcome across all trials included in the meta‐analysis (<a href="./appendices#CD003220-sec-0387">Appendix 8</a>). In addition, the different types of mineral trioxide aggregate (MTA) (unspecified MTA, grey MTA and white MTA) were combined, and if a trial compared two types of MTA, we included data for both arms. </p> <p>We synthesised trials comparing different medicaments for the same pulp treatment technique (pulpotomy versus pulpotomy; pulpectomy versus pulpectomy; direct pulp capping versus direct pulp capping). The decision about whether to combine the results of individual studies depended on the assessment of heterogeneity. Combined estimates and associated 95% CIs were calculated by Mantel‐Haenszel fixed‐effect or random‐effects methods. In all cases, we considered the results from both fixed‐effect and random‐effects models. For random‐effects models, the estimate of the heterogeneity parameter is likely to be unreliable when the meta‐analysis is based on a small number of studies. Hence, when results from the trials were consistent, we preferred fixed‐effect analysis (<a href="./references#CD003220-bbs2-0189" title="WhiteheadA . Meta‐Analysis of Controlled Clinical Trials. Chichester: Wiley, 2002. ">Whitehead 2002</a>). All P values were two‐sided and P value &lt; 0.05 was deemed significant. </p> </section> <section id="CD003220-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where possible, subgroup analyses were to be undertaken to compare: results for teeth that were symptomatic versus symptom free preoperatively; effect of participant age at treatment, e.g. up to seven years and seven to 10 years; comparison of different types of final filling materials; and site of treatment ‐ primary versus secondary care sectors. </p> </section> <section id="CD003220-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were to be undertaken as follows:</p> <p> <ol id="CD003220-list-0005"> <li> <p>excluding unpublished studies;</p> </li> <li> <p>excluding studies of the lowest quality; and</p> </li> <li> <p>excluding one or more large studies (if found) to assess how much they dominated the result. </p> </li> </ol> </p> <section id="CD003220-sec-0061"> <h5 class="title">Summarising findings and assessing the quality of the evidence</h5> <p>We created three 'Summary of findings' tables (one each for pulpotomy, pulpectomy and direct pulp capping) to present effect estimates for our main comparisons and primary outcomes. We also presented our assessment of the quality of the evidence, which we assessed as high, moderate, low or very low, according to GRADE critieria (<a href="./references#CD003220-bbs2-0183" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003220-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003220-sec-0062"></div> <section id="CD003220-sec-0063"> <h3 class="title">Description of studies</h3> <section id="CD003220-sec-0064"> <h4 class="title">Results of the search</h4> <p>We provide summary details in the <a href="./references#CD003220-sec-0402" title="">Characteristics of included studies</a>, <a href="./references#CD003220-sec-0403" title="">Characteristics of excluded studies</a> and <a href="./references#CD003220-sec-0404" title="">Characteristics of ongoing studies</a> tables<i>.</i> </p> <p>Searches from all sources identified 3330 references, 1709 of which remained after removing duplicates. After scanning the titles and abstracts (when available), we obtained the full reports of 157 records that looked potentially eligible and performed data extraction. After communication or attempted communication with 30 authors, and partial or complete translation of 20 papers, we listed 55 as excluded studies, with reasons for exclusion. We classified 14 registered trials as ongoing studies (see <a href="./references#CD003220-sec-0404" title="">Characteristics of ongoing studies</a>), none of which had reported results. </p> <p>In total, 87 trials (91 references) satisfied the eligibility criteria and were included in the review (<a href="#CD003220-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD003220-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD003220-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>The 87 trials involved 7140 randomised teeth. Seventeen studies (20%) were split‐mouth design (without description of appropriate analysis); the remaining 70 studies (80%) were parallel‐arm design. </p> </section> <section id="CD003220-sec-0065"> <h4 class="title">Included studies</h4> <section id="CD003220-sec-0066"> <h5 class="title">Year of publication, setting and operators</h5> <p>The earliest trial was published in 1989 (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>), 34 trials (39%) were published between 2005 and 2012, and 38 trials (44%) were published between 2013 and 2017. </p> <p>All included studies were single‐centre trials conducted primarily in paediatric dentistry departments of universities. Treatment settings and operators varied. </p> <p> <ul id="CD003220-list-0006"> <li> <p>20 (23%) trials were conducted in India (<a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>; <a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>; <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0055" title="NaikS , HegdeAH . Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2005;23(1):13‐6. [PUBMED: 15858300] ">Naik 2005</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>; <a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>; <a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>; <a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>; <a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>16 (18%) in Turkey (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>; <a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>; <a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>; <a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>; <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>; <a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>; <a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>; <a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>12 (14%) in Iran (<a href="./references#CD003220-bbs2-0001" title="AeinehchiM , DadvandS , FayaziS , Bayat‐MovahedS . Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal2007; Vol. 40, issue 4:261‐7. ">Aeinehchi 2007</a>; <a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>; <a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>; <a href="./references#CD003220-bbs2-0009" title="AnsariG , RanjpourM . Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2‐year follow‐up. International Endodontic Journal2010;43(5):413‐8. [PUBMED: 20518934] ">Ansari 2010</a>; <a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>; <a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0039" title="HaghgooR , MollaAsadollaF , AbbasiF . Evaluation of clinical and radiographic success rates of root MTA and formocresol in pulpotomy of primary molars. Journal of Dental Medicine2009;22(2):136‐41. ">Haghgoo 2009</a>; <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>; <a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0059" title="NoorollahianH . Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British Dental Journal2008; Vol. 204, issue 11:E20. ">Noorollahian 2008</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>); </p> </li> <li> <p>six (7%) in the USA (<a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>; <a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>; <a href="./references#CD003220-bbs2-0086" title="ZealandCM , BriskieDM , BoteroTM , BoyntonJR , HuJC . Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry2010;32(5):393‐9. [PUBMED: 21070705] ">Zealand 2010</a>; <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>); </p> </li> <li> <p>six (7%) in Brazil (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>; <a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>; <a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>); </p> </li> <li> <p>four (5%) in Canada (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>; <a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>); </p> </li> <li> <p>three (3%) in Israel (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>); </p> </li> <li> <p>two in Egypt (<a href="./references#CD003220-bbs2-0002" title="AgamyHA , BakryNS , MounirMM , AveryDR . Comparison of mineral trioxide aggregate and formocresol as pulp‐capping agents in pulpotomized primary teeth. Pediatric Dentistry2004; Vol. 26, issue 4:302‐9. ">Agamy 2004</a>; <a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>); </p> </li> <li> <p>three in Saudi Arabia (<a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>; <a href="./references#CD003220-bbs2-0028" title="FarsiN , AlamoudiN , BaltoK , MushaytA . Success of mineral trioxide aggregate in pulpotomized primary molars. Journal of Clinical Pediatric Dentistry2005;29(4):307‐11. ">Farsi 2005</a>; <a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>); </p> </li> <li> <p>two in Thailand (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>); </p> </li> <li> <p>two in Spain (<a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>); </p> </li> <li> <p>two in China (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>); and </p> </li> <li> <p>one each in Germany (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>), Kuwait (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>), Mexico (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>), Serbia and Montenegro (<a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>), Korea (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>), Nigeria (<a href="./references#CD003220-bbs2-0060" title="OlatosiOO , SoteEO , OrenugaOO . Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. Nigerian Journal of Clinical Practice2015;18(2):292‐6. ">Olatosi 2015</a>), Syria (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>) Belgium (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>), and the UK (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). </p> </li> </ul> </p> <p>The study setting was not mentioned in 19 (22%) trials.</p> <p>Operators were dentists in 38 (43%) trials, undergraduate dental students supervised by senior staff members of clinics in one trial (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>), postgraduate dental students supervised by one or two investigators in two trials (<a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>), and professor, doctoral graduate, doctoral student, master graduate and master student in one trial (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). Operators were not mentioned in 44 (50%) trials. </p> </section> <section id="CD003220-sec-0067"> <h5 class="title">Participants</h5> <p>The weighted mean age of children in the 87 included studies was 6.3 years. Age‐related inclusion criteria varied among studies; children's ages ranged from two years to 13 years. </p> <p>All included studies were small; the median number of enrolled children in each trial was 45.5 (interquartile range (IQR) 27 to 71; minimum to maximum 15 to 155). The median number of treated teeth for each trial was 70 (IQR 50 to 100; minimum to maximum 20 to 291). </p> </section> <section id="CD003220-sec-0068"> <h5 class="title">Interventions</h5> <section id="CD003220-sec-0069"> <h6 class="title">Number of arms</h6> <p>Overall, 17 (20%) were split‐mouth studies, 38 (44%) trials were two‐arm studies, 21 (24%) were three‐arm studies, 10 (11%) were four‐arm studies, and one trial described a five‐arm study (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). </p> </section> <section id="CD003220-sec-0070"> <h6 class="title">Treatments and medicaments</h6> <p>The 87 trials described 125 different combinations of pulp treatment (pulpotomy, pulpectomy or direct pulp capping) and medicament. </p> <section id="CD003220-sec-0071"> <p><b>Pulpotomy</b></p> <p>In total, 53 trials (61%) compared different medicaments/techniques for pulpotomy (75 comparisons): </p> <p> <ul id="CD003220-list-0007"> <li> <p>Mineral trioxide aggregate (MTA) compared with formocresol in 19 trials (23%)</p> <ul id="CD003220-list-0008"> <li> <p>full strength formocresol (<a href="./references#CD003220-bbs2-0001" title="AeinehchiM , DadvandS , FayaziS , Bayat‐MovahedS . Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal2007; Vol. 40, issue 4:261‐7. ">Aeinehchi 2007</a>; <a href="./references#CD003220-bbs2-0002" title="AgamyHA , BakryNS , MounirMM , AveryDR . Comparison of mineral trioxide aggregate and formocresol as pulp‐capping agents in pulpotomized primary teeth. Pediatric Dentistry2004; Vol. 26, issue 4:302‐9. ">Agamy 2004</a>; <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>; <a href="./references#CD003220-bbs2-0028" title="FarsiN , AlamoudiN , BaltoK , MushaytA . Success of mineral trioxide aggregate in pulpotomized primary molars. Journal of Clinical Pediatric Dentistry2005;29(4):307‐11. ">Farsi 2005</a>; <a href="./references#CD003220-bbs2-0039" title="HaghgooR , MollaAsadollaF , AbbasiF . Evaluation of clinical and radiographic success rates of root MTA and formocresol in pulpotomy of primary molars. Journal of Dental Medicine2009;22(2):136‐41. ">Haghgoo 2009</a>; <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>; <a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>) </p> </li> <li> <p>1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0009" title="AnsariG , RanjpourM . Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2‐year follow‐up. International Endodontic Journal2010;43(5):413‐8. [PUBMED: 20518934] ">Ansari 2010</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0055" title="NaikS , HegdeAH . Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2005;23(1):13‐6. [PUBMED: 15858300] ">Naik 2005</a>; <a href="./references#CD003220-bbs2-0059" title="NoorollahianH . Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British Dental Journal2008; Vol. 204, issue 11:E20. ">Noorollahian 2008</a>; <a href="./references#CD003220-bbs2-0060" title="OlatosiOO , SoteEO , OrenugaOO . Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. Nigerian Journal of Clinical Practice2015;18(2):292‐6. ">Olatosi 2015</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a>; <a href="./references#CD003220-bbs2-0086" title="ZealandCM , BriskieDM , BoteroTM , BoyntonJR , HuJC . Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry2010;32(5):393‐9. [PUBMED: 21070705] ">Zealand 2010</a>). </p> </li> </ul> </li> <li> <p>MTA compared with calcium hydroxide in six trials (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>; <a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); </p> </li> <li> <p>MTA compared with ferric sulphate with or without eugenol, in five trials (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>) (two comparisons); </p> </li> <li> <p>MTA compared with ferric sulphate + MTA (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>); </p> </li> <li> <p>MTA compared with Portland cement in three trials (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>MTA compared with calcium‐enriched mixture (CEM) (<a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>); </p> </li> <li> <p>MTA compared with sodium hypochlorite (NaOCl) (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>); </p> </li> <li> <p>MTA compared with calcium hydroxide + NaOCl (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>); </p> </li> <li> <p>MTA + NaOCl versus calcium hydroxide + NaOCl (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>); </p> </li> <li> <p>MTA compared with buffered glutaraldehyde (<a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>); </p> </li> <li> <p>MTA compared with zinc oxide eugenol (ZOE) (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>); </p> </li> <li> <p>MTA compared with diode laser (<a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>); </p> </li> <li> <p>MTA + diode laser versus formocresol + ZOE (<a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>); </p> </li> <li> <p>MTA compared with low‐level laser therapy (LLLT) (<a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a>); </p> </li> <li> <p>MTA compared with enamel matrix derivative (EMD) (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>MTA compared with Biodentine in four trials (<a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>); </p> </li> <li> <p>MTA compared with propolis (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>); </p> </li> <li> <p>MTA compared with aloe vera (<i>Aloe barbadensis</i> Mill, family <i>Liliaceae</i>) (<a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>); </p> </li> <li> <p>MTA compared with Tempophore (iodoform‐based paste) (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>); </p> </li> <li> <p>Comparisons between different types of MTA:</p> <ul id="CD003220-list-0009"> <li> <p>white MTA compared with grey MTA (<a href="./references#CD003220-bbs2-0002" title="AgamyHA , BakryNS , MounirMM , AveryDR . Comparison of mineral trioxide aggregate and formocresol as pulp‐capping agents in pulpotomized primary teeth. Pediatric Dentistry2004; Vol. 26, issue 4:302‐9. ">Agamy 2004</a>); </p> </li> <li> <p>MTA versus MTA + NaOCl (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>); </p> </li> <li> <p>ProRoot MTA compared with OrthoMTA (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>); </p> </li> <li> <p>ProRoot MTA compared with RetroMTA (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>); </p> </li> <li> <p>OrthoMTA compared with RetroMTA (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>). </p> </li> </ul> </li> <li> <p>calcium hydroxide compared with formocresol in eight trials (9%):</p> <ul id="CD003220-list-0010"> <li> <p>full strength formocresol (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>); </p> </li> <li> <p>1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>; <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). </p> </li> </ul> </li> <li> <p>calcium hydroxide compared with ferric sulphate in three trials (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); </p> </li> <li> <p>calcium hydroxide compared with Portland cement (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>); </p> </li> <li> <p>calcium hydroxide compared with MTA + NaOCl (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>); </p> </li> <li> <p>calcium hydroxide compared with Er:YAG laser (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>); </p> </li> <li> <p>calcium hydroxide compared with calcium hydroxide/iodoform (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>); </p> </li> <li> <p>calcium hydroxide compared with low‐level laser therapy (LLLT) (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>); </p> </li> <li> <p>calcium hydroxide compared with LLLT + calcium hydroxide (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>); </p> </li> <li> <p>calcium hydroxide + LLLT compared with LLLT (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>); </p> </li> <li> <p>calcium hydroxide compared with calcium hydroxide + NaOCl (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>); </p> </li> <li> <p>calcium hydroxide compared with Biodentine (<a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>). </p> </li> <li> <p>ferric sulphate compared with formocresol in 10 trials (11%):</p> <ul id="CD003220-list-0011"> <li> <p>full strength formocresol (<a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>); </p> </li> <li> <p>1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>). </p> </li> </ul> </li> <li> <p>ferric sulphate compared with NaOCl in two trials (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>); </p> </li> <li> <p>ferric sulphate compared with buffered glutaraldehyde (<a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>); </p> </li> <li> <p>ferric sulphate versus ZOE (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>); </p> </li> <li> <p>ferric sulphate compared with Er:YAG laser (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>); </p> </li> <li> <p>ferric sulphate compared with diode laser in three trials (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>ferric sulphate compared with electrosurgery in two trials (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>ferric sulphate/MTA compared with ferric sulphate (with or without eugenol) (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>) (two comparisons); </p> </li> <li> <p>ferric sulphate compared with Ankaferd Blood Stopper in two trials (<a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>): </p> <ul id="CD003220-list-0012"> <li> <p>full strength formocresol (<a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>); </p> </li> <li> <p>1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>). </p> </li> </ul> </li> <li> <p>Portland cement compared with full strength formocresol (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>Portland cement compared with EMD (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>Portland cement compared with Portland cement + radio‐opacifying agents (iodoform (CHI₃ or zirconium oxide (ZrO₂)) (<a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>) (two comparisons); </p> </li> <li> <p>Glutaraldehyde + calcium hydroxide compared with full strength formocresol (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>); </p> </li> <li> <p>Glutaraldehyde + ZOE compared with full strength formocresol (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>); </p> </li> <li> <p>Glutaraldehyde + calcium hydroxide compared with glutaraldehyde + ZOE in two trials (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>; <a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>); </p> </li> <li> <p>Electrofulguration + calcium hydroxide compared with electrofulguration + ZOE (<a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>). </p> </li> <li> <p>Electrosurgery compared with formocresol in two trials:</p> <ul id="CD003220-list-0013"> <li> <p>full strength formocresol (<a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>); </p> </li> <li> <p>1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>). </p> </li> </ul> </li> <li> <p>Electrosurgery compared with diode laser in two trials (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>Electrosurgery compared with CEM (<a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>); </p> </li> <li> <p>Biodentine compared with formocresol (<a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>) </p> </li> <li> <p>Biodentine compared with diode laser (<a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>); </p> </li> <li> <p>Biodentine compared with Tempophore (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>); </p> </li> <li> <p>Biodentine compared with propolis (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>). </p> </li> <li> <p>1:5 diluted formocresol compared with NaOCl in two trials (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>); </p> </li> <li> <p>Full strength formocresol compared with calcium hydroxide/iodoform (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with ZOE (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with Er:YAG laser (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with diode laser (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with LLLT (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with LLLT + calcium hydroxide (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with Ankaferd Blood Stopper (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>); </p> </li> <li> <p>formocresol compared with EMD in two trials:</p> <ul id="CD003220-list-0014"> <li> <p>full strength formocresol (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>); </p> </li> </ul> </li> <li> <p>Full strength formocresol compared with 1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>); </p> </li> <li> <p>Full strength formocresol compared with 1:25 diluted formocresol (<a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>); </p> </li> <li> <p>1:5 diluted formocresol compared with 1:25 diluted formocresol (<a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>). </p> </li> </ul> </p> </section> <section id="CD003220-sec-0072"> <p><b>Pulpectomy</b></p> <p>In total, 15 trials (17%) compared different medicaments for pulpectomy (25 comparisons):</p> <p> <ul id="CD003220-list-0015"> <li> <p>calcium hydroxide compared with ZOE in two trials (<a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>calcium hydroxide compared with Sealapex (composition: isobutyl salicylate resin, SiO₂, BiO₃, TiO₂, N‐ethyl toluene sulfenamide resin, ZnO, CaO, eugenol‐free calcium hydroxide) (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>calcium hydroxide compared with Vitapex (calcium hydroxide/ 50% iodoform) (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>Metapex (composition: calcium hydroxide &lt; 36 w/w%, iodoform 30 to 37w/w%, polydimethylsiloxane &lt; 26 w/w%) compared with ZOE in two trials (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>); </p> </li> <li> <p>Metapex compared with ZOE + calcium hydroxide with iodoform (Endoflas) in two trials (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>); </p> </li> <li> <p>Metapex compared with ZOE with iodoform (RC Fill) (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>); </p> </li> <li> <p>Metapex compared with endoflas‐chlorophenol‐free (Endoflas‐CF) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>); </p> </li> <li> <p>Metapex compared with zinc oxide and propolis (ZOP) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>); </p> </li> <li> <p>Sealapex compared with ZOE (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>Sealapex compared with Vitapex (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>Vitapex compared with ZOE in five trials (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>); </p> </li> <li> <p>Vitapex compared with 3Mix (ciprofloxacin + metronidazole + minocycline) (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>); </p> </li> <li> <p>Vitapex compared with RC Fill (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>); </p> </li> <li> <p>Vitapex compared with a mixture of ZOE + calcium hydroxide + iodoform (unnamed product) (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>); </p> </li> <li> <p>Endoflas compared with ZOE in two trials (<a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>); </p> </li> <li> <p>Endoflas compared with RC Fill (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>); </p> </li> <li> <p>Endoflas‐CF compared with ZOE (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>); </p> </li> <li> <p>Endoflas‐CF compared with ZOP (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>); </p> </li> <li> <p>ZOE compared with ozonated sesame oil‐ZO (<a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>); </p> </li> <li> <p>ZOE compared with RC Fill (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>); </p> </li> <li> <p>ZOE compared with ZOP (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>); </p> </li> <li> <p>ZOE compared with ZOE + calcium hydroxide + iodoform (unnamed product) (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>); </p> </li> <li> <p>ciprofloxacin + metronidazole + minocycline (3Mix) compared with ciprofloxacin + ornidazole + minocycline (<a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>); </p> </li> <li> <p>MTA compared with intermediate restorative material (IRM) (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>); </p> </li> <li> <p>MTA compared with gutta‐percha/AH‐Plus (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>). </p> </li> </ul> </p> </section> <section id="CD003220-sec-0073"> <p><b>Both pulpotomy and pulpectomy</b></p> <p>Four trials compared pulpotomy and pulpectomy with different medicaments (four comparisons):</p> <p> <ul id="CD003220-list-0016"> <li> <p>full strength formocresol pulpotomy compared with calcium hydroxide pulpectomy (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>). </p> </li> <li> <p>ferric sulphate/ZOE pulpotomy compared with ZOE pulpectomy (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>); </p> </li> <li> <p>ferric sulphate/MTA pulpotomy compared with ZOE (Sedanol) pulpectomy (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>). </p> </li> <li> <p>3Mix (ciprofloxacin + metronidazole + minocycline) pulpotomy compared with 3Mix pulpectomy (<a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a>). </p> </li> </ul> </p> </section> <section id="CD003220-sec-0074"> <p><b>Direct pulp capping</b></p> <p>Seven trials (8%) compared different medicaments for direct pulp capping (21 comparisons):</p> <p> <ul id="CD003220-list-0017"> <li> <p>calcium hydroxide compared with formocresol (<a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>); </p> </li> <li> <p>calcium hydroxide compared with acetone‐based total‐etch adhesive (with or without non‐rinse conditioner or total etching with 36% phosphoric acid) (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>, four comparisons); </p> </li> <li> <p>calcium hydroxide compared with EMD (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>); </p> </li> <li> <p>calcium hydroxide compared with MTA (<a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>); </p> </li> <li> <p>Acetone‐based total‐etch adhesive compared with acetone‐based total‐etch adhesive + non‐rinse conditioner or total‐etching with 36% phosphoric acid or self etch adhesive system (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>) (3 comparisons); </p> </li> <li> <p>Non‐rinse conditioner + acetone‐based total‐etch adhesive compared with acetone‐based total‐etch adhesive + total‐etching with 36% phosphoric acid or self‐etch adhesive system (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>, two comparisons); </p> </li> <li> <p>Self etch adhesive system + acetone‐based total‐etch adhesive versus total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>); </p> </li> <li> <p>MTA compared with CEM (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>); </p> </li> <li> <p>MTA compared with 3Mix (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>MTA compared with 3Mixtatin (a combination of simvastatin and 3Mix antibiotic) (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>MTA compared with simvastatin (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>3Mix compared with 3Mixtatin (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>3Mix compared with simvastatin (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>3Mixtatin compared with simvastatin (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>calcium hydroxide cement (Dycal) compared with a bone graft calcium sulphate hemihydrate material (DentoGen) (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>). </p> </li> </ul> </p> </section> </section> <section id="CD003220-sec-0075"> <h6 class="title">Duration of follow‐up</h6> <p>The duration of follow‐up was fixed in 78 (90%) trials. Data were assessed at six months in 70 (80%) trials, at 12 months in 59 (68%) trials and at 24 months in 24 (28%) trials. </p> </section> <section id="CD003220-sec-0076"> <h6 class="title">Rubber dam</h6> <p>In 67 trials (77%), treatments were completed with rubber dam isolation. In four trials, either rubber dam or cotton rolls were used (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>; <a href="./references#CD003220-bbs2-0086" title="ZealandCM , BriskieDM , BoteroTM , BoyntonJR , HuJC . Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry2010;32(5):393‐9. [PUBMED: 21070705] ">Zealand 2010</a>; <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>); in four trials, cotton rolls were used (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>; <a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); and in 12 trials there was insufficient information to determine if a rubber dam or cotton rolls were used (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>; <a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>; <a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>; <a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>; <a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0055" title="NaikS , HegdeAH . Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2005;23(1):13‐6. [PUBMED: 15858300] ">Naik 2005</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>). </p> </section> <section id="CD003220-sec-0077"> <h6 class="title">Pulp access</h6> <p>Caries were removed prior to pulpal access in 68 (78%) trials. Pulp was accessed with a high‐speed bur in 37 (43%) trials, a slow‐speed bur in six trials (<a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>; <a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>), a high‐speed followed by a slow‐speed bur in six trials (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>; <a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>), a combination of slow‐speed bur and excavator in one trial (<a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>), a combination of high‐speed bur and round carbide bur in three trials (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>; <a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>), a high‐speed followed by a combination of slow‐speed bur and round carbide bur in one trial (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>), a number 557 round bur in one trial (<a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>), or a handpiece with a round bur (with no precision) followed by a high speed and round carbide bur in one trial (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>). </p> <p>Removal of coronal pulp involved an excavator in 35 (40%) trials, a combination of slow‐speed bur and excavator in 11 (13%) trials, a slow‐speed bur in 11 (13%) trials, a high‐speed bur in two trials (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>), a high speed bur followed by excavator in one trial (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>), round burs numbers ½ and ¼ or excavator in one trial (<a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>), or a number 6 carbide round bur in one trial (<a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>). </p> <p>In the case of pulpectomy, complete extirpation of the pulp involved barbed broaches, K files or H files. </p> </section> <section id="CD003220-sec-0078"> <h6 class="title">Haemostasis</h6> <p>Before application of the pulpotomy or direct pulp capping medicament, haemostasis of the pulp stumps was achieved with either dry or moistened (water or saline) cotton wool pellets in 53 trials (61%). </p> <p>In two trials, haemostasis of the pulp stumps was achieved with techniques that differed according to the group: in <a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>, haemostasis was obtained with dry cotton wool pellets in the pulpotomy group and with moistened cotton pellets with saline in the pulpectomy group; whereas, in <a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>, haemostasis was obtained with saline/water flush in the three ferric sulphate arms and with dry cotton pellets in the MTA arm. </p> <p>In five trials, haemostasis was obtained using other techniques: a sterile cotton pellet soaked in 1.25% sodium hypochlorite solution and placed over the exposure site for 62 seconds without pressure (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>), a damp sterile cotton pellet (<a href="./references#CD003220-bbs2-0028" title="FarsiN , AlamoudiN , BaltoK , MushaytA . Success of mineral trioxide aggregate in pulpotomized primary molars. Journal of Clinical Pediatric Dentistry2005;29(4):307‐11. ">Farsi 2005</a>), a dry sterile cotton pellet and electrofulguration (<a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>), a cotton pellet moistened with 10% sodium hypochlorite maintained for one minute in one group (no haemostasis in the other group, <a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>), a cotton pellet moistened with 3% hydrogen peroxide (<a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>), or diode laser (810 nm with the pulsed contact mode of application for two seconds delivered by optical fibre tip and 1.5 W power) (<a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>). The other trials involved no haemostasis technique or no details about haemostasis. </p> </section> <section id="CD003220-sec-0079"> <h6 class="title">Irrigation</h6> <p>Irrigation was performed in 48 (55%) trials (in one group only in three trials (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>; <a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>). Irrigants used were: </p> <p> <ul id="CD003220-list-0018"> <li> <p>saline in 33 (38%) trials;</p> </li> <li> <p>0.9% saline solution (<a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>); </p> </li> <li> <p>0.5% saline (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>); </p> </li> <li> <p>5.25% sodium hypochlorite and distilled water (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>); </p> </li> <li> <p>2.5% sodium hypochlorite in three trials (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>; <a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>); </p> </li> <li> <p>2.5% sodium hypochlorite and saline in four trials (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>; <a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>); </p> </li> <li> <p>1% sodium hypochlorite and saline or water in three trials (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>; <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>); </p> </li> <li> <p>5% sodium hypochlorite followed by a 0.5% metronidazole solution (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>a mixture of 2.25% sodium hypochlorite (1.5 mL) and 0.12% chlorhexidine gluconate (1.5 mL) (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>); </p> </li> <li> <p>alternating irrigations of sterile saline and a chlorhexidine solution (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>); </p> </li> <li> <p>saline and finally with 2% chlorhexidine (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>); </p> </li> <li> <p>3% hydrogen peroxide and sterile saline (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>); and </p> </li> <li> <p>water in three trials (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). </p> </li> </ul> </p> </section> <section id="CD003220-sec-0080"> <h6 class="title">Number of visits</h6> <p>Only one intervention session for both groups was necessary for 62 (71%) trials. In six trials (7%), the number of visits was one in one treatment group and two (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>; <a href="./references#CD003220-bbs2-0009" title="AnsariG , RanjpourM . Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2‐year follow‐up. International Endodontic Journal2010;43(5):413‐8. [PUBMED: 20518934] ">Ansari 2010</a>; <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>; <a href="./references#CD003220-bbs2-0059" title="NoorollahianH . Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British Dental Journal2008; Vol. 204, issue 11:E20. ">Noorollahian 2008</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>) or one or two (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>) in the other groups. </p> <p>The number of visits was:</p> <p> <ul id="CD003220-list-0019"> <li> <p>one or two in both groups in two trials (<a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>two in 12 (14%) trials (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>; <a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>; <a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>; <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0055" title="NaikS , HegdeAH . Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2005;23(1):13‐6. [PUBMED: 15858300] ">Naik 2005</a>; <a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>; <a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>); </p> </li> <li> <p>three in two trials (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>; <a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>); and </p> </li> <li> <p>four in one trial (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>). </p> </li> </ul> </p> </section> <section id="CD003220-sec-0081"> <h6 class="title">Description of medicaments used</h6> <section id="CD003220-sec-0082"> <p><b>Pulpotomy</b></p> <p>The formocresol technique used in 31 trials (36%) involved application of a cotton wool pellet soaked with formocresol on the pulp stumps for five minutes after pulpotomy. <a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a> and <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a> involved applying the cotton wool pellet soaked with formocresol on the pulp stumps for three to four minutes, and <a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a> and <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a> involved applying a cotton wool pellet soaked with formocresol on the pulp stumps for one minute after pulpotomy. </p> <p>The MTA technique used after pulpotomy involved a 3:1 powder:saline ratio in 21 trials (24%), followed by placement of moistened cotton pellet over MTA for 15 minutes in one trial (<a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>). The MTA technique used by <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a> after pulpotomy involved a 1:1 powder:saline ratio. <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a> or <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a> did not define the powder:saline ratio involved (they tried to obtain a "homogeneous paste" or a "thick paste"). </p> <p>The calcium hydroxide technique used by <a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a> involved application of calcium hydroxide powder mixed with sterile water in a 3:1 ratio to produce a homogeneous paste. The calcium hydroxide technique used by <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a> involved application of calcium hydroxide paste with the help of disposable tip topped by light cured calcium hydroxide. </p> <p>The ferric sulphate technique used by <a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a> and <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a> involved application of a 16% or 15.5% aqueous ferric sulphate solution on the pulp stumps for 10 to 15 seconds after pulpotomy, followed by a water flush in the pulp chamber (with an air‐water syringe). The ferric sulphate technique used in nine (10%) trials involved application of 15.5% aqueous ferric sulphate or eugenol‐free ferric sulphate for 15 seconds (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>), or 10 to 15 seconds (<a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>), after pulpotomy. The technique used by <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a> involved application of 15.5% ferric sulphate. The ferric sulphate technique used by <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>, <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a> and <a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a> was described as application of ferric sulphate for 15 seconds after pulpotomy (followed by irrigation of saline in <a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>). The ferric sulphate technique used by <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a> and <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a> involved application of a 15.5% ferric sulphate solution on the pulp stumps for 15 seconds after pulpotomy, followed by irrigation of normal saline. </p> <p>The ferric sulphate‐MTA technique used by <a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a> involved application of a 15.5% aqueous ferric sulphate solution, followed by MTA application for 15 seconds after pulpotomy. </p> <p>The Portland cement technique, with or without CHI₃ or ZrO₂, used by <a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>, involved application of cements prepared using an MTA kit spoon (1 g) of powder as the measure parameter with two drops (0.3 mL) of distilled water and mixed in sterilised glass to obtain a paste consistency; cements were applied with a spatula. The Portland cement technique used by <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a> involved 0.1 g Portland cement (previously sterilised with ethylene oxide and then mixed with sterile water) mixed with sterile saline to produce a homogeneous paste. The Portland cement technique used by <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a> was sterilised with ethylene oxide prior to use, and 0.16 g of the cement was mixed with distilled water until a homogeneous paste was obtained. </p> <p>The 5% NaOCl technique used by <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a> and <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a> involved application of a cotton wool pellet soaked with 5% NaOCl on the pulp stumps for 30 seconds after pulpotomy. The 3% NaOCl technique used by <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a> involved application of a cotton pellet saturated with 3% NaOCI on the pulp stumps for 30 seconds after pulpotomy. </p> <p>The 2% unbuffered glutaraldehyde technique used by <a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a> involved application on the pulp stumps of 2% unbuffered glutaraldehyde for five minutes after pulpotomy, followed by ZOE in one group, and calcium hydroxide in the other group. <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a> used the same technique followed by ZOE. <a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a> used the same technique, except glutaraldehyde was applied for three minutes after pulpotomy, followed by eugenol + intermediate restorative material (IRM) (a reinforced ZOE) in one group and calcium hydroxide in the other group. </p> <p>The CEM technique used by <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a> involved application of a 2 mm layer of CEM cement directly over the radicular pulp (3:1 powder:liquid ratio). </p> <p>The technique used by <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a> involved a diode laser of 810 nm with the pulsed contact mode of application for two seconds delivered by an optical fibre tip with at 1.5 W. The diode laser technique used by <a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a> involved a beam at a wavelength of 810 nm transmitted; the diode laser fibre tip was kept 1 mm to 2 mm away from the tissue; the pulp at canal orifices was treated for 10 seconds with a frequency of 30 Hz, at 50 mJ, and 1.5 W, under air‐cooling operation mode without water. In <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>, the pulp was ablated to the level of the canal orifice using a diode laser at 980 nm wavelength, 3 W power and the continuous pulse mode. The laser energy of 4.0 J/cm² was delivered through a 0.5 mm diameter optical fibre in contact with the pulp tissue for 2 minutes and 31 seconds. If additional ablation was required, subsequent multiple applications were administered. In <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>, the remaining coronal pulp tissue was exposed to laser energy through an optical fibre using a diode laser of 810 nm and 7 W set at a 3 W power in the continuous mode. The laser energy was delivered through a 400 μm diameter optical fibre in a non contact mode but close to the pulp tissue for not more than two to three seconds (PD = 2388.53, Fluence = 7165.60). </p> <p>The erbium:yttrium‐aluminium garnet (Er:YAG) laser technique used by <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a> involved an application of 2 Hz and 180 mJ laser in the pulse mode without water cooling, with a mean number (± standard deviation) of laser pulses for each tooth of 31.5 ± 5.9 equally distributed to each pulp stump. </p> <p>The low‐level laser therapy (LLLT) technique used by <a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a> involved a diode laser wavelength 810 nm, under continuous mode; an energy of 2 J/cm² was applied over the radicular stumps for about 10 seconds. The InGaAlP laser radiation used by <a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a> was delivered through a 320 lm diameter optical fibre in contact with pulp tissue; the parameters were set at 660 nm wavelength, 10 mW power output, 2.5 J/cm² energy density, 50 to 60 Hz frequency, 0.04 cm² focus beam diameter and irradiation time of 10 seconds. The same author used the LLLT (as described before) followed by calcium hydroxide. </p> <p>The electrosurgery technique used by <a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a> and <a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a> involved a maximum of three applications of one second to each pulpal orifice, with cool‐down periods of five seconds (<a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>), or 10 to 15 seconds (<a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>), between applications to limit heat build‐up, at 40% power. In <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>, an electrosurgery electrode tip (unit T4, fine wire; 50 W power; 110 V ± 5% 50/60 Hz 92 VA; work frequency 1.5 ˜ 1.7 MHz ± 5%) was used for the pulpotomy procedure. During the procedure, the electrode tip was positioned slightly above the pulp tissue but close enough for electrical arcing to occur (about 1 mm above the tissue). The current was applied for 1 to 2 seconds over each pulpal stump. This procedure was repeated up to three times on each pulpal orifice, until brown appearance was observed in the tissue. In <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>, the ART‐E1 electrosurgery unit was set to the COAG 1 mode to perform both electrofulguration and electrocoagulation.The handpiece with appropriate electrode tips, kept 1 to 2 mm away from the pulpal tissue, was used to deliver the electric arc. The duration of application was not more than two to three seconds followed by a cool‐down period of five seconds. If necessary, this procedure was repeated up to a maximum of three times. After each current application, a new large moist sterile cotton pellet was placed with pressure on the pulpal tissue near to orifice to absorb any blood or tissue fluids before the next current application (e.g. pellet‐electrode‐pellet‐electrode). When properly completed, the pulpal stumps appeared dry and completely blackened. The electrosurgery/electrofulguration (Hyfrecator) used by <a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a> involved application of the active electrode tip about 1 mm above each pulpal stump tissue for one to two seconds; if additional fulguration was required, 10 seconds elapsed before subsequent current application. In <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>, an electrosurgical ball‐shaped electrode was immediately used for tissue coagulation. The unit was set at 55 W, 3.69 MHz, 600 Ω, and COAG mode. The electrode was placed 1 to 2 mm above the pulp orifices and then electrical arc allowed to bridge for 1 second. This procedure was repeated up to three times on each pulpal orifice with 5 to 10 second cool‐down intervals, until a dark brown appearance was observed in the tissues; then copious irrigation. </p> <p>The enamel matrix derivative (EMD) technique used by <a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a> after pulpotomy involved application of a cotton pellet on the amputated pulpal stump; the tooth was then conditioned with polyacrylic acid gel; the cotton pellet was then removed, and the amputated pulpal stump was covered with protein EMD gel from a 0.3 mL syringe. The technique used by <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a> involved 0.7 mL of EMD injected over the root pulp tissue. </p> <p>The Biodentine technique used by <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a> involved mixing pre‐measured unit dose capsules for 30 seconds at 4200 rpm in a triturator to obtain a putty‐like consistency. It was then carried with an amalgam carrier and condensed lightly with a metal condenser on the pulp stumps, to a thickness of 2 to 3 mm. The Biodentine used by <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a> involved the following procedure: before the capsule was opened, it was tapped gently on a hard surface to diffuse the powder; five drops of liquid from the single‐dose dispenser were poured into the capsule, after which the capsule was placed in a triturator for 30 seconds; the material was then transferred with the aid of the manufacturer‐supplied spatula and placed inside the cavity with the aid of an amalgam carrier or spatula. A plugger or sterile cotton pellet was used to adjust the material against the walls without excessive compression. </p> <p>The propolis technique used by <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a> involved 1.5 g 100% standardised propolis extract powder mixed with 1.75 mL of polyethylene glycol to form a thick consistency on a clean dry glass slab using a metal spatula. The paste was carried to the pulp stumps with a metal carrier and then condensed lightly to a thickness of 2 to 3 mm. </p> <p>The aloe vera technique used by <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a> involved use of a healthy plant of pure aloe vera, approximately four years old, certified by the Indian Agricultural Research Institute, procured at regular intervals throughout the study period. A healthy leaf was selected from the plant and cut from its stem base, cleaned with 70% ethyl alcohol, and stored in distilled water for one hour to eliminate aloin. After one hour, the outer green rind portion was removed using a sterile Bard‐Parker blade, and the blade was introduced inside the inner mucilage layer. The mucilage or the inner clear jelly‑like substance (approximately 10 mm) was removed and washed again. The mucilage was cut in half and placed onto the pulp stumps of the tooth. </p> <p>The Ankaferd Blood Stopper technique used by <a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a> and <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a> involved application of solution to the pulp stumps with a dental syringe for 15 seconds, before the pulp stumps were rinsed with saline solution and pulp chamber dried with sterile cotton pellets. </p> <p>The following techniques after pulpotomy were not described in sufficient detail: formocresol (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>), diode laser with MTA (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>), MTA (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>), ZOE (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>), calcium hydroxide (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>; <a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>; <a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>; <a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>; <a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>; <a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>; <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>), CEM (<a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>), Portland cement (<a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>) and Biodentine (<a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>). </p> </section> <section id="CD003220-sec-0083"> <p><b>Pulpectomy</b></p> <p>The Vitapex paste technique used by <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a> after pulpectomy involved application of an formocresol‐moistened cotton pellet in the pulp chamber after pulpotomy, followed by a ZOE paste (zonalin) temporary restoration at the first visit. Vitapex was applied after pulpectomy during the second visit. The Vitapex technique used by (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>) was available in preformed syringes, the syringe was inserted into the canal near the apex, the paste was extruded into the canal, and the syringe was then slowly withdrawn as it filled the entire canal. </p> <p>For the ZOE technique, <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a> also applied an formocresol‐moistened cotton pellet in the pulp chamber after pulpotomy, followed by a ZOE paste (zonalin) temporary restoration at the first visit; a ZOE paste was applied after pulpectomy during the second visit. The ZOE technique used by <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a> and <a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a> involved application of ZOE with a needle placed 1 or 2 mm short of the radiographic apex. The ZOE technique used by <a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>, <a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a> and <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a> involved application of ZOE paste after pulpectomy to the root canal with a spiral paste filler inserted into the canal to a point just short of the apex. The ZOE technique used by <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a> involved application of ZOE in the root canal with an endodontic pressure syringe. The ZOE technique used by <a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a> involved use of a Lentulo spiral mounted on a slow‐speed hand piece. </p> <p>For the Metapex technique, <a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a> used performed syringe with disposable plastic needles to inject the paste into the root canal; after inserting the tape of the needle near the apex, and the paste was gently pressed into the canal pulling the tape back slowly until the canal was filled. </p> <p>The calcium hydroxide technique used by <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a> involved application of calcium hydroxide with a needle placed 2 mm short of the radiographic apex. </p> <p>The MTA technique used by <a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a> involved application of approximately 3 mm of MTA on the pulpal floor, then a moistened cotton pellet in contact with the MTA was left in the cavity before application of the temporary filling material. The MTA technique used by <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a> involved application of MTA (mixed according to the manufacturer’s recommendations) in the canal using the MTA Gun System and compacted using endodontic pluggers; the MTA was allowed to set completely by placing a cotton pellet moistened with sterile water inside the pulp chamber. </p> <p>The RC Fill technique used by <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a> was available in powder and liquid form, mixed to the desired consistency according to the manufacturer’s instructions; a Lentulo spiral was used to place the RC Fill. </p> <p>The gutta‐percha/AH‐Plus technique used by <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a> involved application of gutta‐percha points filling root canals, using a size 30 master cone and size 25, 20 and 15 accessory cones, with finger spreaders sizes 25 and 20 and AH‐Plus Sealer using a cold lateral condensation technique. </p> <p>The ozonated sesame oil‐ZO technique used by <a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a> involved application of a mixture of ZO powder (0.2 g, arsenic free) and ozonated sesame oil filling root canals 1 mm short of the apex using Lentulo spirals. </p> <p>The Endoflas technique used by <a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a> involved a Lentulo spiral mounted on a slow‐speed hand piece. </p> <p>The technique used by <a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a> involved application of Endoflas‐CF. The powder of Endoflas‐CF paste was synthesised by adding 56.5% zinc oxide, 40.6% iodoform, 1.63% barium sulphate and 1.07% calcium hydroxide, and mixed with eugenol without adding chlorophenol. Paste was inserted into the root canal using Lentulo spirals at low speed. </p> <p>The 3Mix (ciprofloxacin + metronidazole + minocycline) and the ciprofloxacin + ornidazole + minocycline technique after pulpectomy involved application of ciprofloxacin, metronidazole and minocycline in the first group and ciprofloxacin, ornidazole and minocycline in the second group (<a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>). After removal of the coating, the drugs were pulverised using a sterile porcelain mortar and pestle. The powdered drugs were mixed in two different combinations at a ratio of 1:3:3 and kept separately to prevent exposure to light and moisture. One increment of each powdered drug was mixed with propylene glycol to form an ointment just before use. Canal orifices were enlarged to receive the medication using a round bur, then cavities were cleaned and irrigated using saline and dried. </p> <p>The pulpectomy techniques used by <a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a> involved application of 3Mix after necrotic coronal pulp removal in one group and after removal of both necrotic coronal as well as all accessible radicular pulp tissue in the other group. </p> <p>The pulpectomy technique used by <a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a> involved application of ZOP. The hydrolytic propolis of ZOP paste was extracted from raw propolis. ZOP paste was synthesised by mixing 50% zinc oxide powder with 50% hydrolytic propolis, to form a radiopaque paste with appropriate viscosity for filling the root canal. The paste was inserted into the root canal using Lentulo spirals at low speed. </p> <p>The following techniques after pulpectomy were not described in sufficient detail: IRM (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>), MTA (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>), Vitapex technique (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>), 3Mix (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>), Sealapex and calcium hydroxide (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>), RC Fill, Metapex, ZOE + Metapex techniques and Endoflas (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). </p> </section> <section id="CD003220-sec-0084"> <p><b>Direct pulp capping</b></p> <p>The formocresol technique involved application of a cotton pellet soaked with formocresol on the pulp exposure for five minutes (<a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>). </p> <p>The MTA technique involved a 3:1 powder:saline ratio in <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>. In <a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>, MTA was mixed with normal saline to form a creamy mixture delivered to the exposure site using a small amalgam carrier to reach a thickness of 1.5 to 2 mm and extending 2 mm beyond the margins of the exposure site. A wet cotton pellet was pressed slightly for better adaptation of capping material with pulp at the exposure site. </p> <p>The etch‐and‐rinse adhesive technique involved application of 36% phosphoric acid gel on enamel margins for 15 seconds, followed by extending the gel application to the cavity for an additional 10 seconds with care not to contact the exposed pulp (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). </p> <p>The calcium sulphate hemihydrate technique involved application of calcium sulphate powder, mixed with three to four drops of regular‐set liquid until a putty‐like consistency was achieved, and applied with ball‐ended instruments at the exposure site (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>). </p> <p>In <a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>, 3Mix, 3Mixtatin and simvastatin were mixed with normal saline to form a creamy mixture and delivered to the exposure site using a small amalgam carrier to reach a thickness of 1.5 to 2 mm and extending 2 mm beyond the margins of the exposure site. A dry cotton pellet was pressed slightly for better adaptation of capping material with pulp at the exposure site. </p> <p>The following techniques after direct pulp capping were not described in sufficient detail: EMD (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>), calcium hydroxide (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>), acetone‐based total‐etch adhesive, non‐rinse conditioner, self‐etch adhesive system (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>), calcium hydroxide cement (Dycal) (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>), CEM (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>), Biodentine (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>), Tempophore (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>) and MTA (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). </p> </section> </section> <section id="CD003220-sec-0085"> <h6 class="title">Intermediate restoration</h6> <p>Formocresol techniques were followed by placement of:</p> <p> <ul id="CD003220-list-0020"> <li> <p>ZOE in 14 trials (16%);</p> </li> <li> <p>ZOE and IRM in eight trials (<a href="./references#CD003220-bbs2-0002" title="AgamyHA , BakryNS , MounirMM , AveryDR . Comparison of mineral trioxide aggregate and formocresol as pulp‐capping agents in pulpotomized primary teeth. Pediatric Dentistry2004; Vol. 26, issue 4:302‐9. ">Agamy 2004</a>; <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>; <a href="./references#CD003220-bbs2-0028" title="FarsiN , AlamoudiN , BaltoK , MushaytA . Success of mineral trioxide aggregate in pulpotomized primary molars. Journal of Clinical Pediatric Dentistry2005;29(4):307‐11. ">Farsi 2005</a>; <a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>); </p> </li> <li> <p>IRM in six trials (<a href="./references#CD003220-bbs2-0009" title="AnsariG , RanjpourM . Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2‐year follow‐up. International Endodontic Journal2010;43(5):413‐8. [PUBMED: 20518934] ">Ansari 2010</a>; <a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>; <a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>; <a href="./references#CD003220-bbs2-0086" title="ZealandCM , BriskieDM , BoteroTM , BoyntonJR , HuJC . Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry2010;32(5):393‐9. [PUBMED: 21070705] ">Zealand 2010</a>); </p> </li> <li> <p>two successive IRM temporary restorations (formocresol dressing changed after seven days, ZOE placement at third visit) (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>); </p> </li> <li> <p>calcium hydroxide liner and glass‐ionomer cement (<a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>); </p> </li> <li> <p>Cavit (<a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>); </p> </li> <li> <p>ZOE and zinc phosphate cement (<a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); and </p> </li> <li> <p>ZOE and glass ionomer cement in two trials (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). </p> </li> </ul> </p> <p>The type of intermediate restoration after formocresol technique was not specified in two trials (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>; <a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>). </p> <p>MTA techniques were followed by placement of:</p> <p> <ul id="CD003220-list-0021"> <li> <p>IRM in 15 trials (17%);</p> </li> <li> <p>ZOE in nine trials (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>; <a href="./references#CD003220-bbs2-0055" title="NaikS , HegdeAH . Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2005;23(1):13‐6. [PUBMED: 15858300] ">Naik 2005</a>; <a href="./references#CD003220-bbs2-0059" title="NoorollahianH . Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British Dental Journal2008; Vol. 204, issue 11:E20. ">Noorollahian 2008</a>; <a href="./references#CD003220-bbs2-0060" title="OlatosiOO , SoteEO , OrenugaOO . Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. Nigerian Journal of Clinical Practice2015;18(2):292‐6. ">Olatosi 2015</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>); </p> </li> <li> <p>glass‐ionomer cement in six trials (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>; <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>; <a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>); </p> </li> <li> <p>metal‐reinforced glass ionomer cement (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>); </p> </li> <li> <p>reinforced glass ionomer cement (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>); and </p> </li> <li> <p>ZOE and glass ionomer cement (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>). </p> </li> </ul> </p> <p>There was no intermediate restoration in three trials after MTA technique (<a href="./references#CD003220-bbs2-0001" title="AeinehchiM , DadvandS , FayaziS , Bayat‐MovahedS . Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal2007; Vol. 40, issue 4:261‐7. ">Aeinehchi 2007</a>; <a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>). </p> <p>Calcium hydroxide techniques were followed by placement of:</p> <p> <ul id="CD003220-list-0022"> <li> <p>ZOE in five trials (<a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>; <a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>); </p> </li> <li> <p>IRM in five trials (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>); </p> </li> <li> <p>ZOE and IRM (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>); </p> </li> <li> <p>glass‐ionomer cement in four trials (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>); and </p> </li> <li> <p>dentine adhesive (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>). </p> </li> </ul> </p> <p>The type of intermediate restoration after calcium hydroxide technique was not specified (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>), and there was no intermediate restoration in three trials (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). </p> <p>Ferric sulphate techniques were followed by placement of:</p> <p> <ul id="CD003220-list-0023"> <li> <p>IRM in three trials (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>); </p> </li> <li> <p>IRM and glass ionomer cement (<a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>); </p> </li> <li> <p>ZOE in six trials (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>ZOE and IRM in two trials (<a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>); </p> </li> <li> <p>ZOE and glass‐ionomer cement (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>); and </p> </li> <li> <p>MTA followed by a layer of light‐cured glass ionomer (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>). </p> </li> </ul> </p> <p>Eugenol‐free ferric sulphate was followed by placement of:</p> <p> <ul id="CD003220-list-0024"> <li> <p>Cimpact S (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>); </p> </li> <li> <p>ZOE then IRM for five days over the ZOE paste for very uncooperative children (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>); </p> </li> <li> <p>calcium hydroxide and glass‐ionomer cement (<a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>); and </p> </li> <li> <p>ZOE and zinc phosphate cement (<a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>). </p> </li> </ul> </p> <p>Ferric sulphate/MTA technique was followed by IRM (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). </p> <p>Calcium hydroxide cement and calcium sulphate hemihydrate techniques were followed by glass‐ionomer cement restoration (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>). </p> <p>Portland cement technique was followed by:</p> <p> <ul id="CD003220-list-0025"> <li> <p>IRM in three trials (<a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>; <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>); and </p> </li> <li> <p>ZOE and glass ionomer cement (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). </p> </li> </ul> </p> <p>NaOCl techniques were followed by IRM in three trials (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>). </p> <p>The techniques for 2% glutaraldehyde + eugenol + IRM and 2% glutaraldehyde + calcium hydroxide were followed by placement of compomer in <a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>. There was no intermediate restoration after 2% unbuffered glutaraldehyde + ZOE and 2% unbuffered glutaraldehyde + calcium hydroxide techniques in <a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>. <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a> reported use of 2% buffered glutaraldehyde followed by ZOE. </p> <p>EMD technique was followed by ZOE and glass ionomer cement in <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>. There was no intermediate restoration in <a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a> and <a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>. </p> <p>CEM technique was followed by IRM in <a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>. There was no intermediate restoration after CEM in <a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a> and <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>. </p> <p>Diode laser technique was followed by:</p> <p> <ul id="CD003220-list-0026"> <li> <p>ZOE in three trials (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); and </p> </li> <li> <p>ZOE and glass ionomer cement (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>). </p> </li> </ul> </p> <p>Er:YAG laser technique was followed by IRM (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>). </p> <p>Electrosurgery techniques were followed by placement of:</p> <p> <ul id="CD003220-list-0027"> <li> <p>ZOE in five trials (<a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>; <a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>; <a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>IRM (<a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>); and </p> </li> <li> <p>calcium hydroxide (<a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>). </p> </li> </ul> </p> <p>LLLT technique was followed by glass ionomer cement in <a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a> and by ZOE + IRM in <a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>. </p> <p>Biodentine technique was followed by ZOE and glass ionomer cement in <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>, by IRM in <a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>, and by glass ionomer cement in <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>. There was no intermediate restoration following Biodentine in three trials (<a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>; <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>). </p> <p>Propolis technique was followed by ZOE and glass ionomer cement in <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>. </p> <p>Aloe vera technique was followed by a layer of collagen sponge and glass ionomer cement in <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>. </p> <p>Ankaferd Blood Stopper technique was followed by IRM and glass ionomer cement in <a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>, and by ZOE in <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>. </p> <p>Tempophore was followed by glass ionomer cement in <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>. </p> <p>Vitapex technique was followed by IRM placement (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>) and glass‐ionomer cement (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). There was no intermediate restoration in three trials (<a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>). </p> <p>Metapex technique was followed by ZOE placement in <a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>, ZOE and glass ionomer (Miracle mix) (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>), and glass ionomer (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). </p> <p>ZOE + Metapex and RC Fill techniques were followed by placement of ZOE (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>). </p> <p>Endoflas technique was followed by placement of ZOE and glass ionomer (Miracle mix) (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>), ZOE (<a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>), and glass ionomer (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). </p> <p>ZOE technique was followed by glass ionomer in four trials (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>; <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>), thick ZOE paste (<a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>), and no intermediate restoration in six trials (<a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>). </p> <p>IRM technique was followed by placement of metal‐reinforced glass ionomer cement (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>). </p> <p>The type of intermediate restoration after calcium hydroxide/iodoform techniques was not specified in <a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>. </p> <p>3Mix and ciprofloxacin + ornidazole + minocycline techniques were followed by ZOE or IRM in three trials (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>; <a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>; <a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>). </p> <p>3Mixtatin and simvastatin were followed by IRM in <a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>. </p> <p>The gutta‐percha/AH‐Plus technique was followed by reinforced glass ionomer cement in <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>. </p> <p>There was no intermediate restoration following ozonated sesame oil‐ZO technique in <a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>. </p> <p>ZOP technique was followed by glass ionomer in <a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>. </p> <p>There was no intermediate restoration after ZOE technique (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>), acetone‐based total‐etch adhesive (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>), Sealapex technique (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>), calcium hydroxide technique (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>), and antibacterial mix technique (<a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a>). </p> </section> <section id="CD003220-sec-0086"> <h6 class="title">Final restoration</h6> <p>Final restorations after placement of formocresol were:</p> <p> <ul id="CD003220-list-0028"> <li> <p>stainless‐steel crown in 18 (21%) trials;</p> </li> <li> <p>amalgam in four trials (<a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>; <a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); </p> </li> <li> <p>glass‐ionomer cement and stainless‐steel crown in three trials (<a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>; <a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a>); </p> </li> <li> <p>amalgam or stainless‐steel crown in three trials (<a href="./references#CD003220-bbs2-0009" title="AnsariG , RanjpourM . Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2‐year follow‐up. International Endodontic Journal2010;43(5):413‐8. [PUBMED: 20518934] ">Ansari 2010</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>); </p> </li> <li> <p>amalgam or glass‐ionomer cement (<a href="./references#CD003220-bbs2-0001" title="AeinehchiM , DadvandS , FayaziS , Bayat‐MovahedS . Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal2007; Vol. 40, issue 4:261‐7. ">Aeinehchi 2007</a>); </p> </li> <li> <p>glass‐ionomer cement or stainless‐steel crown if the restoration was not satisfactory (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>); </p> </li> <li> <p>composite or stainless‐steel crown (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>); </p> </li> <li> <p>glass‐ionomer cement or composite or stainless‐steel crown (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>); </p> </li> <li> <p>glass‐ionomer cement in two trials (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>); </p> </li> <li> <p>stainless steel crown and/or glass ionomer restoration and silver amalgam (<a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>); </p> </li> <li> <p>glass‐ionomer cement or composite or amalgam, and stainless‐steel crown if indicated (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). </p> </li> </ul> </p> <p>Final restoration after placement of formocresol was not mentioned in <a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>. </p> <p>Final restorations after placement of MTA were:</p> <p> <ul id="CD003220-list-0029"> <li> <p>stainless‐steel crown in 21 trials (24%);</p> </li> <li> <p>amalgam in five trials (<a href="./references#CD003220-bbs2-0001" title="AeinehchiM , DadvandS , FayaziS , Bayat‐MovahedS . Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal2007; Vol. 40, issue 4:261‐7. ">Aeinehchi 2007</a>; <a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>), followed by a light‐cured fissure sealant material in one trial (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>); </p> </li> <li> <p>glass‐ionomer cement in two trials (<a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>); </p> </li> <li> <p>resin modified glass ionomer cement (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>); </p> </li> <li> <p>composite resin in two trials (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>); </p> </li> <li> <p>composite resin or amalgam or stainless (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>); </p> </li> <li> <p>amalgam or stainless‐steel crown (<a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>); </p> </li> <li> <p>glass ionomer and amalgam (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>); </p> </li> <li> <p>stainless steel crown and/or glass ionomer restoration and silver amalgam (<a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>); </p> </li> <li> <p>glass‐ionomer cement and stainless‐steel crown (<a href="./references#CD003220-bbs2-0076" title="SubramaniamP , KondeS , MathewS , SugnaniS . Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry2009; Vol. 33, issue 4:311‐4. ">Subramaniam 2009</a>). </p> </li> </ul> </p> <p>Final restorations after placement of calcium hydroxide were:</p> <p> <ul id="CD003220-list-0030"> <li> <p>stainless‐steel crown in four trials (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>; <a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>; <a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>; <a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>); </p> </li> <li> <p>amalgam in four trials (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>) followed by a light‐cured fissure sealant material (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>); </p> </li> <li> <p>glass‐ionomer cement or stainless‐steel crown if the restoration was not satisfactory (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>); </p> </li> <li> <p>glass‐ionomer cement or composite or stainless‐steel crown (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>); </p> </li> <li> <p>glass‐ionomer cement in two trials (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>; <a href="./references#CD003220-bbs2-0052" title="MorettiAB , SakaiVT , OliveiraTM , FornettiAP , SantosCF , MachadoMA , et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal2008; Vol. 41, issue 7:547‐55. ">Moretti 2008</a>); </p> </li> <li> <p>resin modified glass ionomer cement (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>); </p> </li> <li> <p>glass‐ionomer cement and amalgam (<a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); </p> </li> <li> <p>glass‐ionomer cement or composite or amalgam, and stainless‐steel crown if indicated (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>); </p> </li> <li> <p>glass‐ionomer cement and stainless‐steel crown (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>) </p> </li> <li> <p>composite resin (<a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>); and </p> </li> <li> <p>nanohybrid composite resin (<a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>). </p> </li> </ul> </p> <p>Final restorations after placement of ferric sulphate were:</p> <p> <ul id="CD003220-list-0031"> <li> <p>stainless‐steel crown in eight trials (<a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>; <a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>); </p> </li> <li> <p>amalgam in three trials (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0051" title="MarkovicD , ZivojinovicV , VuceticM . Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry2005; Vol. 6, issue 3:133‐8. ">Markovic 2005</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>); </p> </li> <li> <p>amalgam or stainless‐steel crown in three trials (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>); </p> </li> <li> <p>glass‐ionomer cement (<a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>); </p> </li> <li> <p>acid etch resin (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>); and </p> </li> <li> <p>glass‐ionomer cement or composite or stainless‐steel crown (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>). </p> </li> </ul> </p> <p>Final restorations after placement of ZOE were amalgam in three trials (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>), stainless‐steel crown in four trials (<a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>) and acid‐etch resin (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>). </p> <p>Final restoration after placement of 2% glutaraldehyde + eugenol + IRM and 2% glutaraldehyde + calcium hydroxide techniques was stainless‐steel crown in one trial (<a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>). Final restoration after placement of 2% unbuffered glutaraldehyde + ZOE and 2% unbuffered glutaraldehyde + calcium hydroxide was not mentioned in one trial (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>). Final restoration after placement of 2% buffered glutaraldehyde was stainless steel crown in one trial (<a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>). </p> <p>Final restoration after diode laser was stainless steel crown in three trials (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>) and glass‐ionomer cement in one trial (<a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>). </p> <p>Final restorations after electrosurgery were stainless‐steel crowns in four trials (<a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>; <a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>; <a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>; <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>), amalgam in one trial (<a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>) and glass‐ionomer cement in one trial (<a href="./references#CD003220-bbs2-0084" title='YadavP , IndushekarK , SarafB , SheoranN , SardanaD . Comparative evaluation of Ferric Sulfate, Electrosurgical and Diode Laser on human primary molars pulpotomy: an "in‐vivo" study. Laser Therapy2014;23(1):41‐7. '>Yadav 2014</a>). </p> <p>Final restoration after placement of acetone‐based total‐etch adhesive, acetone‐based total‐etch adhesive, total‐etching with 36% phosphoric acid and self etch adhesive system was composite in one trial (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). </p> <p>Final restorations after placement of EMD were stainless‐steel crowns in two trials (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>; <a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>), and glass‐ionomer cement and stainless‐steel crowns in one other trial (<a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>). </p> <p>Final restorations after Er:YAG laser were glass‐ionomer cement and composite or stainless‐steel crowns in one trial (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>). </p> <p>Final restoration after LLLT was stainless‐steel crown in one trial (<a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a>) and glass ionomer cement in one trial (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>). </p> <p>Final restorations after placement of CEM were amalgam or stainless‐steel crowns in one trial (<a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>), amalgam in one trial (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>), and stainless steel crown in one trial (<a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>). </p> <p>Final restoration after placement of Portland cement was:</p> <p> <ul id="CD003220-list-0032"> <li> <p>glass‐ionomer cement in two trials (<a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>); </p> </li> <li> <p>resin‐modified glass‐ionomer cement in one trial (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>); and </p> </li> <li> <p>stainless steel crown in one trial (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>) </p> </li> </ul> </p> <p>Final restoration after placement of calcium hydroxide cement and calcium sulphate hemihydrate was amalgam followed by a light‐cured fissure sealant material in one trial (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>). </p> <p>Final restoration after placement of Biodentine was stainless steel crown in five trials (<a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>; <a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>) and nanohybrid composite resin in one trial (<a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>). </p> <p>Final restoration was stainless steel crown after placement of propolis (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>), Tempophore (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>) and aloe vera (<a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>). </p> <p>Final restoration after Ankaferd Blood Stopper was stainless steel crown in one trial (<a href="./references#CD003220-bbs2-0013" title="CantekinK , GümüşH . Success rates of ankaferd blood stopper and ferric sulfate as pulpotomy agents in primary molars. International Scholarly Research Notices2014;2014:819605. ">Cantekin 2014</a>), and amalgam or stainless steel crown in one trial (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). </p> <p>Final restorations after placement of Vitapex or Metapex were:</p> <p> <ul id="CD003220-list-0033"> <li> <p>amalgams in two trials (<a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>); </p> </li> <li> <p>glass‐ionomer cement and stainless‐steel crowns in one trial (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>); and </p> </li> <li> <p>stainless‐steel crowns in five trials (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>). </p> </li> </ul> </p> <p>Final restorations after placement of 3Mix were glass‐ionomer cement and stainless‐steel crowns in two trials (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>; <a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>), and glass ionomer and amalgam in one trial (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). </p> <p>Final restoration after placement of 3Mixtatin and simvastatin were glass ionomer and amalgam in one trial (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). </p> <p>Final restoration after placement of Sealapex or calcium hydroxide was amalgam in one trial (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). </p> <p>Final restorations after placement of ciprofloxacin + metronidazole + minocycline and ciprofloxacin + ornidazole + minocycline were glass‐ionomer cement and stainless‐steel crowns in one trial (<a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>). </p> <p>Final restorations after antibacterial mix technique were made of glass‐ionomer cement and composite resin in one trial (<a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a>). </p> <p>Final restoration after gutta‐percha/AH‐Plus technique was resin composite in one trial (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>). </p> <p>Final restoration after placement of calcium hydroxide/iodoform (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>), ZOE (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>; <a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>; <a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>), IRM (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>), ozonated sesame oil‐ZO (<a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>), ferric sulphate: MTA (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>), RC Fill (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>), ZOE + Metapex (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>), Endoflas or Endoflas‐CF (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>; <a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>), ZOP (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>) and 3% or 5% NaOCl (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>) was stainless‐steel crown in 10 trials. </p> </section> </section> </section> <section id="CD003220-sec-0087"> <h4 class="title">Excluded studies</h4> <p>We excluded 55 studies: 30 were not RCTs, 14 had only an abstract, with insufficient information and no response from authors; in 2 articles biomaterials were not compared; 4 articles were reviews, 2 were case reports and 1 was a terminated trial; 1 was an in vitro study in dogs and humans, 1 focused on restorative dentistry, and 1 was a duplicate. </p> </section> </section> <section id="CD003220-sec-0088"> <h3 class="title">Risk of bias in included studies</h3> <p>Summary details are given in the <a href="./references#CD003220-sec-0402" title="">Characteristics of included studies</a> table and <a href="#CD003220-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD003220-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD003220-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD003220-sec-0089"> <h4 class="title">Allocation</h4> <section id="CD003220-sec-0090"> <h5 class="title">Random sequence generation</h5> <p>The risk of selection bias with regard to sequence generation was low in 37 trials (43%). The sequence was generated by random number tables or computerised random‐number generators in 24 trials (28%) and coin toss in 13 trials (15%). </p> <p>One included trial described an alternate allocation (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>), and was judged to be at high risk of bias. </p> <p>There was insufficient information to make a clear judgement about risk of bias in 49 trials (56%). </p> </section> <section id="CD003220-sec-0091"> <h5 class="title">Allocation concealment</h5> <p>Allocation concealment was applied for eight included studies (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>; <a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>; <a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>; <a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>; <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>; <a href="./references#CD003220-bbs2-0086" title="ZealandCM , BriskieDM , BoteroTM , BoyntonJR , HuJC . Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry2010;32(5):393‐9. [PUBMED: 21070705] ">Zealand 2010</a>), which were assessed as being at low risk of bias for this domain. In the other 79 trials (91%), allocation concealment was unclear. </p> </section> </section> <section id="CD003220-sec-0092"> <h4 class="title">Blinding</h4> <section id="CD003220-sec-0093"> <h5 class="title">Blinding of participants and personnel</h5> <p>Participants and personnel were blinded in five trials (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>; <a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>; <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>). Blinding of participants and personnel was unclear in 82 included trials (94%). </p> </section> <section id="CD003220-sec-0094"> <h5 class="title">Blinding of clinical outcomes assessment</h5> <p>The children were examined clinically by examiners blinded to the technique in 45 trials (50%). Children were examined clinically by examiners who were not blinded to the treatment in four trials (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>; <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>). There was insufficient information to make a clear judgement of blinding in 38 trials (44%). </p> </section> <section id="CD003220-sec-0095"> <h5 class="title">Blinding of radiological outcomes assessment</h5> <p>The children were examined radiographically by examiners blinded to the technique in 51 trials (59%). Children were examined radiographically by examiners who were not blinded to the treatment in two trials (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>). There was insufficient information to make a clear judgement on radiological blinding in 34 trials (39%). </p> </section> </section> <section id="CD003220-sec-0096"> <h4 class="title">Incomplete outcome data</h4> <p>The risk of bias for incomplete outcome data was low for 53 trials (61%): 32 trials (37%) had no missing data, the proportion of missing outcomes was lower than 10% of children or teeth randomly assigned for 18 trials (21%), and missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups in three trials (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>; <a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). </p> <p>The proportion of missing outcomes was higher than 10% of children or teeth randomly assigned for 31 trials (36%) </p> <p>There was insufficient information pertaining to attrition/exclusion in three trials (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>; <a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>; <a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). </p> </section> <section id="CD003220-sec-0097"> <h4 class="title">Selective reporting</h4> <p>We assessed two trials as being at low risk of reporting bias (<a href="./references#CD003220-bbs2-0019" title="Cuadros‐FernándezC , Lorente RodríguezAI , Sáez‐MartínezS , García‐BinimelisJ , AboutI , MercadéM . Short‐term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical Oral Investigations2016;20(7):1639‐45. ">Cuadros‐Fernández 2016</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). We did not have access to 97% of trial protocols, so we judged these trials to be at unclear risk of bias for the selective outcome reporting. We judged <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a> to be at high risk of bias. </p> <section id="CD003220-sec-0098"> <h5 class="title">Overall risk of bias</h5> <p>The overall risk of bias was high in 36 trials (41%) (<a href="./references#CD003220-bbs2-0001" title="AeinehchiM , DadvandS , FayaziS , Bayat‐MovahedS . Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal2007; Vol. 40, issue 4:261‐7. ">Aeinehchi 2007</a>; <a href="./references#CD003220-bbs2-0002" title="AgamyHA , BakryNS , MounirMM , AveryDR . Comparison of mineral trioxide aggregate and formocresol as pulp‐capping agents in pulpotomized primary teeth. Pediatric Dentistry2004; Vol. 26, issue 4:302‐9. ">Agamy 2004</a>; <a href="./references#CD003220-bbs2-0009" title="AnsariG , RanjpourM . Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2‐year follow‐up. International Endodontic Journal2010;43(5):413‐8. [PUBMED: 20518934] ">Ansari 2010</a>; <a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>; <a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>; <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>; <a href="./references#CD003220-bbs2-0028" title="FarsiN , AlamoudiN , BaltoK , MushaytA . Success of mineral trioxide aggregate in pulpotomized primary molars. Journal of Clinical Pediatric Dentistry2005;29(4):307‐11. ">Farsi 2005</a>; <a href="./references#CD003220-bbs2-0029" title="FeiAL , UdinRD , JohnsonR . A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry1991;13(6):327‐32. [MEDLINE: 93181319] ">Fei 1991</a>; <a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>; <a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>; <a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>; <a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>; <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>; <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>; <a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>; <a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>; <a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>; <a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>; <a href="./references#CD003220-bbs2-0048" title="LiuH , ZhouQ , QinM . Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars. Chinese Journal of Dental Research2011;14(2):121‐5. ">Liu 2011</a>; <a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>; <a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>; <a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>; <a href="./references#CD003220-bbs2-0059" title="NoorollahianH . Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British Dental Journal2008; Vol. 204, issue 11:E20. ">Noorollahian 2008</a>; <a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>; <a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>; <a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>; <a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>; <a href="./references#CD003220-bbs2-0073" title="ShabzendedarM , MazhariF , AlamiM , TalebiM . Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1‐year follow‐up. Pediatric Dentistry2013;35(4):329‐32. ">Shabzendedar 2013</a>; <a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>; <a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>; <a href="./references#CD003220-bbs2-0082" title="VargasKG , PackhamB , LowmanD . Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry2006; Vol. 28, issue 6:511‐7. ">Vargas 2006</a>; <a href="./references#CD003220-bbs2-0086" title="ZealandCM , BriskieDM , BoteroTM , BoyntonJR , HuJC . Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry2010;32(5):393‐9. [PUBMED: 21070705] ">Zealand 2010</a>; <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). </p> <p>For the other 51 trials (59%), the risk of bias was unclear, frequently due to lack of information about allocation concealment and blinding of participants and staff. </p> </section> </section> </section> <section id="CD003220-sec-0099"> <h3 class="title" id="CD003220-sec-0099">Effects of interventions</h3> <p>See: <a href="./full#CD003220-tbl-0001"><b>Summary of findings for the main comparison</b> Pulpotomy compared with pulpotomy using alternative medicament/technique for extensive decay in primary teeth</a>; <a href="./full#CD003220-tbl-0002"><b>Summary of findings 2</b> Pulpectomy compared with pulpectomy using alternative medicament for extensive decay in primary teeth</a>; <a href="./full#CD003220-tbl-0003"><b>Summary of findings 3</b> Direct pulp capping compared with direct pulp capping using alternative medicament for extensive decay in primary teeth</a> </p> <p>We identified 19 trials for the comparison of MTA and formocresol, six for the comparison of MTA and calcium hydroxide, five for the comparison of MTA and ferric sulphate, three for the comparison of MTA and Portland cement, four for the comparison of MTA and Biodentine, eight for the comparison of calcium hydroxide and formocresol, three for the comparison of calcium hydroxide and ferric sulphate, 10 for the comparison of ferric sulphate and formocresol, two for the comparison of NaOCl and ferric sulphate, three for the comparison of diode laser and ferric sulphate, two for the comparison of electrosurgery and ferric sulphate, two for the comparison of ferric sulphate and Ankaferd Blood Stopper, two for the comparison of glutaraldehyde + calcium hydroxide versus glutaraldehyde + ZOE, two for the comparison of diode laser and electrosurgery, two for the comparison of NaOCl and formocresol, two for the comparison of EMD and formocresol, two for the comparison of calcium hydroxide and ZOE, two for the comparison of Metapex and ZOE, two for the comparison of Metapex and Endoflas, five for the comparison of Vitapex and ZOE, and two for the comparison of Endoflas and ZOE. Two trials compared two different types of MTA (<a href="./references#CD003220-bbs2-0002" title="AgamyHA , BakryNS , MounirMM , AveryDR . Comparison of mineral trioxide aggregate and formocresol as pulp‐capping agents in pulpotomized primary teeth. Pediatric Dentistry2004; Vol. 26, issue 4:302‐9. ">Agamy 2004</a>; <a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>); we combined data for these two arms as prespecified. All other comparisons were addressed by only one trial each. Overall, only 59 of 87 trials (68%) were included in meta‐analyses. </p> <section id="CD003220-sec-0100"> <h4 class="title">Pulpotomy versus pulpotomy</h4> <p>We included 53 trials that compared pulpotomy using different types of medicaments. We assessed that 28 (32%) trials were at high risk of bias, and for 25 (29%) other trials, the risk of bias was unclear. </p> <section id="CD003220-sec-0101"> <h5 class="title">MTA versus full strength or 1:5 diluted formocresol</h5> <section id="CD003220-sec-0102"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from 13 RCTs totaling 1048 teeth. In 10 of the 13 trials, there was no clinical failure in any of the participants regardless of the intervention. From the three remaining trials (N = 394 participants), the pooled results showed no statistically significant difference in clinical failure with MTA compared with formocresol. The pooled risk ratio (RR) was 0.37 (95% confidence interval (CI) 0.07 to 1.89). At 12 months, data were extractable from 12 RCTs totaling 740 teeth. In seven of the 12 trials, there was no clinical failure in any of the participants regardless of the intervention. From the five remaining trials, the results showed a statistically significant difference (RR 0.31, 95% CI 0.10 to 0.93) with no evidence of statistical heterogeneity among included trials (I² = 0%). At 24 months, data were extractable from nine RCTs totaling 548 teeth. In five of the nine trials, there was no clinical failure in any of the participants regardless of the intervention. From the four remaining trials, the results showed no statistically significant difference (RR 0.47, 95% CI 0.18 to 1.19; <a href="./references#CD003220-fig-0003" title="">Analysis 1.1</a>). </p> <p>The results showed no statistically significant difference at any time point in clinical failure when full strength formocresol and 1:5 diluted formocresol results were not pooled (<a href="./references#CD003220-fig-0014" title="">Analysis 2.1</a>; <a href="./references#CD003220-fig-0021" title="">Analysis 3.1</a>). </p> </section> <section id="CD003220-sec-0103"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from 12 RCTs totaling 922 teeth. In eight of the 12 trials, there was no radiological failure in any participants regardless of the intervention. From the four remaining trials, the pooled results showed a statistically significant difference in radiological failure with MTA compared with formocresol. The pooled RR was 0.38 (95% CI 0.17 to 0.86) with no evidence of statistical heterogeneity among included trials (I² = 0%). At 12 months, results were similar with seven trials providing data for a pooled RR of 0.41 (95% CI 0.19 to 0.89) with no evidence of statistical heterogeneity among included trials (I² = 0%). At 24 months, data were extractable from nine RCTs totaling 548 teeth, with eight trials providing data. The results showed a statistically significant difference (RR 0.42, 95% CI 0.22 to 0.80) with no evidence of statistical heterogeneity among included trials (I² = 18%; <a href="./references#CD003220-fig-0004" title="">Analysis 1.2</a>). </p> <p>The results showed a statistically significant difference at 12 and 24 months in radiological failure for MTA compared with full strength formocresol (<a href="./references#CD003220-fig-0015" title="">Analysis 2.2</a>) (no statistically significant difference at 6 months); the results showed no statistically significant difference at any point in radiological failure for MTA compared with 1:5 diluted formocresol (<a href="./references#CD003220-fig-0022" title="">Analysis 3.2</a>). </p> </section> <section id="CD003220-sec-0104"> <h6 class="title">Overall failure</h6> <p>At six months, data were extractable from six RCTs totaling 328 teeth. In four of the six trials, there was no overall failure in any of the participants regardless of the intervention. From the two remaining trials, the results showed no statistically significant difference in overall failure with MTA compared with formocresol (RR 0.23, 95% CI 0.04 to 1.32). Results were similar at 12 months with four trials providing data for an overall pooled RR of 0.48 (96% CI 0.17 to 1.36). At 24 months, data were extractable from seven RCTs totaling 368 teeth, with all seven trials providing data for a pooled RR of 0.50 (95% CI 0.25 to 1.01; <a href="./references#CD003220-fig-0005" title="">Analysis 1.3</a>). </p> <p>Five of six included trials compared MTA with 1:5 diluted formocresol. One compared MTA with full strength formocresol with no statistically significant difference (<a href="./references#CD003220-bbs2-0043" title="JayamC , MitraM , MishraJ , BhattacharyaB , JanaB . Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(1):13‐8. ">Jayam 2014</a>). </p> <p>Two additional trials, which randomised 32 (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>) and 64 teeth (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>), did not assess overall failure at a fixed time point but at a mean (range) follow‐up of 13 (6 to 31) and 36 (4 to 74) months, respectively. The RRs were 0.30 (95% CI 0.01 to 6.77) for <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a> and 0.19 (95% CI 0.02 to 1.52) for <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>. </p> </section> <section id="CD003220-sec-0105"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from six RCTs totaling 390 teeth. In five trials, there was no pain in any of the participants regardless of the intervention. From the remaining trial, the results showed no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.91). Results were similar at 12 months, with two trials providing data for a pooled RR of 0.25 (95% CI 0.03 to 2.18). At 24 months, data were extractable from four RCTs totaling 290 teeth. In one of the four trials, there was no pain in any of the participants regardless of the intervention. For the three remaining trials, the pooled results showed no statistically significant difference in pain with MTA compared with formocresol (RR 0.71, 95% CI 0.14 to 3.56; <a href="./references#CD003220-fig-0006" title="">Analysis 1.4</a>). </p> <p>The results showed no statistically significant difference at any point in pain for MTA compared with full strength formocresol or 1:5 diluted formocresol (<a href="./references#CD003220-fig-0016" title="">Analysis 2.3</a>; <a href="./references#CD003220-fig-0023" title="">Analysis 3.3</a>). </p> <p>One trial, which randomised 32 teeth, did not assess pain at a fixed time point but at a mean (range) follow‐up of 13 (6 to 31) (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>). There was no pain in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0106"> <h6 class="title">Soft tissue pathology</h6> <p>At six months, data were extractable from seven RCTs totaling 410 teeth. In six trials, there was no soft tissue pathology in any participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.91). At 12 months, in three trials, there was no soft tissue pathology in any participants regardless of the intervention. Of the remaining four trials, results showed no statistically significant difference (RR 0.22, 95% CI 0.05 to 1.01). At 24 months, data were extractable from five RCTs totaling 310 teeth, with two trials providing data for a pooled RR of 0.33 (95% CI 0.04 to 3.10; <a href="./references#CD003220-fig-0007" title="">Analysis 1.5</a>). </p> <p>The results showed no statistically significant difference at any time point in soft tissue pathology for MTA compared either with full strength formocresol or 1:5 diluted formocresol (<a href="./references#CD003220-fig-0017" title="">Analysis 2.4</a>; <a href="./references#CD003220-fig-0024" title="">Analysis 3.4</a>). </p> <p>In addition, two trials, which randomised 32 (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>) and 64 (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>) teeth, did not assess soft tissue pathology at a fixed time point but at a mean (range) follow‐up of 13 (6 to 31) for <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a> and 38 (4 to 74) months for <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>. There was no soft tissue pathology in any of the participants regardless of the intervention in <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>, and for <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>, the RR was 0.94 (95% CI 0.06 to 14.4). </p> </section> <section id="CD003220-sec-0107"> <h6 class="title">Pathological mobility</h6> <p>At six months, data were extractable from five RCTs totaling 250 teeth. In both trials, there was no pathological mobility in any of the participants regardless of the intervention. At 12 months, data were extractable from four RCTs totaling 200 teeth. For three trials, there was no pathological mobility in any of the participants regardless of the intervention. Results from the remaining trial showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.97). At 24 months, data were extractable from three RCTs totaling 150 teeth. In both trials, there was no pathological mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0008" title="">Analysis 1.6</a>). </p> <p>The results showed no statistically significant difference at any time point in pathological mobility between MTA and either full strength formocresol or 1:5 diluted formocresol (<a href="./references#CD003220-fig-0018" title="">Analysis 2.5</a>; <a href="./references#CD003220-fig-0025" title="">Analysis 3.5</a>). </p> </section> <section id="CD003220-sec-0108"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from 13 RCTs totaling 1010 teeth. In nine of the 13 trials, there was no pathological radiolucency in any of the participants regardless of the intervention. From the four remaining trials, the pooled results showed no evidence of a statistically significant difference in pathological radiolucency with MTA compared with formocresol (pooled RR 0.54, 95% CI 0.27 to 1.08). At 12 months, data were extractable from 11 RCTs totaling 652 teeth. In five of the 11 trials, there was no pathological radiolucency in any participants regardless of the intervention. From the six remaining trials, the pooled results showed evidence of a statistically significant difference in pathological radiolucency between MTA and formocresol (pooled RR 0.43, 95% CI 0.19 to 0.98) with no evidence of statistical heterogeneity among included trials (I² = 0%). At 24 months, data were extractable from eight RCTs totaling 460 teeth. In two of the eight trials, there was no pathological radiolucency in any participants regardless of the intervention. From the six remaining trials, the pooled results showed no evidence of a statistically significant difference in pathological radiolucency with MTA compared with formocresol (pooled RR 0.55, 95% CI 0.25 to 1.22; <a href="./references#CD003220-fig-0009" title="">Analysis 1.7</a>). </p> <p>The results showed no statistically significant difference at any time point in pathological radiolucency between MTA and either full strength formocresol or 1:5 diluted formocresol (<a href="./references#CD003220-fig-0018" title="">Analysis 2.5</a>; <a href="./references#CD003220-fig-0026" title="">Analysis 3.6</a>). </p> <p>In addition, two trials, which randomised 32 (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>) and 64 (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>) teeth, did not assess pathological radiolucency at a fixed time point but at a mean (range) follow‐up of 13 (6 to 31) for <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a> and 36 (4 to 74) months for <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>. For one trial, there was no pathological radiolucency in any of the participants regardless of the intervention, and for the other trial, the RR was 0.94 (95% CI 0.06 to 14.4). </p> </section> <section id="CD003220-sec-0109"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from 11 RCTs totaling 866 teeth. In seven of the trials, there was no pathological root resorption in any participants regardless of the intervention. From the four remaining trials, the pooled results showed no evidence of a statistically significant difference in pathological root resorption with MTA compared with formocresol (pooled RR 0.47, 95% CI 0.18 to 1.21). At 12 months, data were extractable from nine RCTs totaling 508 teeth. In five of the trials, there was no pathological root resorption in any participants regardless of the intervention. From the four remaining trials, the pooled results showed no evidence of a statistically significant difference in pathological root resorption between MTA and formocresol (pooled RR 0.26, 95% CI 0.07 to 1.03). At 24 months, data were extractable from six RCTs totaling 338 teeth. In one of the five trials, there was no pathological root resorption in any of the participants regardless of the intervention. From the five remaining trials, the pooled results showed evidence of a statistically significant difference in pathological root resorption between MTA and formocresol (pooled RR 0.25, 95% CI 0.08 to 0.81), with no evidence of statistical heterogeneity among included trials (I² = 0%; <a href="./references#CD003220-fig-0010" title="">Analysis 1.8</a>). </p> <p>The results showed a statistically significant difference at 24 months in pathological root resorption between MTA and full strength formocresol; the results showed no statistically significant difference at 6 and 12 months between MTA and full strength formocresol, or at any point between MTA and 1:5 diluted formocresol (<a href="./references#CD003220-fig-0019" title="">Analysis 2.6</a>; <a href="./references#CD003220-fig-0027" title="">Analysis 3.7</a>). </p> <p>A further two trials, which randomised 32 (<a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a>) and 64 (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>) teeth, did not assess pathological root resorption at a fixed time point but at a mean (range) follow‐up of 13 (6 to 31) months for <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a> and 36 (4 to 74) months for <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>. The RR was 0.06 (95% CI 0.00 to 0.92) for <a href="./references#CD003220-bbs2-0024" title="EidelmanE , HolanG , FuksAB . Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry2001;23(1):15‐8. [MEDLINE: 21133329] ">Eidelman 2001</a> and 0.30 (95% CI 0.01 to 6.77) for <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>. </p> </section> <section id="CD003220-sec-0110"> <h6 class="title">Pulp canal obliteration</h6> <p>At six months, data were extractable from nine RCTs totaling 712 teeth. In six of the trials, there was no pulp canal obliteration in any participants regardless of the intervention. From the three remaining trials, the pooled results showed no statistically significant difference in pulp canal obliteration between MTA and formocresol (pooled RR 1.52, 95% CI 1.00 to 2.30). Results were similar at 12 months, with five of seven trials providing data (RR 1.70, 95% CI 0.81 to 3.57). At 24 months, data were extractable from six RCTs totaling 338 teeth; the pooled results showed a larger risk of pulp canal obliteration with MTA compared with formocresol (RR 2.05, 95% CI 1.07 to 3.94), with no evidence of statistical heterogeneity among included trials (I² = 22%; <a href="./references#CD003220-fig-0011" title="">Analysis 1.9</a>). </p> <p>The results showed no statistically significant difference at any time point in pulp canal obliteration between MTA and either full strength or 1:5 diluted formocresol (<a href="./references#CD003220-fig-0020" title="">Analysis 2.7</a>; <a href="./references#CD003220-fig-0028" title="">Analysis 3.8</a>). </p> <p>One additional trial, which randomised 64 teeth, did not assess pulp canal obliteration at a fixed time point but at a mean (range) follow‐up of 36 (4 to 74) months (<a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>). The RR was 1.19 (95% CI 0.75 to 1.90). </p> </section> <section id="CD003220-sec-0111"> <h6 class="title">Dentin bridge formation</h6> <p>At six months, data were extractable from three RCTs totaling 322 teeth. The pooled results showed a greater chance of dentin bridge formation with MTA than with formocresol (RR 18.16, 95% CI 3.63 to 90.91), with evidence of a moderate statistical heterogeneity among included trials (I² = 34%). At 12 months, data were extractable from two RCTs totaling 70 teeth; the pooled results showed no statistically significant difference in dentin bridge formation with MTA compared with formocresol. The pooled RR was 6.00 (95% CI 0.76 to 47.22). Results were similar at 24 months (<a href="./references#CD003220-fig-0012" title="">Analysis 1.10</a>). </p> <p>All included trials compared MTA with 1:5 diluted formocresol.</p> <p>In addition, the trial by <a href="./references#CD003220-bbs2-0040" title="HolanG , EidelmanE , FuksAB . Long‐term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry2005; Vol. 27, issue 2:129‐36. ">Holan 2005</a>, which randomised 64 teeth, did not assess dentin bridge formation at a fixed time point but at a mean (range) follow‐up of 36 (4 to 74) months. The RR was 2.82 (95% CI 0.12 to 66.82). </p> </section> <section id="CD003220-sec-0112"> <h6 class="title">Physiological root resorption</h6> <p>At six months, data were extractable from two RCTs totaling 170 teeth. In both trials, there was no physiological root resorption in any of the participants regardless of the intervention. Results were similar at 12 months. At 24 months, one of the two trials showed no cases of physiological root resorption, regardless of the intervention. In the other trial, the results showed no statistically significant difference in physiological root resorption with MTA compared with formocresol (RR 0.33, 95% CI 0.01 to 7.83; <a href="./references#CD003220-fig-0013" title="">Analysis 1.11</a>). </p> <p>The trial providing data assessed 1:5 diluted formocresol.</p> </section> </section> <section id="CD003220-sec-0113"> <h5 class="title">MTA versus calcium hydroxide</h5> <section id="CD003220-sec-0114"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from four RCTs totaling 150 teeth. In three trials, there was no clinical failure in any participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.85). At 12 months, with four trials providing data, the pooled results showed a statistically significant difference in clinical failure between MTA and calcium hydroxide (RR 0.16 (95% CI 0.04 to 0.70), with no evidence of statistical heterogeneity among the included trials (I² = 0%). At 24 months, data were extractable from five RCTs totaling 284 teeth. All trials provided data. The pooled results showed a statistically significant difference in favour of MTA (RR 0.25, 95% CI 0.12 to 0.52), with evidence of a moderate statistical heterogeneity among included trials (I² = 31%; <a href="./references#CD003220-fig-0038" title="">Analysis 5.1</a>). </p> </section> <section id="CD003220-sec-0115"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from four RCTs totaling 150 teeth. In one trial, there was no radiological failure in any participants regardless of the intervention. In the other trials, the results showed a statistically significant difference in radiological failure in favour of MTA compared to calcium hydroxide (RR 0.08, 95% CI 0.02 to 0.41), with no evidence of statistical heterogeneity among included trials (I² = 0%). Results were similar at 12 months (RR 0.12, 95% CI 0.04 to 0.36). At 24 months, data were extractable from five RCTs totaling 284 teeth. All trials provided data. The pooled results showed a statistically significant difference in favour of MTA (RR 0.14, 95% CI 0.08 to 0.26), with evidence of substantial statistical heterogeneity among included trials (I² = 68%; <a href="./references#CD003220-fig-0039" title="">Analysis 5.2</a>). </p> </section> <section id="CD003220-sec-0116"> <h6 class="title">Overall failure</h6> <p>At six months, data were extractable from two RCTs totaling 68 teeth. In one trial, there was no overall failure in any of the participants regardless of the intervention. In the other trial, the results showed no statistically significant differences (RR 0.20, 95% CI 0.01 to 3.92). Results were similar at 12 months with all trials providing data (RR 0.34, 95% CI 0.10 to 1.19). At 24 months, the pooled results showed a statistically significant difference in favour of MTA (RR 0.42, 95% CI 0.18 to 0.95), with evidence of moderate statistical heterogeneity among included trials (I² = 36%; <a href="./references#CD003220-fig-0040" title="">Analysis 5.3</a>). </p> </section> <section id="CD003220-sec-0117"> <h6 class="title">Pain</h6> <p>At six and 12 months, one trial, which randomised 62 teeth, assessed spontaneous pain (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>). There was no pain in any of the participants regardless of the intervention. At 24 months, data were extractable from two RCTs totaling 196 teeth. The results showed no statistically significant difference between MTA and calcium hydroxide (RR 0.41, 95% CI 0.09 to 1.73; <a href="./references#CD003220-fig-0041" title="">Analysis 5.4</a>). </p> <p><b>Defective restoration (clinically)</b> </p> <p>One trial, which randomised 139 teeth, assessed amalgam restorations with ditched margins (<a href="./references#CD003220-bbs2-0015" title="CelikB , AtaçAS , CehreliZC , UysalS . A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies. Journal of Dentistry for Children (Chicago, Ill.)2013;80(3):126‐32. ">Celik 2013</a>). At 24 months, there was no statistically significant difference between MTA and calcium hydroxide (RR 0.54, 95% CI 0.08 to 3.71). </p> </section> <section id="CD003220-sec-0118"> <h6 class="title">Soft tissue pathology</h6> <p>At six months, data were extractable from three RCTs totaling 122 teeth. In one trial, there was no soft tissue pathology in any of the participants regardless of the intervention. In the other trials, results showed no statistically significant difference (RR 0.20, 95% CI 0.02 to 1.62). At 12 months, with all trials providing data, the results were statistically significant and in favour of MTA (RR 0.12, 95% CI 0.02 to 0.62), with no evidence of statistical heterogeneity among included trials (I² = 0%). At 24 months, data were extractable from four RCTs totaling 256 teeth. All trials provided data. The results were statistically significant (RR 0.17, 95% CI 0.06 to 0.47) with no evidence of statistical heterogeneity among included trials (I² = 0%; <a href="./references#CD003220-fig-0042" title="">Analysis 5.5</a>). </p> </section> <section id="CD003220-sec-0119"> <h6 class="title">Pathological mobility</h6> <p>At six and 12 months, data were extractable from three RCTs totaling 122 teeth. In one trial, there was no pathological mobility in any of the participants regardless of the intervention. In the other trials, results showed no statistically significant difference (RR 0.20, 95% CI 0.02 to 1.62). Results were statistically significant at 12 and 24 months, clearly favouring MTA (RR 0.09, 95% CI 0.01 to 0.66), with no evidence of statistical heterogeneity among included trials (I² = 0%). At 24 months, data were extractable from four RCTs totaling 256 teeth with all trials providing data (<a href="./references#CD003220-fig-0043" title="">Analysis 5.6</a>). </p> </section> <section id="CD003220-sec-0120"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from four RCTs totaling 162 teeth. For one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trials, results were statistically significant and in favour of MTA (RR 0.10, 95% CI 0.02 to 0.50), with no evidence of statistical heterogeneity among included trials (I² = 0%). Results were similar at 12 (RR 0.14, 95% CI 0.04 to 0.47) and 24 months (RR 0.08, 95% CI 0.03 to 0.22). At 24 months, data were extractable from five RCTs totaling 296 teeth with all trials providing data (<a href="./references#CD003220-fig-0044" title="">Analysis 5.7</a>). </p> </section> <section id="CD003220-sec-0121"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from five RCTs totaling 190 teeth. In one of the trials, there was no pathological root resorption in any of the participants regardless of the intervention. From the other trials, the pooled results showed statistically significant difference in pathological root resorption between MTA and calcium hydroxide (RR 0.10, 95% CI 0.02 to 0.39) with no evidence of statistical heterogeneity among included trials (I² = 0%). Results were similar at 12 (RR 0.07, 95% CI 0.02 to 0.29) and 24 months (RR 0.08, 95% CI 0.03 to 0.18). At 24 months, data were extractable from five RCTs totaling 324 teeth with all trials providing data (<a href="./references#CD003220-fig-0045" title="">Analysis 5.8</a>). </p> </section> <section id="CD003220-sec-0122"> <h6 class="title">Pulp canal obliteration</h6> <p>At six months, data were extractable from three RCTs totaling 120 teeth. In one of the trials, there was no pulp canal obliteration in any of the participants regardless of the intervention. From the other trials, the results showed a statistically significant difference between MTA and calcium hydroxide (RR 7.77, 95% CI 1.56 to 38.69), showing a higher risk of pulp canal obliteration with MTA than with calcium hydroxide, with no evidence of statistical heterogeneity among included trials (I² = 0%). At 12 months, results were not statistically significantly different with all trials providing data (RR 2.01, 95% CI 0.97 to 4.17). At 24 months, data were extractable from four RCTs totaling 254 teeth, with all trials providing data. The results showed a statistically significantly higher risk of pulp canal obliteration with MTA than with calcium hydroxide (RR 2.05, 95% CI 1.01 to 4.19), with evidence of substantial statistical heterogeneity among included trials (I² = 69%; <a href="./references#CD003220-fig-0046" title="">Analysis 5.9</a>). </p> </section> <section id="CD003220-sec-0123"> <h6 class="title">Dentin bridge formation</h6> <p>Data were extractable from two RCTs totaling 60 teeth. At six months, the results showed a statistically significant difference and a greater chance of dentin bridge formation when MTA is applied than when calcium hydroxide is applied (RR 0.20, 95% CI 0.05 to 0.84), with no evidence of statistical heterogeneity among included trials (I² = 0%). Results were not statistically significant at 12 and 24 months (RR 0.80, 95% CI 0.37 to 1.74; <a href="./references#CD003220-fig-0047" title="">Analysis 5.10</a>). </p> </section> </section> <section id="CD003220-sec-0124"> <h5 class="title">MTA versus ferric sulphate</h5> <section id="CD003220-sec-0125"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from four RCTs totaling 190 teeth. In three trials, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference in clinical failure between MTA and ferric sulphate (RR 0.08, 95% CI 0.00 to 1.31). At 12 months, data were extractable from three RCTs totaling 130 teeth. In two trials, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference in clinical failure for MTA compared with ferric sulphate (RR 0.20, 95% CI 0.01 to 3.97). Results were similar at 24 months, with all trials providing data (RR 0.52, 95% CI 0.20 to 1.39; <a href="./references#CD003220-fig-0029" title="">Analysis 4.1</a>). </p> </section> <section id="CD003220-sec-0126"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from four RCTs totaling 190 teeth. In two trials, there was no clinical failure in any of the participants regardless of the intervention. For the two remaining trials, the pooled results showed a statistically significant difference (RR 0.06, 95% CI 0.01 to 0.40) with evidence of moderate statistical heterogeneity among included trials (I² = 30%). At 12 months, data were extractable from three RCTs totaling 130 teeth. In one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining two trials, the pooled results showed no statistically significant difference (RR 0.71, 95% CI 0.15 to 3.44). Results were similar at 24 months, with all trials providing data (RR 0.58, 95% CI 0.25 to 1.36; <a href="./references#CD003220-fig-0030" title="">Analysis 4.2</a>). </p> </section> <section id="CD003220-sec-0127"> <h6 class="title">Overall failure</h6> <p>At six months, data were extractable from four RCTs totaling 190 teeth. In two trials, there was no overall failure in any participants regardless of the intervention. For the two remaining trials, the pooled results showed a statistically significant difference favouring MTA over ferric sulphate (RR 0.06, 95% CI 0.01 to 0.40) with evidence of a moderate statistical heterogeneity among included trials (I² = 30%). At 12 months, data were extractable from three RCTs totaling 130 teeth. In one trial, there was no overall failure in any of the participants regardless of the intervention. For the remaining two trials, the pooled results showed no statistically significant difference (RR 0.71, 95% CI 0.15 to 3.44). Results were similar at 24 months, with all trials providing data (RR 0.78, 95% CI 0.32 to 1.89; <a href="./references#CD003220-fig-0031" title="">Analysis 4.3</a>). </p> </section> <section id="CD003220-sec-0128"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from three RCTs totaling 160 teeth. In two trials, there was no pain in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 4.00). At 12 months, data were extractable from two RCTs totaling 100 teeth. In the two trials, there was no pain in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0032" title="">Analysis 4.4</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed pain (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pain in any of the participants regardless of the intervention. </p> <p>One additional trial, which randomised 111 teeth, did not assess pain at a fixed time point but at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). The RR was 0.36 (95% CI 0.02 to 8.75). </p> </section> <section id="CD003220-sec-0129"> <h6 class="title">Soft tissue pathology</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. In one trial, there was no soft tissue pathology in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 4.00; <a href="./references#CD003220-fig-0033" title="">Analysis 4.5</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no soft tissue pathology in any of the participants regardless of the intervention. </p> <p>One additional trial assessed soft tissue pathology at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). There was no statistically significant difference between groups (RR 0.36, 95% CI 0.02 to 8.75). </p> </section> <section id="CD003220-sec-0130"> <h6 class="title">Adjacent tissues inflammation</h6> <p>One trial, which randomised 50 teeth, assessed adjacent tissues inflammation (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). At six months, there was no adjacent tissue inflammation in any of the participants regardless of the intervention. At 12 and 24 months, the results showed no statistically significance between groups (RR 0.33, 95% CI 0.01 to 7.81; RR 0.20, 95% CI 0.01 to 3.97, respectively). </p> <p>One additional trial, which randomised 111 teeth, assessed adjacent tissues inflammation at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). There was no statistically significant difference between groups (RR 0.36, 95% CI 0.02 to 8.75). </p> </section> <section id="CD003220-sec-0131"> <h6 class="title">Pathological mobility</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. In one trial, there was no pathological mobility in any of the participants regardless of the intervention. In the other trial, the results showed no statistically significant difference (RR 0.08, 95% CI 0.00 to 1.31; <a href="./references#CD003220-fig-0034" title="">Analysis 4.6</a>). </p> <p>At 12 and 24 months, one trial, which randomised 50 teeth, assessed pathological mobility (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pathological mobility in any of the participants regardless of the intervention. </p> <p>One additional trial, which randomised 111 teeth, assessed pathological mobility at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). There was no statistically significant difference between groups (RR 0.22, 95% CI 0.01 to 4.45). </p> </section> <section id="CD003220-sec-0132"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from three RCTs totaling 160 teeth. In two trials, there was no pathological radiolucency in any of the participants regardless of the intervention. In the remaining trial, the results showed a statistically significant difference favouring MTA over ferric sulphate (RR 0.03, 95% CI 0.00 to 0.48). At 12 and 24 months, data were extractable from two RCTs totaling 100 teeth. In one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference at 12 and 24 months (RR 0.33, 95% CI 0.01 to 7.81; RR 0.20, 95% CI 0.01 to 3.97; respectively; <a href="./references#CD003220-fig-0035" title="">Analysis 4.7</a>). </p> <p>One additional trial, which randomised 111 teeth, did not assess pathological radiolucency at a fixed time point but at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). The RR was 0.36 (95% CI 0.02 to 8.75). </p> </section> <section id="CD003220-sec-0133"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from four RCTs totaling 190 teeth. In two trials, there was no pathological root resorption in any of the participants regardless of the intervention. For the two remaining trials, the pooled results showed a statistically significant difference favouring MTA over ferric sulphate (RR 0.07, 95% CI 0.01 to 0.53), with no evidence of statistical heterogeneity among included trials (I² = 8%). At 12 months, data were extractable from three RCTs totaling 130 teeth. In two trials, there was no pathological root resorption in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.97). Results were similar at 24 months, with all trials providing data (RR 0.56, 95% CI 0.12 to 2.51; <a href="./references#CD003220-fig-0036" title="">Analysis 4.8</a>). </p> <p>One trial, which randomised 111 teeth, did not assess pathological root resorption at a fixed time point but at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). The RR was 0.22 (95% CI 0.07 to 0.71). </p> </section> <section id="CD003220-sec-0134"> <h6 class="title">Pulp canal obliteration</h6> <p>At six months, data were extractable from three RCTs totaling 140 teeth. In the three trials, there was no pulp canal obliteration in any of the participants regardless of the intervention. At 12 months, data were extractable from two RCTs totaling 80 teeth. In one trial, there was no pulp canal obliteration in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 3.00, 95% CI 0.13 to 70.30). Results were similar at 24 months, with all trials providing data (RR 1.57, 95% CI 0.47 to 5.27; <a href="./references#CD003220-fig-0037" title="">Analysis 4.9</a>). </p> <p>One additional trial, which randomised 111 teeth, did not assess pulp canal obliteration at a fixed time point but at a mean (range) follow‐up of 22 (6 to 38) months (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). The RR was 1.68 (95% CI 0.93 to 3.04). </p> </section> <section id="CD003220-sec-0135"> <h6 class="title">Physiological root resorption</h6> <p>One trial, which randomised 50 teeth, assessed physiological root resorption (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>). At six and 12 months, there was no physiological root resorption in any of the participants regardless of the intervention. At 24 months, the RR was 0.14 (95% CI 0.01 to 2.63). </p> <p>Finally, one registered trial assessed clinical and radiographic success at six, nine and 12 months, but no resulting information was published (NCT02783911). </p> </section> </section> <section id="CD003220-sec-0136"> <h5 class="title">Ferric sulphate + MTA versus MTA</h5> <p>One trial, which randomised 130 teeth, assessed ferric sulphate + MTA versus MTA based on pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). This trial did not assess the outcomes at a fixed time point but at a mean (range) follow‐up of 22 (6 to 38) months. There were no statistically significant differences for any outcome (<a href="#CD003220-tbl-0004">Table 1</a>). </p> <div class="table" id="CD003220-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Pulpotomy (FS + MTA) versus pulpotomy (MTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.46 (0.17 to 70.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.75 (0.82 to 9.29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (0.51 to 1.33)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulphate; MTA: mineral trioxide aggregate </p> </div> </div> </section> <section id="CD003220-sec-0137"> <h5 class="title">MTA versus Portland cement</h5> <p><b>Clinical failure</b> </p> <p>At six, 12 and 24 months, data were extractable from three RCTs totaling 130 teeth. In two trials, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 4.02; <a href="./references#CD003220-fig-0048" title="">Analysis 6.1</a>). </p> <p><b>Radiological failure</b> </p> <p>At six and 12 months, data were extractable from three RCTs totaling 130 teeth. In the three trials, there was no radiological failure in any of the participants regardless of the intervention. At 24 months, one trial provided data, and the results showed no statistically significant difference (RR 0.50, 95% CI 0.10 to 2.56; <a href="./references#CD003220-fig-0049" title="">Analysis 6.2</a>). </p> <p><b>Pain</b> </p> <p>At six, 12 and 24 months, data were extractable from three RCTs totaling 130 teeth. In two trials, there was no pain in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.91; <a href="./references#CD003220-fig-0050" title="">Analysis 6.3</a>). </p> <p><b>Soft tissue pathology</b> </p> <p>At six, 12 and 24 months, data were extractable from three RCTs totaling 130 teeth. In two trials, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 4.02; <a href="./references#CD003220-fig-0051" title="">Analysis 6.4</a>). </p> <p><b>Pathological mobility</b> </p> <p>At six, 12 and 24 months, data were extractable from three RCTs totaling 130 teeth. In two trials, there was no pain in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.91; <a href="./references#CD003220-fig-0052" title="">Analysis 6.5</a>). </p> <p><b>Pathological radiolucency</b> </p> <p>At six and 12 months, data were extractable from three RCTs totaling 130 teeth. In the three trials, there was no radiological failure in any of the participants regardless of the intervention. At 24 months, one trial provided data, and the results showed no statistically significant difference (RR 0.67, 95% CI 0.12 to 3.75; <a href="./references#CD003220-fig-0053" title="">Analysis 6.6</a>). </p> <p><b>Pathological root resorption</b> </p> <p>At six and 12 months, data were extractable from three RCTs totaling 130 teeth. In the three trials, there was no radiological failure in any of the participants regardless of the intervention. At 24 months, one trial provided data, and the results showed no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.91; <a href="./references#CD003220-fig-0054" title="">Analysis 6.7</a>). </p> <p><b>Smell</b> </p> <p>One trial, which randomised 30 teeth, assessed smell at six, 12 and 24 months (<a href="./references#CD003220-bbs2-0071" title="SakaiVT , MorettiABS , OliveiraTM , FornettiAPC , SantosCF , MachadoM , et al. Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal2009;207(3):128‐9. [0007‐0610] ">Sakai 2009</a>). There was no smell at any time point regardless of the intervention. </p> <p><b>Pulp canal obliteration</b> </p> <p>Data were extractable from two RCTs totaling 60 teeth. All trials provided data. Results were not statistically significant at 6 (RR 0.73, 95% CI 0.49 to 1.08), 12 (RR 0.83, 95% CI 0.60 to 1.14) and 24 months (RR 0.96, 95% CI 0.71 to 1.29; <a href="./references#CD003220-fig-0055" title="">Analysis 6.8</a>). </p> <p><b>Dentin bridge formation</b> </p> <p>Data were extractable from two RCTs totaling 60 teeth. Results were not statistically significant at 6 (RR 0.56, 95% CI 0.13 to 2.43), 12 and 24 months (RR 1.50, 95% CI 0.61 to 3.71; <a href="./references#CD003220-fig-0056" title="">Analysis 6.9</a>). </p> </section> <section id="CD003220-sec-0138"> <h5 class="title">Calcium‐enriched mixture (CEM) cement versus MTA</h5> <p>One trial, which randomised 80 teeth, assessed CEM cement versus MTA based on clinical failure, radiological failure and pathological root resorption (<a href="./references#CD003220-bbs2-0050" title="MalekafzaliB , ShekarchiF , AsgaryS . Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2‐year randomised clinical trial. European Journal of Paediatric Dentistry2011;12(3):189‐93. [PUBMED: 22077689] ">Malekafzali 2011</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0005">Table 2</a>). </p> <div class="table" id="CD003220-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pulpotomy (CEM cement) versus pulpotomy (MTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CEM: calcium‐enriched mixture; CI: confidence interval; MTA: mineral trioxide aggregate </p> </div> </div> </section> <section id="CD003220-sec-0139"> <h5 class="title">MTA versus sodium hypochlorite (NaOCl)</h5> <p>One trial, which randomised 50 teeth, assessed MTA versus NaOCl based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0006">Table 3</a>). </p> <div class="table" id="CD003220-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.63)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 2.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 2.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologicroot resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.63)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 2.99)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; NaOCl: sodium hypochlorite </p> </div> </div> </section> <section id="CD003220-sec-0140"> <h5 class="title">MTA versus calcium hydroxide + sodium hypochlorite (NaOCl)</h5> <p>One trial, which randomised 62 teeth, assessed MTA versus calcium hydroxide + NaOCl based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, adjacent tissues pathology, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0007">Table 4</a>). </p> <div class="table" id="CD003220-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (CH+NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09 (0.01, 1.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologicroot resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 (0.15, 1.29)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; CH: calcium hydroxyde; NaOCl; sodium hypochlorite </p> </div> </div> </section> <section id="CD003220-sec-0141"> <h5 class="title">MTA + sodium hypochlorite (NaOCl) versus calcium hydroxide + NaOCl</h5> <p>One trial, which randomised 62 teeth, assessed MTA + NaOCl versus calcium hydroxide + NaOCl based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, adjacent tissue pathology, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0008">Table 5</a>). </p> <div class="table" id="CD003220-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Pulpotomy (MTA + NaOCl) versus pulpotomy (CH + NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.02, 1.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 3.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.27, 1.65)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite; CH: calcium hydroxyde. </p> </div> </div> </section> <section id="CD003220-sec-0142"> <h5 class="title">MTA versus buffered glutaraldehyde</h5> <p>One trial, which randomised 60 teeth, assessed MTA versus buffered glutaraldehyde based on pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>). The results showed a statistically significant difference for pain, pathological mobility, pathological radiolucency and pathological root resorption at six months, favouring MTA over buffered glutaraldehyde (RR 0.06, 95% CI 0.00 to 0.98; RR 0.06, 95% CI 0.00 to 0.98; RR 0.03, 95% CI 0.00 to 0.55; RR 0.05, 95% CI 0.00 to 0.78; respectively). There were no statistically significant differences for other outcomes at any time point (<a href="#CD003220-tbl-0009">Table 6</a>). </p> <div class="table" id="CD003220-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (2% buffered glutaraldehyde)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06 (0.00, 0.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.00, 1.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06 (0.00, 0.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03 (0.00, 0.55)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05 (0.00, 0.78)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01, 1.98)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate.</p> </div> </div> </section> <section id="CD003220-sec-0143"> <h5 class="title">MTA versus zinc oxide and eugenol (ZOE)</h5> <p>One trial, which randomised 50 teeth, assessed MTA versus ZOE based on clinical failure, radiological failure, overall failure, pain, pathological radiolucency, pathological root resorption, pulp canal obliteration and physiological root resorption (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>). There was a statistically significant difference in radiological failure at 24 months in favour of MTA (RR 0.10, 95% CI 0.01 to 0.72). There were no other statistically significant differences (<a href="#CD003220-tbl-0010">Table 7</a>). </p> <div class="table" id="CD003220-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.03 to 1.59)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 (0.01 to 0.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 (0.02 to 0.93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.00 to 1.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.0 (0.64 to 188.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Physiological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; ZOE: zinc oxide and eugenol </p> </div> </div> </section> <section id="CD003220-sec-0144"> <h5 class="title">MTA versus diode laser</h5> <p>One trial, which randomised 40 teeth, assessed MTA versus diode laser based on pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption, and premature tooth loss (<a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>). There was no premature tooth loss at any time point regardless of the intervention.There were no statistically significant differences for the other outcomes at six months (RR 0.33, 95% CI 0.01 to 7.72). </p> </section> <section id="CD003220-sec-0145"> <h5 class="title">Diode laser + MTA versus formocresol + zinc oxide and eugenol (ZOE)</h5> <p>One trial, which randomised 52 teeth, assessed diode laser + MTA versus formocresol + ZOE based on clinical failure, radiological failure, overall failure, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0072" title="SaltzmanB , SigalM , ClokieC , RukavinaJ , TitleyK , KulkarniGV . Assessment of a novel alternative to conventional formocresol‐zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser‐mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry2005; Vol. 15, issue 6:437‐47. ">Saltzman 2005</a>). This trial did not assess the outcomes at a fixed time point but at a mean (± standard deviation) follow‐up of 2.3 ± 2.1, 5.2 ± 1.9, 9.5 ± 2.3 and 15.7 ± 3 months. There was no clinical failure in any of the participants regardless of the delay. There was no statistically significant difference for radiological failure, overall failure, pathological radiolucency or pathological root resorption at any follow‐up session (<a href="#CD003220-tbl-0011">Table 8</a>). </p> <div class="table" id="CD003220-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Pulpotomy (diode laser + MTA) versus pulpotomy (FC + ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.48 to 33.42)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.40 to 9.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.33 to 26.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.27 to 8.25)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol; MTA: mineral trioxide aggregate; ZOE: zinc oxide and eugenol </p> </div> </div> </section> <section id="CD003220-sec-0146"> <h5 class="title">Low‐level diode laser versus MTA</h5> <p>One trial, which randomised 40 teeth, assessed low‐level diode laser versus MTA based on overall failure at six and 12 months (<a href="./references#CD003220-bbs2-0080" title="UloopiKS , VinayC , RatnadityaA , GopalAS , MrudulaKJ , RaoRC . Clinical evaluation of low level diode laser application for primary teeth pulpotomy. Journal of Clinical and Diagnostic Research2016;10(1):ZC67‐70. ">Uloopi 2016</a>). There was no statistically significant difference at any time point (RR 3.00, 95% CI 0.34 to 26.45; RR 4.00, 95% CI 0.49 to 32.72, respectively). </p> </section> <section id="CD003220-sec-0147"> <h5 class="title">MTA versus enamel matrix derivative (EMD)</h5> <p>One trial, which randomised 70 teeth, assessed MTA versus EMD based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference for any outcome at any time point (<a href="#CD003220-tbl-0012">Table 9</a>). </p> <div class="table" id="CD003220-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (EMD)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 (0.06, 1.28)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.91)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 (0.08, 1.93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.02)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; EMD: enamel matrix derivative </p> </div> </div> </section> <section id="CD003220-sec-0148"> <h5 class="title">Biodentine versus MTA</h5> <p><b>Clinical failure</b> </p> <p>At six months, data were extractable from four RCTs totaling 234 teeth. In one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trials, the pooled results showed no statistically significant difference (RR 1.72, 95% CI 0.42 to 6.99). At 12 months, data were extractable from two RCTs totaling 144 teeth. The pooled results showed no statistically significant difference (RR 0.75, 95% CI 0.16 to 3.62; <a href="./references#CD003220-fig-0057" title="">Analysis 7.1</a>). </p> <p><b>Radiological failure</b> </p> <p>At six months, data were extractable from four RCTs totaling 234 teeth. In one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trials, the pooled results showed no statistically significant difference (RR 2.40, 95% CI 0.65 to 8.84). At 12 months, data were extractable from two RCTs totaling 144 teeth. The pooled results showed no statistically significant difference (RR 1.08, 95% CI 0.22 to 5.27; <a href="./references#CD003220-fig-0058" title="">Analysis 7.2</a>). </p> <p><b>Pain</b> </p> <p>At six months, data were extractable from three RCTs totaling 180 teeth. In two trials, there was no pain in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 5.00, 95% CI 0.26 to 98.00; <a href="./references#CD003220-fig-0059" title="">Analysis 7.3</a>). At 12 months, one trial, which randomised 90 teeth, assessed pain. There was no pain in any of the participants regardless of the intervention. </p> <p><b>Soft tissue pathology</b> </p> <p>At six months, data were extractable from three RCTs totaling 180 teeth. In two trials, there was no soft tissue pathology in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 5.00, 95% CI 0.26 to 98.00; <a href="./references#CD003220-fig-0060" title="">Analysis 7.4</a>). At 12 months, one trial, which randomised 90 teeth, assessed soft tissue pathology. There was no soft tissue pathology in any of the participants regardless of the intervention. </p> <p><b>Adjacent tissue inflammation</b> </p> <p>One trial, which randomised 90 teeth, assessed adjacent tissue inflammation. There was no statistically significant difference at six (RR 0.50, 95% CI 0.05 to 5.32) and 12 months (R 0.33, 95% CI 0.04 to 3.08). </p> <p><b>Pathological mobility</b> </p> <p>At six months, data were extractable from three RCTs totaling 180 teeth. In two trials, there was no pathological mobility in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 5.00, 95% CI 0.26 to 98.00; <a href="./references#CD003220-fig-0061" title="">Analysis 7.5</a>). At 12 months, one trial, which randomised 90 teeth, assessed pathological mobility. There was no pathological mobility in any of the participants regardless of the intervention. </p> <p><b>Pathological radiolucency</b> </p> <p>Data were extractable from two RCTs totaling 144 teeth. At six months, in one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant evidence (RR 3.46, 95% CI 0.15 to 81.36). At 12 months, the pooled results showed no statistically significant evidence (RR 1.09, 95% CI 0.19 to 6.27; <a href="./references#CD003220-fig-0062" title="">Analysis 7.6</a>). </p> <p><b>Pathological root resorption</b> </p> <p>Data were extractable from two RCTs totaling 144 teeth. At six months, in one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant evidence (RR 2.32, 95% CI 0.22 to 24.09). At 12 months, the pooled results showed no statistically significant evidence (RR 1.12, 95% CI 0.30 to 4.19; <a href="./references#CD003220-fig-0063" title="">Analysis 7.7</a>). </p> <p><b>Pulp canal obliteration</b> </p> <p>One trial, which randomised 54 teeth, assessed pulp canal obliteration (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). There was a statistically significant difference at six (RR 5.22, 95% CI 1.24 to 21.94) and 12 months (RR 2.44, 95% CI 1.43 to 4.14) in favour of MTA. </p> <p><b>Dentin bridge formation</b> </p> <p>One trial, which randomised 54 teeth, assessed pulp canal obliteration (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). There was no statistically significant differences at six (RR 0.16, 95% CI 0.01 to 3.04) and 12 months (RR 1.28, 95% CI 0.65 to 2.49). </p> <p>One additional registered trial assessed clinical success (no abscess or any swelling related to the tooth, no fistula or other pathology, no pathological mobility, no post‐operative pain, no pain on palpation or percussion), radiographic success (no root resorption (internal or external), no furcation involvement or periapical radiolucency, no loss of lamina dura, presence of normal appearance of periodontal ligament space) at 36 months (<a href="./references#CD003220-bbs2-0152" title="Vital pulp treatment in primary teeth. Available from www.clinicaltrials.gov/ct2/show/record/NCT02298504 (accessed 26 June 2017). ">NCT02298504</a>). </p> </section> <section id="CD003220-sec-0149"> <h5 class="title">Propolis versus MTA</h5> <p>One trial, which randomised 50 teeth, assessed propolis versus MTA based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>). There was no statistically significant differences for any outcomes at six months (clinical failure: RR 3.00, 95% CI 0.13 to 70.30; radiological failure: RR 3.50, 95% CI 0.80 to 15.23). </p> </section> <section id="CD003220-sec-0150"> <h5 class="title">Aloe vera versus MTA</h5> <p>One trial, which randomised 60 teeth, assessed Aloe vera versus MTA based on clinical failure, radiological failure and overall failure (<a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>). For clinical and overall failures, there was a statistically significant difference at six (RR 51.00, 95% CI 3.25 to 801.15) and 12 months (RR 53.00, 95% CI 3.38 to 831.71) in favour of MTA. For radiological failure, there was a statistically significant difference at six and 12 months (RR 28.00, 95% CI 4.07 to 192.79) in favour of MTA. </p> </section> <section id="CD003220-sec-0151"> <h5 class="title">Tempophore versus MTA</h5> <p>One trial which randomised 56 teeth, assessed Tempophore versus MTA based on clinical failure, radiological failure, pathological radiolucency, pathological root resorption, pulp canal obliteration and dentin bridge formation (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). There were no statistically significant differences for all outcomes at any time points (<a href="#CD003220-tbl-0013">Table 10</a>). </p> <div class="table" id="CD003220-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Pulpotomy (Tempophore) versus pulpotomy (MTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.21 (0.14, 75.68)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.64 (0.54, 171.09)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.69 (0.57, 12.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.21 (0.14, 75.68)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.15 (0.43, 10.79)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.44 (0.83, 50.11)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.30 (1.00, 18.47)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.76 (0.85, 16.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.61 (0.78, 3.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Dentine bridge formation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01, 2.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.07 (0.00, 1.19)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviation: CI: confidence interval</p> </div> </div> </section> <section id="CD003220-sec-0152"> <h5 class="title">MTA versus MTA + sodium hypochlorite (NaOCl)</h5> <p>One trial, which randomised 62 teeth, assessed MTA versus MTA+NaOCl based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, adjacent tissue pathology, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0014">Table 11</a>). </p> <div class="table" id="CD003220-tbl-0014"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (MTA + NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.21, 2.13)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite. </p> </div> </div> </section> <section id="CD003220-sec-0153"> <h5 class="title">ProRoot MTA versus OrthoMTA</h5> <p>One trial, which randomised 94 teeth, assessed ProRoot MTA versus OrthoMTA based on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0015">Table 12</a>). </p> <div class="table" id="CD003220-tbl-0015"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Pulpotomy (ProRoot MTA) versus pulpotomy (OrthoMTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.06, 15.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 71.82)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.06, 15.52)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation: CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0154"> <h5 class="title">ProRoot MTA versus RetroMTA</h5> <p>One trial, which randomised 96 teeth, assessed ProRoot MTA versus RetroMTA based on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0016">Table 13</a>). </p> <div class="table" id="CD003220-tbl-0016"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Pulpotomy (ProRoot MTA) versus pulpotomy (RetroMTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.01, 8.32)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation: CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0155"> <h5 class="title">OrthoMTA versus RetroMTA</h5> <p>One trial, which randomised 96 teeth, assessed OrthoMTA versus RetroMTA based on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0045" title="KangC‐M , KimS‐H , ShinY , LeeH‐S , LeeJ‐H , KimGT , et al. A randomized controlled trial of ProRoot MTA, Ortho MTA and Retro MTA for pulpotomy in primary molars. Oral Diseases2015;21(6):785‐91. ">Kang 2015</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0017">Table 14</a>). </p> <div class="table" id="CD003220-tbl-0017"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Pulpotomy (OrthoMTA) versus pulpotomy (RetroMTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.13 (0.13, 74.85)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70 (0.12, 3.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.13 (0.13, 74.85)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.07, 16.19)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.09 (0.20, 22.24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01, 2.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation: CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0156"> <h5 class="title">Calcium hydroxide versus formocresol</h5> <section id="CD003220-sec-0157"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from six RCTs totaling 332 teeth. In two of the trials, there was no clinical failure in any of the participants regardless of the intervention. From the four remaining trials, the pooled results showed a larger risk of clinical failure with calcium hydroxide compared with formocresol. The pooled RR was 1.98 (95% CI 1.17 to 3.37). The statistical heterogeneity among included trials was substantial (I² = 57%). Results were similar at 12 months (RR 1.87, 95% CI 1.22 to 2.89). At 24 months, data were extractable from three RCTs totaling 150 teeth. The pooled results showed no statistically significant difference (RR 2.18, 95% CI 0.78 to 6.11; <a href="./references#CD003220-fig-0064" title="">Analysis 8.1</a>). </p> <p>One additional trial, which randomised 76 teeth, did not assess clinical failure at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). Between zero and six months, the RR was 1.00 (95% CI 0.06 to 15.41). Results were similar between seven and 12 months and between 13 and 24 months. </p> </section> <section id="CD003220-sec-0158"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from four RCTs totaling 154 teeth. In one of the trials, there was no radiological failure in any of the participants regardless of the intervention. From the three remaining trials, the pooled results showed a larger risk of radiological failure with calcium hydroxide compared with formocresol (RR 15.48, 95% CI 3.86 to 62.06) with no evidence of statistical heterogeneity among included trials (I² = 0%). Results at 12 months were RR 1.86 (95% CI 1.42 to 2.44) with six trials providing data (332 teeth randomised) and with substantial statistical heterogeneity (I² = 89%), and at 24 months the RR was 3.63 (95% CI 1.73 to 7.61) with three trials providing data (150 teeth randomised) and with no evidence of statistical heterogeneity (I² = 0%) (<a href="./references#CD003220-fig-0065" title="">Analysis 8.2</a>). </p> <p>The trial by <a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a> did not assess radiological failure at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months. Between zero and six months, the RR was 1.00 (95% CI 0.06 to 15.41). Results were similar between seven and 12 months. Between 13 and 24 months, the RR was 9 (95% CI 1.20 to 67.60). </p> </section> <section id="CD003220-sec-0159"> <h6 class="title">Overall failure</h6> <p>At 12 months, data were extractable from two RCTs totaling 120 teeth. The pooled results showed no statistically significant difference in overall failure with calcium hydroxide compared with formocresol. The pooled RR was 2.41 (95% CI 0.80 to 7.21). Results were similar at 24 months, although the difference was statistically significant and in favour of formocresol (RR 2.93, 95% CI 1.35 to 6.34), with no evidence of statistical heterogeneity (I² = 0%; <a href="./references#CD003220-fig-0066" title="">Analysis 8.3</a>). </p> <p>One additional trial did not assess overall failure at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). Between zero and six months, the RR was 1.00 (95% CI 0.15 to 6.74). Between seven and 12 months, the RR was 4.50 (95% CI 1.04 to 19.47). Results were similar between 13 and 24 months. </p> </section> <section id="CD003220-sec-0160"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from four RCTs totaling 276 teeth. In three of the trials, there was no pain in any of the participants regardless of the intervention. The results for the remaining trial showed no statistically significant difference in pain with calcium hydroxide compared with formocresol (RR 3.18, 95% CI 0.35 to 29.08). At 12 months, the results were statistically significant (RR 6.30, 95% CI 1.15 to 34.40), in favour of formocresol with no evidence of statistical heterogeneity (I² = 0%; <a href="./references#CD003220-fig-0067" title="">Analysis 8.4</a>). </p> </section> <section id="CD003220-sec-0161"> <h6 class="title">Soft tissue pathology</h6> <p>At six months, data were extractable from five RCTs totaling 306 teeth. In three of the four trials, there was no soft tissue pathology in any of the participants regardless of the intervention. From the two remaining trials, the pooled results showed no statistical difference in soft tissue pathology with calcium hydroxide compared with formocresol. The pooled RR was 5.14 (95% CI 0.63 to 42.25). At 12 months, the results were statistically significant (RR 6.77, 95% CI 1.23 to 37.10) in favour of formocresol with three trials providing data and with no evidence of statistical heterogeneity (I² = 0%). However, this was not statistically significant at 24 months, with only two trials providing data (<a href="./references#CD003220-fig-0068" title="">Analysis 8.5</a>). </p> <p>One additional trial, which randomised 76 teeth, did not assess soft tissue pathology at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). Between zero and six months, the RR was 1.00 (95% CI 0.06 to 15.41). Results were similar between seven and 12 months and between 13 and 24 months. </p> </section> <section id="CD003220-sec-0162"> <h6 class="title">Pathological mobility</h6> <p>At six months, data were extractable from four RCTs totaling 238 teeth. In three of the trials, there was no pathological mobility in any of the participants regardless of the intervention. From the remaining trial, the results showed no statistically significant difference in pathological mobility between calcium hydroxide and formocresol (RR 1.21, 95% CI 0.18 to 8.19). At 12 months, results were similar with two of the four trials providing data (RR 1.14, 95% CI 0.40 to 3.31). At 24 months, results were similar with one of two trials providing data (124 teeth randomised) (RR 9.00, 95% CI 0.53 to 153.79; <a href="./references#CD003220-fig-0069" title="">Analysis 8.6</a>). </p> </section> <section id="CD003220-sec-0163"> <h6 class="title">Secondary caries at the margin (clinically)</h6> <p>One trial, which randomised 84 teeth, assessed secondary caries at the margin (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). At six months, the RR was 0.17 (95% CI 0.01 to 3.23). Results were similar at 12 months. </p> </section> <section id="CD003220-sec-0164"> <h6 class="title">Defective restoration (clinically)</h6> <p>One trial, which randomised 84 teeth, assessed defective restoration (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). At six months, there was no statistically significant difference in the number of defective restorations between treatment groups (RR 0.40, 95% CI 0.02 to 9.59); at 12 months, the RR was 1.21 (95% CI 0.08 to 18.72). </p> </section> <section id="CD003220-sec-0165"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from three RCTs totaling 98 teeth. For one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trials, the pooled results showed no statistically significant difference in pathological radiolucency for calcium hydroxide compared with formocresol (RR 3.78, 95% CI 0.64 to 22.17). Results were similar at 12 months with four trials providing data (276 teeth randomised) (RR 1.90, 95% CI 0.67 to 5.40), and at 24 months with two trials providing data (124 teeth randomised) (RR 3.24, 95% CI 0.79 to 13.28; <a href="./references#CD003220-fig-0070" title="">Analysis 8.7</a>). </p> <p>One additional trial, which randomised 76 teeth, did not assess pathological radiolucency at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). Between zero and six months, the RR was 1.00 (95% CI 0.15 to 6.74). Between seven and 12 months, the RR was 4.50 (95% CI 1.04 to 19.47). Results were similar between 13 and 24 months. </p> </section> <section id="CD003220-sec-0166"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from four RCTs totaling 154 teeth. In one of the trials, there was no pathological root resorption in any of the participants regardless of the intervention. From the remaining trials, the pooled results showed a larger risk of pathological root resorption with calcium hydroxide compared with formocresol (RR 11.87, 95% CI 2.33 to 60.40), with no evidence of statistical heterogeneity among trials (I² = 0%). Results were similar at 12 months, with five of six trials providing data (332 teeth randomised) (RR 6.25, 95% CI 2.04 to 19.14), and at 24 months, with three trials providing data (150 teeth randomised) (RR 4.59, 95% CI 1.33 to 15.81; <a href="./references#CD003220-fig-0071" title="">Analysis 8.8</a>). </p> <p>One additional trial, which randomised 76 teeth, did not assess pathological root resorption at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). Between zero and six months, the RR was 1.00 (95% CI 0.31 to 3.17). Results were similar between seven and 12 months and between 13 and 24 months. </p> </section> <section id="CD003220-sec-0167"> <h6 class="title">Pulp canal obliteration</h6> <p>At six months, data were extractable from two trials totaling 56 teeth. There was no statistically significant difference (RR 4.00, 95% CI 0.47 to 33.75). At 12 months, data were extractable from three RCTs totaling 140 teeth. The pooled results showed no statistically significant difference in pulp canal obliteration with calcium hydroxide compared with formocresol (RR 2.68, 95% CI 0.91 to 7.95; <a href="./references#CD003220-fig-0072" title="">Analysis 8.9</a>). </p> <p>One additional trial, which randomised 76 teeth, did not assess pulp canal obliteration at a fixed time point but at an interval follow‐up of zero to six, seven to 12 and 13 to 24 months. Between zero and six months, the RR was 1.00 (95% CI 0.42 to 2.39) (<a href="./references#CD003220-bbs2-0087" title="ZurnD , SealeNS . Light‐cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry2008; Vol. 30, issue 1:34‐41. ">Zurn 2008</a>). Results were similar between seven and 12 months. Between 13 and 24 months, the RR was 1.88 (95% CI 1.29 to 2.72). </p> </section> <section id="CD003220-sec-0168"> <h6 class="title">Dentin bridge formation</h6> <p>Data were extractable from two RCTs totaling 60 teeth. There was a statistically significant difference in favour of calcium hydroxide at six (RR 13.00, 95% CI 1.81 to 93.60) and 12 months (RR 14.00, 95% CI 1.95 to 100.26; <a href="./references#CD003220-fig-0073" title="">Analysis 8.10</a>)<i>.</i> </p> </section> <section id="CD003220-sec-0169"> <h6 class="title">Physiological root resorption</h6> <p>One trial, which randomised 84 teeth, assessed physiological root resorption at 12 months (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). There was no statistically significant difference between groups (RR 0.40, 95% CI 0.12 to 1.39). </p> </section> <section id="CD003220-sec-0170"> <h6 class="title">Secondary caries (radiographically)</h6> <p>One trial, which randomised 84 teeth, assessed secondary caries at 12 months (<a href="./references#CD003220-bbs2-0083" title="WaterhousePJ , NunnJH , WhitworthJM . An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal2000;188(1):32‐6. [MEDLINE: 20162444] WaterhousePJ , NunnJH , WhitworthJM . Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry2002;12(2):116‐23. [PUBMED: 11966889] ">Waterhouse 2000</a>). There was no statistically significant difference between groups (RR 3.62, 95% CI 0.15 to 86.28). </p> </section> </section> <section id="CD003220-sec-0171"> <h5 class="title">Calcium hydroxide versus ferric sulphate</h5> <section id="CD003220-sec-0172"> <h6 class="title">Clinical failure</h6> <p>At six, 12 and 24 months, data were extractable from two RCTs totaling 122 teeth. At six months, one trial showed no cases of clinical failure in either treatment group. For the second trial, the results showed no statistically difference in clinical failure with calcium hydroxide compared with ferric sulphate (RR 3.40, 95% CI 0.14 to 81.38). At 12 months, the pooled results showed no statistically significant difference in clinical failure with calcium hydroxide compared with ferric sulphate (RR 3.41, 95% CI 0.37 to 31.61). Results were similar at 24 months (RR 3.44, 95% CI 0.90 to 13.18; <a href="./references#CD003220-fig-0074" title="">Analysis 9.1</a>). </p> </section> <section id="CD003220-sec-0173"> <h6 class="title">Radiological failure</h6> <p>At 12 and 24 months, data were extractable from two RCTs totaling 122 teeth. At 12 months, the pooled results showed no statistically significant difference in radiological failure with calcium hydroxide compared with ferric sulphate. The pooled RR was 1.28 (95% CI 0.53 to 3.13). The direction of effect was the same at 24 months, although the difference was statistically significant (RR 1.97, 95% CI 1.04 to 3.75) in favour of ferric sulphate, and there was no evidence of statistical heterogeneity among included trials (I² = 0%; <a href="./references#CD003220-fig-0075" title="">Analysis 9.2</a>). </p> </section> <section id="CD003220-sec-0174"> <h6 class="title">Overall failure</h6> <p>At 12 and 24 months, data were extractable from two RCTs totaling 122 teeth. At 12 months, the pooled results showed no statistically significant difference in overall failure with calcium hydroxide compared with ferric sulphate (RR 1.28, 95% CI 0.53 to 3.13). The statistical heterogeneity among included trials was substantial (I² = 54%). At 24 months, the difference was statistically significant (RR 1.97, 95% CI 1.04 to 3.75) in favour of ferric sulphate, with no evidence of statistical heterogeneity among included trials (I² = 0%; <a href="./references#CD003220-fig-0076" title="">Analysis 9.3</a>). </p> </section> <section id="CD003220-sec-0175"> <h6 class="title">Pathological root resorption</h6> <p>At 12 and 24 months, data were extractable from two RCTs totaling 122 teeth. At 12 months, one of the two trials found no pathological root resorption in any of the participants regardless of the intervention. In the second trial, the results showed no statistically significant difference in pathological root resorption with calcium hydroxide compared with ferric sulphate (RR 0.57, 95% CI 0.05 to 6.05). Results were similar at 24 months, with the two trials providing data (RR 2.29, 95% CI 0.60 to 8.66; <a href="./references#CD003220-fig-0077" title="">Analysis 9.4</a>). </p> </section> <section id="CD003220-sec-0176"> <h6 class="title">Pulp canal obliteration</h6> <p>One trial, which randomised 28 teeth, assessed pulp canal obliteration (<a href="./references#CD003220-bbs2-0075" title="SonmezD , SariS , CetinbaşT . A comparison of four pulpotomy techniques in primary molars: a long‐term follow‐up. Journal of Endodontics2008;34(8):950‐5. ">Sonmez 2008</a>). At six and 12 months, there was no pulp canal obliteration in any of the participants regardless of the intervention. At 24 months, the RR was 0.38 (95% CI 0.05 to 3.26). </p> </section> </section> <section id="CD003220-sec-0177"> <h5 class="title">Calcium hydroxide versus Portland cement</h5> <p>One trial, which randomised 30 teeth, assessed calcium hydroxide versus Portland cement based on clinical failure, radiological failure, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption, and dentin bridge formation (<a href="./references#CD003220-bbs2-0061" title="OliveiraTM , MorettiAB , SakaiVT , Lourenço NetoN , SantosCF , MachadoMA , et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. European Archives of Paediatric Dentistry2013;14(2):65‐71. [PUBMED: 23549993] ">Oliveira 2013a</a>). There were statistically significant differences for radiological failure, pathological radiolucency and pathological root resorption at 12 (RR 17.00, 95% CI 1.07 to 270.41) and 24 months (RR 21.00, 95% CI 1.34 to 328.86). There were no statistically significant differences for other outcomes (<a href="#CD003220-tbl-0018">Table 15</a>). </p> <div class="table" id="CD003220-tbl-0018"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 15.</span> <span class="table-title">Pulpotomy (CH) versus pulpotomy (PC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 96.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.07 to 270.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.00 (1.34 to 328.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 96.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 96.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable *</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.07 to 270.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.00 (1.34 to 328.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.07 to 270.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.00 (1.34 to 328.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dentine bridge formation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.11 to 2.33)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxide; PC: Portland cement.</p> </div> </div> </section> <section id="CD003220-sec-0178"> <h5 class="title">Calcium hydroxide versus MTA + sodium hypochlorite (NaOCl)</h5> <p>One trial, which randomised 62 teeth, assessed MTA+NaOCl versus calcium hydroxide + NaOCl based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, adjacent tissue pathology, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>). The results showed statistically significant differences for radiological failure and pathological root resorption at 12 months (RR 8.00, 95% CI 1.06 to 60.21; RR 17.00, 95% CI 1.02 to 282.30, respectively). There were no statistically significant differences for other outcomes at any time point (<a href="#CD003220-tbl-0019">Table 16</a>). </p> <div class="table" id="CD003220-tbl-0019"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 16.</span> <span class="table-title">Pulpotomy (CH) versus pulpotomy (MTA + NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.62, 40.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.00 (1.06, 60.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.00 (0.89, 251.77)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.02, 282.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.52, 3.39)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxyde; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite. </p> </div> </div> </section> <section id="CD003220-sec-0179"> <h5 class="title">Erbium:yttrium‐aluminium garnet (Er:YAG) laser versus calcium hydroxide</h5> <p>One trial, which randomised 91 teeth, assessed Er:YAG laser versus calcium hydroxide based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>). Statistically significant differences were shown at 24 months with regard to radiological failure (RR 0.31 (95% CI 0.11 to 0.90) and overall failure (RR 0.31 (95% CI 0.11 to 0.90), in favour of Er:YAG laser. There were no statistically significant differences for any other outcome or time point (<a href="#CD003220-tbl-0020">Table 17</a>). </p> <div class="table" id="CD003220-tbl-0020"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 17.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.01 to 7.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.60 to 14.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 (0.11 to 3.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56 (0.14 to 2.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.11 to 0.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56 (0.14 to 2.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.11 to 0.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.01 to 7.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 (0.11 to 3.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.60 to 14.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 (0.11 to 3.56)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; CH: calcium hydroxide. </p> </div> </div> </section> <section id="CD003220-sec-0180"> <h5 class="title">Calcium hydroxide/iodoform versus calcium hydroxide</h5> <p>One trial, which randomised 65 teeth, assessed calcium hydroxide/iodoform versus calcium hydroxide based on clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0021">Table 18</a>). </p> <div class="table" id="CD003220-tbl-0021"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 18.</span> <span class="table-title">Pulpotomy (CH/iodoform) versus pulpotomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.41 (0.77 to 2.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.82 to 1.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.89 to 2.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.17 (0.87 to 1.59)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.72 (0.45 to 6.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 (0.33 to 3.23)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.55 (0.28 to 8.65)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 (0.22 to 4.74)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.15 (0.26 to 103.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.72 (0.45 to 6.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29 (0.38 to 4.37)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; CH: calcium hydroxide.</p> </div> </div> </section> <section id="CD003220-sec-0181"> <h5 class="title">Low‐level laser therapy (LLLT) versus calcium hydroxide</h5> <p>One trial, which randomised 30 teeth, assessed LLLT versus calcium hydroxide based on clinical failure, radiological failure, pain, soft tissue pathology, adjacent tissue inflammation, pathologic mobility, pathologic radiolucency, pathologic root resorption, pulp canal obliteration, and dentin bridge formation at six and 12 months (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>). There was no clinical failure, pain, soft tissue pathology, adjacent tissue inflammation pathologic mobility and pathologic radiolucency in any of the participants regardless of the intervention. There were no statistically significant differences for radiological failure and pathologic root resorption at six and 12 months (RR 0.50, 95% CI 0.15 to 1.64), pulp canal obliteration at six (RR 0.50, 95% CI 0.05 to 4.94) and 12 months (RR 2.50, 95% CI 0.57 to 10.93), and dentin bridge formation at six (RR 0.11, 95% CI 0.01 to 1.90) and 12 months (RR 0.09, 95% CI 0.01 to 1.51). </p> </section> <section id="CD003220-sec-0182"> <h5 class="title">Low‐level laser therapy (LLLT) + calcium hydroxide versus calcium hydroxide</h5> <p>One trial, which randomised 30 teeth, assessed LLLT + calcium hydroxide versus calcium hydroxide based on clinical failure, radiological failure, pain, soft tissue pathology, adjacent tissue inflammation, pathologic mobility, pathologic radiolucency, pathologic root resorption, pulp canal obliteration, and dentin bridge formation at six and 12 months (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>). There was no clinical failure, pain, soft tissue pathology, adjacent tissue inflammation pathologic mobility and pathologic radiolucency in any of the participants regardless of the intervention. There were no statistically significant differences for radiological failure and pathologic root resorption at six (RR 0.33, 95% CI 0.08 to 1.39) and 12 months (RR 0.50, 95% CI 0.15 to 1.64), pulp canal obliteration at six and 12 months (RR 0.50, 95% CI 0.05 to 4.94), and dentin bridge formation at six (RR 1.75, 95% CI 0.64 to 4.75) and 12 months (RR 1.40, 95% CI 0.57 to 3.43). </p> </section> <section id="CD003220-sec-0183"> <h5 class="title">Low‐level laser therapy (LLLT) versus LLLT + calcium hydroxide</h5> <p>One trial, which randomised 30 teeth, assessed LLLT versus LLLT + calcium hydroxide based on clinical failure, radiological failure, pain, soft tissue pathology, adjacent tissue inflammation, pathologic mobility, pathologic radiolucency, pathologic root resorption, pulp canal obliteration, and dentin bridge formation at six and 12 months (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>). There was no clinical failure, pain, soft tissue pathology, adjacent tissue inflammation pathologic mobility and pathologic radiolucency in any of the participants regardless of the intervention. There were no statistically significant differences for radiological failure and pathologic root resorption at six (RR 1.50, 95% CI 0.29 to 7.73) and 12 months (RR 1.00, 95% CI 0.24 to 4.18), pulp canal obliteration at six (RR 1.00, 95% CI 0.07 to 14.55) and 12 months (RR 5.00, 95% CI 0.66 to 37.85), and dentin bridge formation at six and 12 months (RR 0.07, 95% CI 0.00 to 1.07). </p> </section> <section id="CD003220-sec-0184"> <h5 class="title">Calcium hydroxide + sodium hypochlorite (NaOCl) versus calcium hydroxide</h5> <p>One trial, which randomised 62 teeth, assessed calcium hydroxide + NaOCl versus calcium hydroxide based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, adjacent tissue pathology, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0003" title="AkcayM , SariS . The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth. Pediatric Dentistry2014;36(4):316‐21. ">Akcay 2014</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0022">Table 19</a>). </p> <div class="table" id="CD003220-tbl-0022"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 19.</span> <span class="table-title">Pulpotomy (CH + NaOCl) versus pulpotomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09 (0.01, 1.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63 (0.23, 1.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.43 (0.12, 1.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 (0.11, 1.28)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.50, 2.53)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxide; NaOCl: sodium hypochlorite.</p> </div> </div> </section> <section id="CD003220-sec-0185"> <h5 class="title">Biodentine versus calcium hydroxide</h5> <p>One trial, which randomised 62 teeth, assessed calcium hydroxide + NaOCl versus calcium hydroxide based on clinical failure, radiological failure, pain, soft tissue pathology, defective restoration (clinically), secondary caries at the margin (clinically), pathological radiolucency, and pathological root resorption (<a href="./references#CD003220-bbs2-0037" title="GrewalN , SalhanR , KaurN , PatelH B . Comparative evaluation of calcium silicate‐based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemporary Clinical Dentistry2016;7(4):457‐63. ">Grewal 2016</a>). There were no radiological failures, no soft tissue pathology and no secondary caries at the margin at six and 12 months. There were no statistically significant differences for clinical failure and pain at six and 12 months (RR 0.33, 95% CI 0.01 to 7.72), defective restoration at 12 months (RR 1.00, 95% CI 0.39 to 2.58), and pathological root resorption at six (RR 0.33, 95% CI 0.01 to 7.72) and 12 months (RR 0.20, 95% CI 0.01 to 3.92). </p> </section> <section id="CD003220-sec-0186"> <h5 class="title">Ferric sulphate versus formocresol</h5> <section id="CD003220-sec-0187"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from six RCTs totaling 394 teeth. In five RCTs, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trials, there was no statistically significant difference (RR 1.00, 95% CI 0.15 to 6.87). Results were similar at 12 months, with five trials providing data (RR 1.38, 95% CI 0.45 to 4.27). At 24 months, data were extractable from five RCTs totaling 258 teeth. The pooled results for the three trials showed no statistically significant difference in clinical failure (RR 0.83, 95% CI 0.40 to 1.70; <a href="./references#CD003220-fig-0078" title="">Analysis 10.1</a>). </p> <p>One trial, which randomised 164 teeth, did not assess clinical failure at a fixed time point but at an interval follow‐up of three to 20 and 46 to 48 months (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>). The RR was 1.00 (95% CI 0.02 to 49.04) at three to 20 months and RR 1.58 (95% CI 0.27 to 9.18) at 46 to 48 months. </p> </section> <section id="CD003220-sec-0188"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from six RCTs totaling 294 teeth. In two trials, there was no radiological failure in any of the participants regardless of the intervention. From the remaining trials, the pooled results showed no statistically significant difference in clinical failure with ferric sulphate compared with formocresol (RR 0.79, 95% CI 0.32 to 1.92). Results were similar at 12 months, with six trials providing data (394 teeth randomised) (RR 1.33, 95% CI 0.73, 2.42), and at 24 months, with five trials providing data (258 teeth randomised) (RR 1.26, 95% CI 0.71 to 2.24; <a href="./references#CD003220-fig-0079" title="">Analysis 10.2</a>). </p> <p>One trial, which randomised 164 teeth, did not assess radiological failure at a fixed time point but at an interval follow‐up of three to 20 and 46 to 48 months (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>). The RR was 1.00 (95% CI 0.42 to 2.36) at three to 20 months. Results were similar at 46 to 48 months. </p> </section> <section id="CD003220-sec-0189"> <h6 class="title">Overall failure</h6> <p>At six months, data were extractable from four RCTs totaling 184 teeth. In two trials, there was no overall failure in any of the participants regardless of the intervention. From the two remaining trials, the pooled results showed no statistically significant difference in clinical failure with ferric sulphate compared with formocresol (RR 0.53, 95% CI 0.12 to 2.37). Results were similar at 12 months, with four of five trials providing data (284 teeth randomised) (RR 1.16, 95% CI 0.51, 2.64), and at 24 months, with four trials providing data (228 teeth randomised) (RR 1.49, 95% CI 0.74 to 3.01; <a href="./references#CD003220-fig-0080" title="">Analysis 10.3</a>). </p> <p>Two additional trials, which randomised 96 teeth (<a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>) and 164 teeth (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>), did not assess overall failure at a fixed time point but at an interval follow‐up of 24 to 35 months and 46 to 48 months, respectively. The RR was 0.44 (95% CI 0.13 to 1.45) for 24 to 35 months (<a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>) and 1.33 (95% CI 0.44 to 4.03) for 46 to 48 months (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>). </p> </section> <section id="CD003220-sec-0190"> <h6 class="title">Pain</h6> <p>Data were extractable from four RCTs totaling 230 teeth. In three trials, no participant declared pain regardless of the intervention. For the remaining trial, there was no statistically significant difference at six, 12 (RR 0.33, 95% CI 0.01 to 7.58) and 24 months (RR 0.20, 95% CI 0.01 to 3.85; <a href="./references#CD003220-fig-0081" title="">Analysis 10.4</a>). </p> <p><b>Soft tissue pathology</b> </p> <p>One trial, which randomised 30 teeth, assessed soft tissue pathology at six, 12 and 24 months (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no statistically significant evidence (RR 0.33, 95% CI 0.01 to 7.58). </p> <p><b>Pathologic mobility</b> </p> <p>One trial, which randomised 30 teeth, assessed soft tissue pathology at six, 12 and 24 months (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no statistically significant evidence (RR 0.33, 95% CI 0.01 to 7.58). </p> <p><b>Adjacent tissue inflammation</b> </p> <p>One trial, which randomised 50 teeth, assessed adjacent tissue inflammation (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no adjacent tissue inflammation in any of the participants regardless of the intervention. At 12 and 24 months, there was no statistically significant difference (RR 5.00, 95% CI 0.25, 99.16). </p> </section> <section id="CD003220-sec-0191"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, two trials, which randomised 80 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>, <a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no pathological radiolucency in any of the participants regardless of the intervention. At 12 months, data were extractable from four RCTs totaling 230 teeth. In two trials, there was no pathological radiolucency in any of the participants regardless of the intervention. From the remaining trials, the results showed no statistically significant difference in pathological radiolucency with ferric sulphate compared with formocresol (RR 1.80, 95% CI 0.40 to 8.17). Results were similar at 24 months (RR 2.20, 95% CI 0.51 to 9.50; <a href="./references#CD003220-fig-0082" title="">Analysis 10.5</a>). </p> <p>Two additional trials, which randomised 96 (<a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>) and 164 (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>) teeth, did not assess pathological radiolucency at a fixed time point but at an interval follow‐up of six to 11, 12 to 23 and 24 to 35 months for <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a> and three to 20 and 46 to 48 months for <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>. In the two trials, there was no pathological radiolucency in any of the participants regardless of the intervention at the first delays. At 24 to 35 months, the RR was 0.44 (95% CI 0.08 to 2.49) (<a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>) and at 46 to 48 months RR 2.86 (95% CI 0.30 to 26.90) (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>). </p> </section> <section id="CD003220-sec-0192"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from five RCTs totaling 314 teeth. In three trials, there was no pathological root resorption in any of the participants regardless of the intervention. For the remaining trials, the pooled results showed no statistically significant evidence (RR 0.67, 95% CI 0.12 to 3.84). At 12 months, data were extractable from SIX RCTs totaling 314 teeth. In two trials, there was no pathological root resorption in any of the participants regardless of the intervention. From the remaining trials, the pooled results showed no statistically significant difference in pathological root resorption with ferric sulphate compared with formocresol (RR 1.64, 95% CI 0.53 to 5.08). Results were similar at 24 months with four trials providing data (258 teeth randomised) (RR 1.21, 95% CI 0.50 to 2.96; <a href="./references#CD003220-fig-0083" title="">Analysis 10.6</a>). </p> <p>Two additional trials did not assess pathological root resorption at a fixed time point but at an interval follow‐up of six to 11, 12 to 23 and 24 to 35 months for <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a> and three to 20 and 46 to 48 months for <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>. For <a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>, there was no pathological root resorption in any of the participants regardless of the intervention at the first delays. At 24 to 35 months, the RR was 1.31 (95% CI 0.25 to 6.81). In <a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>, the RR was 0.95 (95% CI 0.06 to 14.97) at three to 20 months and RR 0.63 (95% CI 0.11 to 3.70) at 46 to 48 months. </p> </section> <section id="CD003220-sec-0193"> <h6 class="title">Pulp canal obliteration</h6> <p>At six months, data were extractable from three RCTs totaling 134 teeth. In all three trials, there was no pulp canal obliteration in any of the participants regardless of the intervention. At 12 months, data were extractable from three RCTs totaling 134 teeth. In one of the trials, there was no pulp canal obliteration in any of the participants regardless of the intervention. From the two remaining trials, the pooled results showed no statistically significant difference in pulp canal obliteration with ferric sulphate compared with formocresol (RR 0.94, 95% CI 0.54 to 1.64). At 24 months, data were extractable from two RCTs totaling 78 teeth. The pooled results showed no statistically significant difference in pulp canal obliteration with ferric sulphate compared with formocresol (RR 1.24, 95% CI 0.28 to 5.54; <a href="./references#CD003220-fig-0084" title="">Analysis 10.7</a>). </p> <p>One additional trial, which randomised 96 teeth, did not assess pulp canal obliteration at a fixed time point but at an interval follow‐up of six to 11, 12 to 23 and 24 to 35 months (<a href="./references#CD003220-bbs2-0033" title="FuksAB , HolanG , DavisJM , EidelmanE . Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long‐term follow up. Pediatric Dentistry1997;19(5):327‐30. ">Fuks 1997</a>). There was no pulp canal obliteration in any of the participants regardless of the intervention at six to 11 or 12 to 23 months. At 24 to 35 months, the RR was 1.64 (95% CI 0.55 to 4.85). </p> </section> <section id="CD003220-sec-0194"> <h6 class="title">Physiological root resorption</h6> <p>One trial, which randomised 50 teeth, assessed physiological root resorption (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>). At six and 12 months, there was no physiological root resorption in any of the participants regardless of the intervention. At 24 months, the RR was 3.00 (95% CI 0.33 to 26.92). </p> </section> <section id="CD003220-sec-0195"> <h6 class="title">Succedaneous tooth structural anomaly</h6> <p>One trial, which randomised 164 teeth, assessed succedaneous tooth structural anomaly (<a href="./references#CD003220-bbs2-0042" title="IbricevicH , Al‐JameQ . Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow‐up. Journal of Clinical Pediatric Dentistry2000;24(4):269‐72. [MEDLINE: 21210539] IbricevicH , Al‐JameQ . Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow‐up study. European Journal of Paediatric Dentistry2003;4(1):28‐32. [PUBMED: 12870985] ">Ibricevic 2000</a>). At three to 20 and 46 to 48 months, there was no succedaneous tooth structural anomaly in any of the participants regardless of the intervention. </p> </section> </section> <section id="CD003220-sec-0196"> <h5 class="title">Sodium hypochlorite (NaOCl) versus ferric sulphate</h5> <section id="CD003220-sec-0197"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. In the two trials, there was no clinical failure in any of the participants regardless of the intervention. At 12 months, data were extractable from two RCTs totaling 110 teeth. In one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 4.39, 95% CI 0.22 to 87.82; <a href="./references#CD003220-fig-0085" title="">Analysis 11.1</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 3.00, 95% CI 0.13 to 70.30). </p> </section> <section id="CD003220-sec-0198"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. The results showed no statistically significant difference (RR 0.55, 95% CI 0.22 to 1.39). Results were similar at 12 months (RR 0.42, 95% CI 0.17 to 1.02; <a href="./references#CD003220-fig-0086" title="">Analysis 11.2</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 1.50, 95% CI 0.27 to 8.22). </p> </section> <section id="CD003220-sec-0199"> <h6 class="title">Overall failure</h6> <p>One trial, which randomised 50 teeth, assessed overall failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference at six months (RR 3.00, 95% CI 0.33 to 26.92), 12 and 24 months (RR 1.50, 95% CI 0.27 to 8.22). </p> </section> <section id="CD003220-sec-0200"> <h6 class="title">Pain</h6> <p>At six and 12 months, data were extractable from two RCTs totaling 110 teeth. In the two trials, there was no pain in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0087" title="">Analysis 11.3</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed pain (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pain in any of the participants regardless of the intervention. </p> <p><b>Soft tissue pathology</b> </p> <p>At six and 12 months, data were extractable from two RCTs totaling 110 teeth. In the two trials, there was no soft tissue pathology in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0088" title="">Analysis 11.4</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no soft tissue pathology in any of the participants regardless of the intervention. </p> <p><b>Adjacent tissue inflammation</b> </p> <p>At six months, data were extractable from two RCTs totaling 110 teeth. In the two trials, there was no adjacent tissue inflammation in any of the participants regardless of the intervention. At 12 months, data were extractable from two RCTs totaling 110 teeth. The pooled results showed no statistically significant difference (RR 0.31, 95% CI 0.03 to 2.91; <a href="./references#CD003220-fig-0089" title="">Analysis 11.5</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 0.50, 95% CI 0.05 to 5.17). </p> <p><b>Pathological mobility</b> </p> <p>At six and 12 months, data were extractable from two RCTs totaling 110 teeth. In the two trials, there was no pathological mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0090" title="">Analysis 11.6</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed pathological mobility (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pathological mobility in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0201"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. In one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.88, 95% CI 0.06 to 13.35). Results were similar at 12 months, with the two trials providing data (RR 0.56, 95% CI 0.07 to 4.17; <a href="./references#CD003220-fig-0091" title="">Analysis 11.7</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.97). </p> </section> <section id="CD003220-sec-0202"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. The pooled results showed no statistically significant difference (RR 0.51, 95% CI 0.18 to 1.42). Results were similar at 12 months (RR 0.38, 95% CI 0.15 to 1.01; <a href="./references#CD003220-fig-0092" title="">Analysis 11.8</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 1.50, 95% CI 0.27 to 8.22). </p> </section> </section> <section id="CD003220-sec-0203"> <h5 class="title">Ferric sulphate versus buffered glutaraldehyde</h5> <p>One trial, which randomised 60 teeth, assessed ferric sulphate versus buffered glutaraldehyde based on pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0036" title="GoyalP , PanditIK , GugnaniN , GuptaM , GoelR , GambhirRS . Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial. European Journal of Dentistry2016;10(3):315‐20. [PUBMED: 27403046] ">Goyal 2016</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0023">Table 20</a>). </p> <div class="table" id="CD003220-tbl-0023"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 20.</span> <span class="table-title">Pulpotomy (FS) versus pulpotomy (buffered glutaraldehyde)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.06, 1.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.07, 1.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (0.30, 1.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14 (0.69, 1.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20 (0.61, 2.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01, 1.98)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulfate.</p> </div> </div> </section> <section id="CD003220-sec-0204"> <h5 class="title">Ferric sulphate versus zinc oxide and eugenol (ZOE)</h5> <p>One trial, which randomised 50 teeth, assessed ferric sulphate versus ZOE based on clinical failure, radiological failure, overall failure, pain, pathological radiolucency, pathological root resorption, pulp canal obliteration and physiological root resorption (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0024">Table 21</a>). </p> <div class="table" id="CD003220-tbl-0024"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 21.</span> <span class="table-title">Pulpotomy (FS) versus pulpotomy (ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20 (0.42 to 3.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.26 to 1.40)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 (0.11 to 1.25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17 (0.02 to 1.29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Physiological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.27 to 8.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulphate; ZOE: zinc oxide and eugenol </p> </div> </div> </section> <section id="CD003220-sec-0205"> <h5 class="title">Erbium:yttrium‐aluminium garnet (Er:YAG) laser versus ferric sulphate</h5> <p>One trial, which randomised 97 teeth, assessed Er:YAG laser versus ferric sulphate by clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>). There were no statistically significant differences for any outcome or time point (<a href="#CD003220-tbl-0025">Table 22</a>). </p> <div class="table" id="CD003220-tbl-0025"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 22.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (FS)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.19 (0.13 to 76.37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.31 (0.26 to 107.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.13 to 1.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 (0.19 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.13 to 1.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 (0.19 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01 to 2.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71 (0.12 to 4.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53 (0.05 to 5.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.16 to 7.25)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; FS: ferric sulphate </p> </div> </div> </section> <section id="CD003220-sec-0206"> <h5 class="title">Diode laser versus ferric sulphate</h5> <section id="CD003220-sec-0207"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from three RCTs totaling 130 teeth. The pooled results showed no statistically significant difference (RR 0.23, 95% CI 0.04 to 1.30). Results were similar at 12 months, with two trials providing data (100 teeth randomised) (RR 0.20, 95% CI 0.02 to 1.62; <a href="./references#CD003220-fig-0093" title="">Analysis 12.1</a>). </p> </section> <section id="CD003220-sec-0208"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from three RCTs totaling 130 teeth. The pooled results showed no statistically significant difference (RR 0.89, 95% CI 0.38 to 2.12). Results were similar at 12 months, with two trials providing data (100 teeth randomised) (RR 0.91, 95% CI 0.44 to 1.92; <a href="./references#CD003220-fig-0094" title="">Analysis 12.2</a>). </p> </section> <section id="CD003220-sec-0209"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.20, 95% CI 0.03 to 1.60; <a href="./references#CD003220-fig-0095" title="">Analysis 12.3</a>). </p> </section> <section id="CD003220-sec-0210"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.25, 95% CI 0.03 to 2.08; <a href="./references#CD003220-fig-0096" title="">Analysis 12.4</a>). </p> </section> <section id="CD003220-sec-0211"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from twoRCTs totaling 50 teeth. In one trial, there was no pathological root resorption in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 1.50, 95% CI 0.29 to 7.73; <a href="./references#CD003220-fig-0097" title="">Analysis 12.5</a>). </p> </section> </section> <section id="CD003220-sec-0212"> <h5 class="title">Electrosurgery versus ferric sulphate</h5> <section id="CD003220-sec-0213"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.56, 95% CI 0.13 to 2.34; <a href="./references#CD003220-fig-0098" title="">Analysis 13.1</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 1.00, 95% CI 0.17 to 5.77). </p> </section> <section id="CD003220-sec-0214"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 1.25, 95% CI 0.38 to 4.12; <a href="./references#CD003220-fig-0099" title="">Analysis 13.2</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 1.00, 95% CI 0.17 to 5.77). </p> </section> <section id="CD003220-sec-0215"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.56, 95% CI 0.13 to 2.34) (<a href="./references#CD003220-fig-0100" title="">Analysis 13.3</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pain (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 1.00, 95% CI 0.17 to 5.77). </p> <p><b>Pathological mobility</b> </p> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pathological mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0101" title="">Analysis 13.4</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pathological mobility (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). There was no pathological mobility in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0216"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.25, 95% CI 0.03 to 2.08; <a href="./references#CD003220-fig-0102" title="">Analysis 13.5</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70). </p> </section> <section id="CD003220-sec-0217"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 2.20, 95% CI 0.54 to 8.88; <a href="./references#CD003220-fig-0102" title="">Analysis 13.5</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pathological root resorption (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 5.00, 95% CI 0.27 to 92.62). </p> <p><b>Pulp canal obliteration</b> </p> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pulp canal obliteration in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0103" title="">Analysis 13.6</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pulp canal obliteration (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). There was no pulp canal obliteration in any of the participants regardless of the intervention. </p> </section> </section> <section id="CD003220-sec-0218"> <h5 class="title">Ferric sulphate + MTA versus ferric sulphate</h5> <p>One trial, which randomised 135 teeth, assessed ferric sulphate + MTA versus ferric sulphate based on pain, soft tissue pathology, pathological mobility, adjacent tissue inflammation, pathological radiolucency, pathological root resorption, and pulp canal obliteration (<a href="./references#CD003220-bbs2-0022" title="DoyleTL , CasasMJ , KennyDJ , JuddPL . Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry2010;32(1):41‐7. [PUBMED: 20298652] ">Doyle 2010</a>). This trial did not assess the outcomes at a fixed time point but at a mean (range) follow‐up of 22 (6 to 38) months. There were no statistically significant differences for any outcome (<a href="#CD003220-tbl-0026">Table 23</a>). </p> <div class="table" id="CD003220-tbl-0026"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 23.</span> <span class="table-title">Pulpotomy (FS + MTA) versus pulpotomy (FS)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.01 to 6.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.01 to 6.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01 to 3.09)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.01 to 6.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 (0.01 to 6.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.31 to 1.19)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.39 (0.78 to 2.49)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; FS: ferric sulphate; MTA: mineral trioxide aggregate</p> </div> </div> </section> <section id="CD003220-sec-0219"> <h5 class="title">Ferric sulphate versus Ankaferd Blood Stopper</h5> <p><b>Clinical failure</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six months, there was no clinical failure in any of the participants regardless of the intervention. At 12 months, for one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant difference (RR 1.25, 95% CI 0.37 to 4.27; <a href="./references#CD003220-fig-0104" title="">Analysis 14.1</a>). At 24 months, one trial, which randomised 30 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There were no statistically significant differences (RR 5.00, 95% CI 0.26 to 96.13). </p> <p><b>Radiological failure</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six months, for one trial, there was no radiological failure in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant difference (RR 1.00, 95% CI 0.16 to 6.20). At 12 months, the pooled results showed no statistically significant difference (RR 0.88, 95% CI 0.34 to 2.23; <a href="./references#CD003220-fig-0105" title="">Analysis 14.2</a>). At 24 months, one trial, which randomised 30 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no statistically significant difference (RR 1.00, 95% CI 0.16 to 6.20). </p> <p><b>Pain</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six months, there was no pain in any of the participants regardless of the intervention. At 12 months, for one trial, there was no pain in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant differences (RR 1.00, 95% CI 0.15 to 6.71; <a href="./references#CD003220-fig-0106" title="">Analysis 14.3</a>). At 24 months, one trial, which randomised 30 teeth, assessed pain (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no pain in any of the participants regardless of the intervention. </p> <p><b>Soft tissue pathology</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six months, there was no soft tissue pathology in any of the participants regardless of the intervention. At 12 months, for one trial, there was no soft tissue pathology in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant differences (RR 1.50, 95% CI 0.27 to 8.43; <a href="./references#CD003220-fig-0107" title="">Analysis 14.4</a>). At 24 months, one trial, which randomised 30 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no soft tissue pathology in any of the participants regardless of the intervention. </p> <p><b>Pathologic mobility</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six and 12 months, there was no pathologic mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0108" title="">Analysis 14.5</a>). At 24 months, one trial, which randomised 30 teeth, assessed pathologic mobility (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no pathologic mobility in any of the participants regardless of the intervention. </p> <p><b>Pathological radiolucency</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six months, there was no pathological radiolucency in any of the participants regardless of the intervention. At 12 months, for one trial, there was no pathological radiolucency in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant differences (RR 0.67, 95% CI 0.12 to 3.75; <a href="./references#CD003220-fig-0109" title="">Analysis 14.6</a>). At 24 months, one trial, which randomised 30 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no pathological radiolucency in any of the participants regardless of the intervention. </p> <p><b>Pathological root resorption</b> </p> <p>Data were extractable from two trials totaling 100 teeth. At six months, for one trial, there was no pathological root resorption in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant difference (RR 5.00, 95% CI 0.26 to 96.13). At 12 months, the pooled results showed no statistically significant differences (RR 1.00, 95% CI 0.31 to 3.23; <a href="./references#CD003220-fig-0110" title="">Analysis 14.7</a>). At 24 months, one trial, which randomised 30 teeth, assessed pathological root resorption (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There was no statistically significant differences (RR 1.00, 95% CI 0.16 to 6.20). </p> </section> <section id="CD003220-sec-0220"> <h5 class="title">Portland cement versus full strength formocresol</h5> <p>One trial, which randomised 70 teeth, assessed Portland cement versus formocresol based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There were no statistically significant differences for any outcomes at time point (<a href="#CD003220-tbl-0027">Table 24</a>). </p> <div class="table" id="CD003220-tbl-0027"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 24.</span> <span class="table-title">Pulpotomy (PC) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19, 21.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 (0.23, 2.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19, 21.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07, 15.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19, 21.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 71.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.22, 4.62)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.27)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations ‐ CI: confidence interval; PC: Portland cement; FC: formocresol</p> </div> </div> </section> <section id="CD003220-sec-0221"> <h5 class="title">Portland cement versus enamel matrix derivative (EMD)</h5> <p>One trial, which randomised 70 teeth, assessed MTA versus EMD based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There were no statistically significant differences for any outcomes at time point (<a href="#CD003220-tbl-0028">Table 25</a>). </p> <div class="table" id="CD003220-tbl-0028"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 25.</span> <span class="table-title">Pulpotomy (PC) versus pulpotomy (EMD)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.12, 3.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 (0.18, 1.78)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.12, 3.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07, 15.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.15, 6.71)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.27)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.16, 2.32)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.27)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; PC: Portland cement; EMD: enamel matrix derivative</p> </div> </div> </section> <section id="CD003220-sec-0222"> <h5 class="title">Portland cement versus Portland cement + iodoform (Portland cement + CHI₃) or Portland cement + zirconium oxide (Portland cement + ZrO₂) </h5> <p>One trial, which randomised 30 teeth, assessed Portland cement versus Portland cement + CHI₃ or Portland cement + ZrO₂ based on clinical failure, radiological failure, pathological root resorption, pathological radiolucency, soft tissue pathology, pathological mobility (<a href="./references#CD003220-bbs2-0049" title="Lourenço NetoN , MarquesNC , FernandesAP , Hungaro DuarteMA , AbdoRC , MachadoMA , et al. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies. European Archives of Paediatric Dentistry2015;16(5):377‐82. [PUBMED: 25788172] ">Lourenço 2015a</a>). There were no events in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0223"> <h5 class="title">Glutaraldehyde + calcium hydroxide versus full strength formocresol</h5> <p>One trial, which randomised 44 teeth, assessed glutaraldehyde + calcium hydroxide versus ZOE based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>). There were no statistically significant differences for either outcome at three months (clinical failure: RR 1.10, 95% CI 0.17 to 7.10; radiological failure: RR 1.10, 95% CI 0.31 to 3.84). No longer‐term data were reported. </p> </section> <section id="CD003220-sec-0224"> <h5 class="title">Glutaraldehyde + zinc oxide and eugenol (ZOE) versus full strength formocresol</h5> <p>One trial, which randomised 48 teeth, assessed glutaraldehyde + ZOE versus ZOE based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>). There were no statistically significant differences for either outcome at three months (clinical failure: RR 0.46 95% CI 0.04 to 4.74; radiological failure: RR 0.46, 95% CI 0.09 to 2.28). No longer‐term data were reported. </p> </section> <section id="CD003220-sec-0225"> <h5 class="title">Glutaraldehyde + calcium hydroxide versus glutaraldehyde + zinc oxide and eugenol (ZOE) </h5> <p>One trial, which randomised 46 teeth, assessed glutaraldehyde + calcium hydroxide versus glutaraldehyde + ZOE based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0004" title="AlaçamA . Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde‐calcium and glutaraldehyde‐zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics1989;13(4):307‐13. AlaçamA . Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde‐calcium hydroxide, glutaraldehyde‐zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics1989;13:123‐32. ">Alaçam 1989</a>). There were no statistically significant differences for either outcome at three months (clinical failure: RR 2.38, 95% CI 0.23 to 24.46; radiological failure: RR 2.38, 95% CI 0.48 to 11.74). No longer‐term data were reported. </p> <p>An additional trial, which randomised 61 teeth, assessed glutaraldehyde + calcium hydroxide versus glutaraldehyde + ZOE at 12 months based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0074" title="ShumayrikhNM , AdenubiJO . Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics and Dental Traumatology1999;15(6):259‐64. [MEDLINE: 20285582] ">Shumayrikh 1999</a>). There were no statistically significant differences between treatment groups for any outcome (<a href="#CD003220-tbl-0029">Table 26</a>). </p> <div class="table" id="CD003220-tbl-0029"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 26.</span> <span class="table-title">Pulpotomy (glutaraldehyde + CH) versus pulpotomy (glutaraldehyde + ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90 (0.32 to 26.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11 (0.46 to 2.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.39 to 2.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.15 to 6.44)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval; ZOE: zinc oxide and eugenol </p> </div> </div> </section> <section id="CD003220-sec-0226"> <h5 class="title">Electrofulguration + calcium hydroxide versus electrofulguration + zinc oxide eugenol (ZOE) </h5> <p>One trial, which randomised 47 teeth, assessed electrofulguration + calcium hydroxide versus electrofulguration + ZOE based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0032" title="FishmanSA , UdinRD , GoodDL , RodefF . Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry1996;18(5):385‐90. [MEDLINE: 97052902] ">Fishman 1996</a>). There were no statistically significant differences for either outcome at six months (<a href="#CD003220-tbl-0030">Table 27</a>). </p> <div class="table" id="CD003220-tbl-0030"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 27.</span> <span class="table-title">Pulpotomy (electrofulguration + CH) versus pulpotomy (electrofulguration + ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (0.26, 2.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.47, 1.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.47, 1.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (0.26, 2.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.43, 2.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (0.28, 2.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.16, 6.80)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxide; ZOE: zinc oxide eugenol</p> </div> </div> </section> <section id="CD003220-sec-0227"> <h5 class="title">Electrosurgery versus formocresol</h5> <p>One trial, which randomised 70 teeth, assessed electrosurgery versus 1:5 diluted formocresol at fixed time points, reporting on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0011" title="BahrololoomiZ , MoeintaghaviA , EmtiaziM , HosseiniG . Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research2008; Vol. 19, issue 3:219‐23. ">Bahrololoomi 2008</a>). There was no statistically significant difference at any time point for any outcome (<a href="#CD003220-tbl-0031">Table 28</a>). </p> <div class="table" id="CD003220-tbl-0031"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 28.</span> <span class="table-title">Pulpotomy (electrosurgery) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 71.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.62 to 40.64)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 71.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 100.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 100.54)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol</p> </div> </div> <p>One additional trial, which randomised 50 teeth, did not assess electrosurgery versus full strength formocresol at a fixed time point but at a mean (range) follow‐up of 11.5 (5 to 25) months in one the formocresol group and 10.9 (6 to 31) in the other electrosurgery group (<a href="./references#CD003220-bbs2-0020" title="DeanJA , MackRB , FulkersonBT , SandersBJ . Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry2002;12:177‐82. [MEDLINE: 22024492] ">Dean 2002</a>). There was no statistically significant difference for clinical failure (RR 3.00, 95% CI 0.13 to 70.30) or radiological failure (RR 2.00, 95% CI 0.40 to 9.95). </p> </section> <section id="CD003220-sec-0228"> <h5 class="title">Diode laser versus electrosurgery</h5> <section id="CD003220-sec-0229"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70; <a href="./references#CD003220-fig-0111" title="">Analysis 15.1</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70). </p> </section> <section id="CD003220-sec-0230"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.64, 95% CI 0.19 to 2.18; <a href="./references#CD003220-fig-0112" title="">Analysis 15.2</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70). </p> </section> <section id="CD003220-sec-0231"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In one trial, there was no pain in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70; <a href="./references#CD003220-fig-0113" title="">Analysis 15.3</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pain (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70). </p> <p><b>Pathological mobility</b> </p> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pathological mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0114" title="">Analysis 15.4</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pathological mobility (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). There was no pathological mobility in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0232"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pathological radiolucency in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0115" title="">Analysis 15.5</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). There was no pathological radiolucency in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0233"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 0.64, 95% CI 0.19 to 2.18; <a href="./references#CD003220-fig-0116" title="">Analysis 15.6</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pathological root resorption (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). The results showed no statistically significant difference (RR 0.20, 95% CI 0.01 to 3.70). </p> <p><b>Pulp canal obliteration</b> </p> <p>At six months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pulp canal obliteration in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0117" title="">Analysis 15.7</a>). </p> <p>At 12 months, one trial, which randomised 20 teeth, assessed pulp canal obliteration (<a href="./references#CD003220-bbs2-0038" title="GuptaG , RanaV , SrivastavaN , ChandnaP . Laser Pulpotomy‐An Effective Alternative to Conventional Techniques: A 12 Months Clinicoradiographic Study. Jaypees International Journal of Clinical Pediatric Dentistry2015;8(1):18‐21. ">Gupta 2015</a>). There was no pulp canal obliteration in any of the participants regardless of the intervention. </p> </section> </section> <section id="CD003220-sec-0234"> <h5 class="title">Electrosurgery versus calcium‐enriched mixture (CEM)</h5> <p>One trial, which randomised 102 teeth, assessed clinical failure, radiological failure, overall failure and pulp canal obliteration (<a href="./references#CD003220-bbs2-0046" title="KhorakianF , MazhariF , AsgaryS , SahebnasaghM , Alizadeh KasebA , MovahhedT , et al. Two‐year outcomes of electrosurgery and calcium‐enriched mixture pulpotomy in primary teeth: a randomised clinical trial. European Archives of Paediatric Dentistry2014;15(4):223‐8. ">Khorakian 2014</a>). At six, 12 and 24 months, there was no clinical failure in any of the participants regardless of the intervention. For radiological/overall failure, there were no statistically significant differences at six (RR 0.20, 95% CI 0.01 to 4.07), 12 (RR 1.00, 95% CI 0.06 to 15.56) and 24 months (RR 0.50, 95% CI 0.10 to 2.61). For pulp canal obliteration, there were no statistically significant differences at 12 months (RR 1.22, 95% CI 0.88 to 1.70). </p> </section> <section id="CD003220-sec-0235"> <h5 class="title">Biodentine versus formocresol</h5> <p>One trial, which randomised 112 teeth, assessed clinical failure, radiological failure, pain, soft tissue pathology, pathologic mobility, pathological radiolucency, pathological root resorption and pulp canal obliteration at six months (<a href="./references#CD003220-bbs2-0025" title="ElMeligyO A , AllazzamS , AlamoudiN M . Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial. Quintessence International2016;47(7):571‐80. ">El Meligy 2016</a>). There was no clinical failure, radiological failure, pain, soft tissue pathology, pathologic mobility, pathological radiolucency and pathological root resorption in any of the participants regardless of the intervention. For pulp canal obliteration, there was no statistically significant difference (RR 1.43, 95% CI 0.59 to 3.49). </p> </section> <section id="CD003220-sec-0236"> <h5 class="title">Biodentine versus diode laser</h5> <p>One trial, which randomised 40 teeth, assessed Biodentine versus diode based on pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption, and premature tooth loss (<a href="./references#CD003220-bbs2-0058" title="NiranjaniK , PrasadMG , VasaAA , DivyaG , ThakurMS , SaujanyaK . Clinical evaluation of success of primary teeth pulpotomy using Mineral Trioxide Aggregate(®), laser and Biodentine(TM)‐ an in vivo study. Journal of Clinical and Diagnostic Research2015;9(4):ZC35‐7. ">Niranjani 2015</a>). There was no premature tooth loss in any of the participants regardless of the intervention.There were no statistically significant differences for the other outcomes at six months (RR 2.00, 95% CI 0.20 to 20.33). </p> </section> <section id="CD003220-sec-0237"> <h5 class="title">Biodentine versus Tempophore</h5> <p>One trial, which randomised 56 teeth, assessed Biodentine versus Tempophore based on clinical failure, radiological failure, pathological radiolucency, pathological root resorption, pulp canal obliteration and dentin bridge formation at six and 12 months (<a href="./references#CD003220-bbs2-0067" title="RajasekharanS , MartensL C , VandenbulckeJ , JacquetW , BottenbergP , CauwelsR G . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. International Endodontic Journal2017;50(3):215‐28. ">Rajasekharan 2017</a>). There were no statistically significant differences for any outcomes at any time point (<a href="#CD003220-tbl-0032">Table 29</a>). </p> <div class="table" id="CD003220-tbl-0032"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 29.</span> <span class="table-title">Pulpotomy (Biodentine) versus pulpotomy (Tempophore)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 (0.07, 16.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.11, 2.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.16 (0.21, 22.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.11, 2.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36 (0.08, 1.62)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.07, 1.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.39 (0.61, 3.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 (0.60, 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dentine bridge formation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.85 (0.69, 203.86)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval</p> </div> </div> </section> <section id="CD003220-sec-0238"> <h5 class="title">Biodentine versus propolis</h5> <p>One trial, which randomised 50 teeth, assessed Biodentine versus propolis based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0047" title="KusumB , RakeshK , RichaK . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restorative Dentistry and Endodontics2015;40(4):276‐85. ">Kusum 2015</a>). There were no statistically significant differences for any outcomes at six months (clinical failure: RR 0.33, 95% CI 0.01 to 7.81; radiological failure: RR 0.43, 95% CI 0.12 to 1.47). </p> </section> <section id="CD003220-sec-0239"> <h5 class="title">Sodium hypochlorite (NaOCl) versus 1:5 diluted formocresol</h5> <section id="CD003220-sec-0240"> <h6 class="title">Clinical failure</h6> <p>At six and 12 months, data were extractable from two RCTs totaling 150 teeth. In the two trials, there was no clinical failure in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0118" title="">Analysis 16.1</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 3.00, 95% CI 0.13 to 70.30). </p> </section> <section id="CD003220-sec-0241"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two RCTs totaling 150 teeth. The pooled results showed no statistically significant difference (RR 1.29, 95% CI 0.33 to 5.08). Results were similar at 12 months (RR 1.86, 95% CI 0.52 to 6.59; <a href="./references#CD003220-fig-0119" title="">Analysis 16.2</a>). </p> <p>At 24 months, one trial, which randomised 50 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 3.00, 95% CI 0.33 to 26.92). </p> <p><b>Overall failure</b> </p> <p>At six, 12 and 24 months, one trial, which randomised 50 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 7.00, 95% CI 0.38 to 128.87). </p> </section> <section id="CD003220-sec-0242"> <h6 class="title">Pain</h6> <p>At six and 12 months, data were extractable from two RCTs totaling 150 teeth. In the two trials, there was no pain in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0120" title="">Analysis 16.3</a>). </p> <p>At 24 months, one trial, which randomised 20 teeth, assessed pain (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pain in any of the participants regardless of the intervention. </p> <p><b>Soft tissue pathology</b> </p> <p>At six and 12 months, data were extractable from two RCTs totaling 150 teeth. In the two trials, there was no soft tissue pathology in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0121" title="">Analysis 16.4</a>). </p> <p>At 24 months, one trial, which randomised 20 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no soft tissue pathology in any of the participants regardless of the intervention. </p> <p><b>Adjacent tissue inflammation</b> </p> <p>One trial, which randomised 50 teeth, assessed adjacent tissue inflammation (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). At six and 12 months, there was no adjacent tissue inflammation in any of the participants regardless of the intervention. At 24 months, the results showed no statistically significant difference (RR 3.00, 95% CI 0.13 to 70.30). </p> <p><b>Pathological mobility</b> </p> <p>At six and 12 months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pathological mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0122" title="">Analysis 16.5</a>). </p> <p>At 24 months, one trial, which randomised 20 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pathological mobility in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0243"> <h6 class="title">Pathological radiolucency</h6> <p>At six and 12 months, data were extractable from two RCTs totaling 50 teeth. In the two trials, there was no pathological radiolucency in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0123" title="">Analysis 16.6</a>). </p> <p>At 24 months, one trial, which randomised 20 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). There was no pathological radiolucency in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0244"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from two RCTs totaling 50 teeth. The pooled results showed no statistically significant difference (RR 1.29, 95% CI 0.33 to 5.08; <a href="./references#CD003220-fig-0124" title="">Analysis 16.7</a>). Results were similar at 12 months (RR 1.86, 95% CI 0.52 to 6.59). </p> <p>At 24 months, one trial, which randomised 20 teeth, assessed pathological root resorption (<a href="./references#CD003220-bbs2-0031" title="FernándezCC , MartínezSS , JimenoFG , Lorente RodríguezAI , MercadéM . Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2‐year follow‐up. International Journal of Paediatric Dentistry2013;23(6):400‐7. ">Fernández 2013</a>). The results showed no statistically significant difference (RR 3.00, 95% CI 0.33 to 26.92). </p> </section> </section> <section id="CD003220-sec-0245"> <h5 class="title">Calcium hydroxide/iodoform versus full strength formocresol</h5> <p>One trial, which randomised 67 teeth, assessed calcium hydroxide/iodoform versus formocresol, reporting on clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0005" title="AlaçamA , OdabaşME , TüzünerT , SillelioğluH , BayginO . Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;108(5):e127‐33. ">Alaçam 2009</a>). For clinical failure, the RR was 16.41 (95% CI 2.30 to 117.26) at six months and RR 9.11 (95% CI 3.04 to 27.31) at 12 months in favour of formocresol. For radiological failure, the RR was 24.06 (95% CI 3.44 to 168.43) at six months and RR 9.11 (95% CI 3.04 to 27.31) at 12 months. There was no statistically significant difference for any other outcome at either six or 12 months (<a href="#CD003220-tbl-0033">Table 30</a>). </p> <div class="table" id="CD003220-tbl-0033"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 30.</span> <span class="table-title">Pulpotomy (CH/iodoform) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.41 (2.30 to 117.26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.11 (3.04 to 27.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.06 (3.44 to 168.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.11 (3.04 to 27.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.47 (0.67 to 44.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.47 (0.67 to 44.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.64 (0.41 to 142.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.64 (0.41 to 142.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19 (0.21 to 22.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19 (0.21 to 22.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.00 (0.69 to 208.77)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.47 (0.67 to 44.34)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval; FC: formocresol</p> </div> </div> </section> <section id="CD003220-sec-0246"> <h5 class="title">Zinc oxide and eugenol (ZOE) versus formocresol</h5> <p>One trial, which randomised 50 teeth, assessed ZOE versus formocresol based on clinical failure, radiological failure, overall failure, pain, pathological radiolucency, pathological root resorption, pulp canal obliteration and physiological root resorption (<a href="./references#CD003220-bbs2-0026" title="ErdemAP , GuvenY , BalliB , IlhanB , SepetE , UlukapiI , et al. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24‐month study. Pediatric Dentistry2011;33(2):165‐70. [PUBMED: 21703067] ">Erdem 2011</a>). At six and 12 months, there was no clinical failure in any of the participants regardless of the intervention. There was no statistically significant difference for any outcome at any time point (<a href="#CD003220-tbl-0034">Table 31</a>). </p> <div class="table" id="CD003220-tbl-0034"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 31.</span> <span class="table-title">Pulpotomy (ZOE) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (0.29 to 2.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 99.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67 (0.71 to 3.89)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 99.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.67 (0.80 to 8.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.00 (0.78 to 46.29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Physiological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19 to 20.67)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol; ZOE: zinc oxide and eugenol</p> </div> </div> </section> <section id="CD003220-sec-0247"> <h5 class="title">Erbium:yttrium‐aluminium garnet (Er:YAG) laser versus formocresol</h5> <p>One trial, which randomised 97 teeth, assessed Er:YAG laser versus formocresol based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0041" title="HuthKC , PaschosE , Hajek‐Al‐KhatarN , HollweckR , CrispinA , HickelR , et al. Effectiveness of 4 pulpotomy techniques ‐ randomized controlled trial. Journal of Dental Research2005;84(12):1144‐8. ">Huth 2005</a>). There were no statistically significant differences for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0035">Table 32</a>). </p> <div class="table" id="CD003220-tbl-0035"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 32.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.19 (0.13 to 76.37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.13 (0.20 to 22.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 (0.28 to 9.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.28 to 4.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 (0.28 to 9.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.28 to 4.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.01 to 8.49)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 (0.01 to 4.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.16 to 7.25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.19 (0.13 to 76.37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.16 to 7.25)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; FC: formocresol </p> </div> </div> </section> <section id="CD003220-sec-0248"> <h5 class="title">Diode laser versus formocresol</h5> <p>One trial, which randomised 80 teeth, assessed diode laser versus formocresol based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0023" title="DurmusB , TanbogaI . In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. Photomedicine and Laser Surgery2014;32(5):289‐95. ">Durmus 2014</a>). There were no statistically significant differences for any outcome at six and 12 months (<a href="#CD003220-tbl-0036">Table 33</a>). </p> <div class="table" id="CD003220-tbl-0036"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 33.</span> <span class="table-title">Pulpotomy (diode laser) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67 (0.43, 6.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.75, 5.33)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol.</p> </div> </div> </section> <section id="CD003220-sec-0249"> <h5 class="title">Low‐level laser therapy (LLLT) versus formocresol</h5> <p>One trial, which randomised 30 teeth, assessed LLLT versus formocresol based on clinical failure, radiological failure, pain, soft tissue pathology, adjacent tissue inflammation, pathologic mobility, pathologic radiolucency, pathologic root resorption, pulp canal obliteration, and dentin bridge formation at six and 12 months (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>). There was no clinical failure, pain, soft tissue pathology, adjacent tissue inflammation pathologic mobility, pathologic radiolucency and dentin bridge formation in any of the participants regardless of the intervention. There were no statistically significant differences for radiological failure and pathologic root resorption at six and 12 months (RR 7.00, 95% CI 0.39 to 124.83), pulp canal obliteration at six (RR 3.00, 95% CI 0.13 to 68.26) and 12 months (RR 1.67, 95% CI 0.48 to 5.76). </p> </section> <section id="CD003220-sec-0250"> <h5 class="title">Low‐level laser therapy (LLLT) + calcium hydroxide versus formocresol</h5> <p>One trial, which randomised 30 teeth, assessed LLLT + calcium hydroxide versus formocresol based on clinical failure, radiological failure, pain, soft tissue pathology, adjacent tissue inflammation, pathologic mobility, pathologic radiolucency, pathologic root resorption, pulp canal obliteration, and dentin bridge formation at six and 12 months (<a href="./references#CD003220-bbs2-0030" title="FernandesA P , Lourenco NetoN , Teixeira MarquesN C , Silveira MorettiA B , SakaiV T , Cruvinel SilvaT , et al. Clinical and radiographic outcomes of the use of Low‐Level Laser Therapy in vital pulp of primary teeth. International Journal of Paediatric Dentistry2015;25(2):144‐50. ">Fernandes 2015</a>). There was no clinical failure, pain, soft tissue pathology, adjacent tissue inflammation pathologic mobility and pathologic radiolucency in any of the participants regardless of the intervention. There were no statistically significant differences for radiological failure and pathologic root resorption at six (RR 5.00, 95% CI 0.26 to 96.13) and 12 months (RR 7.00, 95% CI 0.39 to 124.83), pulp canal obliteration at six (RR 3.00, 95% CI 0.13 to 68.26) and 12 months (RR 0.33, 95% CI 0.04 to 2.85), and dentin bridge formation at six and 12 months (RR 15.00, 95% CI 0.93 to 241.20). </p> </section> <section id="CD003220-sec-0251"> <h5 class="title">Ankaferd Blood Stopper versus formocresol</h5> <p>One trial, which randomised 30 teeth, assessed Ankaferd Blood Stopper versus formocresol based on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathologic root resorption (<a href="./references#CD003220-bbs2-0063" title="OzmenB , BayrakS . Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Nigerian Journal of Clinical Practice2017;20(7):832‐8. ">Ozmen 2017</a>). There were no statistically significant differences for all outcomes at any time points (<a href="#CD003220-tbl-0037">Table 34</a>). </p> <div class="table" id="CD003220-tbl-0037"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 34.</span> <span class="table-title">Pulpotomy (ABS) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.13, 3.44)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.13, 3.44)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval</p> </div> </div> </section> <section id="CD003220-sec-0252"> <h5 class="title">Enamel matrix derivative (EMD) versus formocresol</h5> <p>Two trials assessed EMD versus formocresol: one trial assessed full strength formocresol (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>), and the other trial assessed 1:5 diluted formocresol (<a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>). </p> <section id="CD003220-sec-0253"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from two RCTs totaling 100 teeth. The results showed no statistically significant difference (RR 0.80, 95% CI 0.23 to 2.83; <a href="./references#CD003220-fig-0125" title="">Analysis 17.1</a>). </p> <p>At 12 and 24 months, one trial, which randomised 70 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 3.00, 95% CI 0.33 to 27.46). </p> </section> <section id="CD003220-sec-0254"> <h6 class="title">Radiological failure</h6> <p>At six months, one trial, which randomised 30 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a>). There was a statistically significant difference in favour of EMD (RR 0.46, 95% CI 0.24 to 0.88). </p> <p>At 24 months, one trial, which randomised 70 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 1.40, 95% CI 0.49 to 3.99). </p> </section> <section id="CD003220-sec-0255"> <h6 class="title">Overall failure</h6> <p>At six, 12 and 24 months, one trial, which randomised 70 teeth, assessed overall failure (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 3.00, 95% CI 0.33 to 27.46). </p> </section> <section id="CD003220-sec-0256"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two RCTs totaling 100 teeth. The results showed no statistically significant difference (RR 0.40, 95% CI 0.08 to 1.92; <a href="./references#CD003220-fig-0126" title="">Analysis 17.2</a>). </p> <p>At 12 and 24 months, one trial, which randomised 70 teeth, assessed pain (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 1.00, 95% CI 0.07 to 15.36). </p> </section> <section id="CD003220-sec-0257"> <h6 class="title">Soft tissue pathology</h6> <p>At six months, data were extractable from two RCTs totaling 100 teeth. In one trial, there was no soft tissue pathology in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 2.00, 95% CI 0.19 to 21.06; <a href="./references#CD003220-fig-0127" title="">Analysis 17.3</a>). </p> <p>At 12 and 24 months, one trial, which randomised 70 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 2.00, 95% CI 0.19 to 21.06). </p> </section> <section id="CD003220-sec-0258"> <h6 class="title">Pathological mobility</h6> <p>At six months, data were extractable from two RCTs totaling 100 teeth. In one trial, there was no pathological mobility in any of the participants regardless of the intervention. For the remaining trial, the results showed no statistically significant difference (RR 5.00, 95% CI 0.26 to 96.13; <a href="./references#CD003220-fig-0128" title="">Analysis 17.4</a>). </p> <p>At 12 and 24 months, one trial, which randomised 70 teeth, assessed pathological mobility (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 5.00, 95% CI 0.25 to 100.53). </p> </section> <section id="CD003220-sec-0259"> <h6 class="title">Pathological radiolucency</h6> <p>At 24 months, one trial, which randomised 70 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 1.67, 95% CI 0.43 to 6.45). </p> </section> <section id="CD003220-sec-0260"> <h6 class="title">Pathological root resorption</h6> <p>At 24 months, one trial, which randomised 70 teeth, assessed pathological root resorption (<a href="./references#CD003220-bbs2-0085" title="YildirimC , BasakF , AkgunOM , PolatGG , AltunC . Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow‐Up. Journal of Clinical Pediatric Dentistry2016;40(1):14‐20. ">Yildirim 2016</a>). There was no statistically significant difference (RR 1.00, 95% CI 0.15 to 6.71). </p> </section> </section> <section id="CD003220-sec-0261"> <h5 class="title">Full strength formocresol compared with 1:5 diluted formocresol</h5> <p>One trial, which randomised 30 teeth, assessed clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption at six months (<a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>). There was no event in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0262"> <h5 class="title">Full strength formocresol compared with 1:25 diluted formocresol</h5> <p>One trial, which randomised 30 teeth, assessed clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption at six months (<a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>). There was no event in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0263"> <h5 class="title">1:5 diluted formocresol compared with 1:25 diluted formocresol</h5> <p>One trial, which randomised 30 teeth, assessed clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption at six months (<a href="./references#CD003220-bbs2-0035" title="GoyalS , AbuwalaT , JoshiK , MehtaJ , IndushekarKR , HallikerimathS . The clinical, radiographic and histological evaluation of three different concentrations of formocresol as a pulpotomy agent. Journal of International Oral Health2014;6(2):118‐25. ">Goyal 2014</a>). There was no event in any of the participants regardless of the intervention. </p> </section> </section> <section id="CD003220-sec-0264"> <h4 class="title">Pulpectomy versus pulpectomy</h4> <p>We assessed 15 trials that compared pulpectomy using different types of medicaments. Two trials were assessed at high risk of bias, and the risk of bias was unclear for 13 trials. </p> <section id="CD003220-sec-0265"> <h5 class="title">Calcium hydroxide versus zinc oxide and eugenol (ZOE)</h5> <section id="CD003220-sec-0266"> <h6 class="title">Clinical failure</h6> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>, which randomised 40 teeth, assessed calcium hydroxide versus ZOE based on clinical failure at six and 12 months; there was no statistically significant difference at either time point (six months: RR 3.00, 95% CI 0.13 to 69.52; 12 months: RR 9.00, 95% CI 0.52 to 156.92). </p> <p><a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>, which randomised 70 teeth, assessed calcium hydroxide versus ZOE based on clinical failure at nine months. There was no statistically significant difference (RR 0.25, 95% CI 0.03 to 2.13). </p> </section> <section id="CD003220-sec-0267"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. The pooled results showed no statistically significant difference in radiological failure between calcium hydroxide and ZOE (RR 2.50, 95% CI 0.50 to 12.50; <a href="./references#CD003220-fig-0129" title="">Analysis 18.1</a>). </p> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a> provided data on radiological failure at 12 months. There was no statistically significant difference (RR 9.00, 95% CI 0.52 to 156.92). </p> </section> <section id="CD003220-sec-0268"> <h6 class="title">Overall failure</h6> <p><a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>, which randomised 70 teeth, provided data on overall failure. There was no statistically significant difference at nine months (RR 0.50, 95% CI 0.10 to 2.56). Data at other time points were unavailable. </p> </section> <section id="CD003220-sec-0269"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. The pooled RR was 1.00 (95% CI 0.14 to 6.90; <a href="./references#CD003220-fig-0130" title="">Analysis 18.2</a>). </p> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>, which randomised 40 teeth, provided data on pain at 12 months. There was no statistically significant difference (RR 3.00, 95% CI 0.13 to 69.52). </p> </section> <section id="CD003220-sec-0270"> <h6 class="title">Pathological mobility</h6> <p>At six months, data were extractable from two RCTs totaling 110 teeth. The pooled RR was 1.00 (95% CI 0.14 to 6.90; <a href="./references#CD003220-fig-0131" title="">Analysis 18.3</a>). </p> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>, which randomised 40 teeth, also provided data on pathological mobility at 12 months. There was no statistically significant difference (RR 3.00, 95% CI 0.13 to 69.52). </p> </section> <section id="CD003220-sec-0271"> <h6 class="title">Pathological radiolucency</h6> <p>Two trials (110 teeth) provided data on pathological radiolucency at six months (<a href="./references#CD003220-bbs2-0054" title="NadkarniU , DamleSG . Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2000;18(1):1‐10. [MEDLINE: 21222096] ">Nadkarni 2000</a>; <a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). The pooled results showed no statistically significant difference between calcium hydroxide and ZOE (RR 1.50, 95% CI 0.26 to 8.72; <a href="./references#CD003220-fig-0132" title="">Analysis 18.4</a>). </p> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a> provided data at 12 months. There was no statistically significant difference (RR 5.00, 95% CI 0.26 to 98.00). </p> </section> <section id="CD003220-sec-0272"> <h6 class="title">Pathological root resorption</h6> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a> provided data on pathological root resorption. There was no pathological root resorption in any of the participants regardless of the time of assessment. </p> </section> <section id="CD003220-sec-0273"> <h6 class="title">Filling material anomaly</h6> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>, which randomised 40 teeth, provided data on filling material anomaly. There was no filling material anomaly in any of the participants regardless of the time of assessment. </p> </section> </section> <section id="CD003220-sec-0274"> <h5 class="title">Sealapex versus calcium hydroxide</h5> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>, which randomised 40 teeth, assessed Sealapex (eugenol‐free calcium hydroxide) versus calcium hydroxide based on clinical failure, radiological failure, pain, pathological mobility, pathological radiolucency, pathological root resorption and filling material anomaly. There was no statistically significant difference for any outcome at either six or 12 months (<a href="#CD003220-tbl-0038">Table 35</a>). </p> <div class="table" id="CD003220-tbl-0038"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 35.</span> <span class="table-title">Pulpectomy (Sealapex) versus pulpectomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.10 to 2.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.10 to 2.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26 to 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Filling material anomaly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Sealapex: eugenol‐free CH; CH: calcium hydroxide.</p> </div> </div> </section> <section id="CD003220-sec-0275"> <h5 class="title">Vitapex versus calcium hydroxide</h5> <p><a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>, which randomised 40 teeth, assessed Vitapex versus calcium hydroxide based on clinical failure, radiological failure, pain, pathological mobility, pathological radiolucency, pathological root resorption and filling material anomaly. There was no statistically significant difference for any outcome at either six or 12 months (<a href="#CD003220-tbl-0039">Table 36</a>). </p> <div class="table" id="CD003220-tbl-0039"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 36.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Filling material anomaly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide.</p> </div> </div> </section> <section id="CD003220-sec-0276"> <h5 class="title">Metapex versus zinc oxide and eugenol (ZOE)</h5> <section id="CD003220-sec-0277"> <h6 class="title">Clinical failure</h6> <p>Data were extractable from two trials, totaling 62 teeth (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>; <a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There were no statistically significant differences at six (RR 0.60, 95% CI 0.08 to 4.29) and 12 months (RR 0.71, 95% CI 0.15 to 3.33; <a href="./references#CD003220-fig-0134" title="">Analysis 19.1</a>). </p> </section> <section id="CD003220-sec-0278"> <h6 class="title">Radiological failure</h6> <p>At six and 12 months, data were extractable from two trials, totaling 62 teeth. There was no statistically significant difference (RR 1.00, 95% CI 0.31 to 3.27; <a href="./references#CD003220-fig-0135" title="">Analysis 19.2</a>). </p> </section> <section id="CD003220-sec-0279"> <h6 class="title">Pain</h6> <p>At six and 12 months, one trial, which randomised 30 teeth, assessed pain (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58). </p> </section> <section id="CD003220-sec-0280"> <h6 class="title">Pathologic mobility</h6> <p>At six and 12 months, one trial, which randomised 30 teeth, assessed pathologic mobility (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58). </p> </section> <section id="CD003220-sec-0281"> <h6 class="title">Soft tissue pathology</h6> <p>At six and 12 months, one trial, which randomised 30 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no soft tissue pathology in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0282"> <h6 class="title">Adjacent tissue inflammation</h6> <p>At six and 12 months, one trial, which randomised 30 teeth, assessed adjacent tissue inflammation (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There were no adjacent tissue inflammation in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0283"> <h6 class="title">Pathologic radiolucency</h6> <p>At six and 12 months, data were extractable from two trials, totaling 62 teeth. There was no pathologic radiolucency in one trial; for the remaining trial, there was no statistically significant difference (RR 1.33, 95 CI 0.35 to 5.03) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). </p> </section> <section id="CD003220-sec-0284"> <h6 class="title">Pathologic root resorption</h6> <p>At six and 12 months, one trial, which randomised 30 teeth, assessed adjacent tissue inflammation (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58). </p> </section> </section> <section id="CD003220-sec-0285"> <h5 class="title">Metapex versus Endoflas</h5> <section id="CD003220-sec-0286"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from two trials totaling 92 teeth. In one trial, there was no clinical failure in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58; <a href="./references#CD003220-fig-0136" title="">Analysis 20.1</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58). </p> </section> <section id="CD003220-sec-0287"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two trials totaling 92 teeth. There was no statistically significant difference (RR 2.02, 95% CI 0.79 to 5.15; <a href="./references#CD003220-fig-0137" title="">Analysis 20.2</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.35, 95% CI 0.02 to 8.39). </p> </section> <section id="CD003220-sec-0288"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two trials totaling 92 teeth. In one trial, there was no pain in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58; <a href="./references#CD003220-fig-0138" title="">Analysis 20.3</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed pain (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.35, 95% CI 0.02 to 8.39). </p> <p><b>Soft tissue pathology</b> </p> <p>At six months, data were extractable from two trials totaling 92 teeth. In one trial, there was no soft tissue pathology in any of the participants regardless of the intervention. For the remaining trial, there was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58; <a href="./references#CD003220-fig-0139" title="">Analysis 20.4</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.35, 95% CI 0.02 to 8.39). </p> </section> <section id="CD003220-sec-0289"> <h6 class="title">Pathological mobility</h6> <p>At six months, data were extractable from two trials totaling 92 teeth. In the two trials, there was no pathological mobility in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0140" title="">Analysis 20.5</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed pathological mobility (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no pathological mobility in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0290"> <h6 class="title">Pathological radiolucency</h6> <p>At six months, data were extractable from two trials totaling 92 teeth. There was no statistically significant difference (RR 2.02, 95% CI 0.79 to 5.15; <a href="./references#CD003220-fig-0141" title="">Analysis 20.6</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.35, 95% CI 0.02 to 8.39). </p> </section> <section id="CD003220-sec-0291"> <h6 class="title">Pathological root resorption</h6> <p>At six months, data were extractable from two trials totaling 92 teeth. In the two trials, there was no pathological root resorption in any of the participants regardless of the intervention (<a href="./references#CD003220-fig-0142" title="">Analysis 20.7</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed pathological root resorption (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no pathological root resorption in any of the participants regardless of the intervention. </p> <p><b>Succedaneous tooth anomaly (radiographically)</b> </p> <p>One trial, which randomised 30 teeth, assessed Metapex versus Endoflas based on unerupted succedaneous tooth anomaly (radiographically) (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no cases in any of the participants regardless of the delay. </p> </section> </section> <section id="CD003220-sec-0292"> <h5 class="title">Metapex versus RC Fill</h5> <p>One trial, which randomised 64 teeth, assessed Metapex versus RC Fill based on pain, pathological radiolucency, pathological root resorption and filling material anomaly (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>). There was no statistically significant difference for any outcome at six months (pain: RR 0.38, 95% CI 0.02 to 8.91; pathological radiolucency and filling material anomaly: RR 0.10, 95% CI 0.01 to 1.78; pathological root resorption: RR 2.27, 95% CI 0.87 to 5.89). </p> </section> <section id="CD003220-sec-0293"> <h5 class="title">Metapex compared with Endoflas chlorophenol free (Endoflas‐CF)</h5> <p>One trial, which randomised 32 teeth, assessed Metapex versus Endoflas‐CF based on clinical failure and radiologic failure (pathologic radiolucency) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). There was no statistically significant differences for clinical failure at six (RR 3.00, 95% CI 0.13 to 68.57) and 12 months (RR 1.00, 95% CI 0.16 to 6.25), and for radiological failure (pathologic radiolucency) at six and 12 months (RR 1.33, 95% CI 0.35 to 5.03). </p> </section> <section id="CD003220-sec-0294"> <h5 class="title">Metapex compared with zinc oxide and propolis (ZOP)</h5> <p>One trial, which randomised 32 teeth, assessed Metapex versus Endoflas‐CF based on clinical failure and radiologic failure (pathologic radiolucency) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). There were no statistically significant differences for clinical failure at six (RR 3.00, 95% CI 0.13 to 68.57) and 12 months (RR 2.00, 95% CI 0.20 to 19.91), and for radiological failure (pathologic radiolucency) at six (RR 1.33, 95% CI 0.35 to 5.03) and 12 months (RR 0.80, 95% CI 0.26 to 2.45). </p> </section> <section id="CD003220-sec-0295"> <h5 class="title">Sealapex versus zinc oxide and eugenol (ZOE)</h5> <p>One trial, which randomised 40 teeth, assessed Sealapex (eugenol‐free calcium hydroxide) versus ZOE based on clinical failure, radiological failure, pain, pathological mobility, pathological radiolucency, pathological root resorption and filling material anomaly (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). There was no statistically significant difference for any outcome at either six or 12 months. For clinical failure, the RR was 3.00 (95% CI 0.13 to 69.52) at six months and 5.00 (95% CI 0.26 to 98.00) at 12 months. For radiological failure and pathological root resorption, the RR was 5.00 (95% CI 0.26 to 98.00) at six and 12 months. For pain and pathological mobility, the RR was 3.00 (95% CI 0.13 to 69.52) at six and 12 months. There was no pathological radiolucency or filling material anomaly in any of the participants. </p> </section> <section id="CD003220-sec-0296"> <h5 class="title">Vitapex versus Sealapex</h5> <p>One trial, which randomised 40 teeth, assessed Vitapex (calcium hydroxide/iodoform) versus Sealapex (eugenol‐free calcium hydroxide) based on clinical failure, radiological failure, pain, pathological mobility, pathological radiolucency, pathological root resorption and filling material anomaly (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). There was no statistically significant difference for any outcome at either six or 12 months (<a href="#CD003220-tbl-0040">Table 37</a>). </p> <div class="table" id="CD003220-tbl-0040"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 37.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (Sealapex)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Filling material anomaly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide; Sealapex: eugenol‐free CH. </p> </div> </div> </section> <section id="CD003220-sec-0297"> <h5 class="title">Vitapex versus zinc oxide and eugenol (ZOE)</h5> <section id="CD003220-sec-0298"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from four RCTs totaling 287 teeth. In three of the trials, there was no clinical failure in any of the participants regardless of the intervention. From the remaining trial, the results showed no statistically significant difference in clinical failure with Vitapex compared with ZOE (RR 0.33, 95% CI 0.01 to 7.84). At 12 months, in two trials, there was no clinical failure in any of the participants regardless of the intervention. From the two remaining trials, the pooled results showed a statistically significant difference (RR 4.75, 95% CI 1.21 to 18.55) with evidence of statistical heterogeneity among included trials (I² = 78%; <a href="./references#CD003220-fig-0143" title="">Analysis 21.1</a>). <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a> (86 teeth randomised) assessed clinical failure at 30 months, and reported no failures. </p> </section> <section id="CD003220-sec-0299"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from four RCTs totaling 287 teeth. In one of the trials, there was no radiological failure in any of the participants regardless of the intervention. From the three remaining trials, the pooled results showed no statistically significant difference in radiological failure with Vitapex compared with ZOE (RR 2.36, 95% CI 0.86 to 6.50). At 12 months, the pooled results showed a statistically significant difference (RR 6.56, 95% CI 2.58 to 16.67), with evidence of statistical heterogeneity among included trials (I² = 82%; <a href="./references#CD003220-fig-0144" title="">Analysis 21.2</a>). At 30 months, one trial, which randomised 86 teeth, assessed radiological failure, and there was a statistically significant difference (RR 19.00, 95% CI 1.14 to 316.52) (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). </p> </section> <section id="CD003220-sec-0300"> <h6 class="title">Overall failure</h6> <p>Data were extractable from two trials totaling 140 teeth. There was no statistically significant difference at six (RR 1.89, 95% CI 0.63 to 5.66) and 12 months (RR 2.56, 95% CI 0.89 to 7.32; <a href="./references#CD003220-fig-0145" title="">Analysis 21.3</a>). </p> <p>An additional trial, which randomised 58 teeth, did not assess the outcome at a fixed time point but at a mean (range) follow‐up of 12 (10 to 16) months (RR 1.01, 95% CI 0.63 to 1.64) (<a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>). </p> </section> <section id="CD003220-sec-0301"> <h6 class="title">Pain</h6> <p>At six and 12 months, data were extractable from three RCTs totaling 180 teeth. There was no pain in any of the participants in either trial or intervention (<a href="./references#CD003220-fig-0146" title="">Analysis 21.4</a>). At 30 months, one trial, which randomised 86 teeth, assessed pain, and there was no cases (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). </p> <p><a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>, which randomised 58 teeth, did not assess the outcome at a fixed time point but at a mean (range) follow‐up of 12 (10 to 16) months. There was no pain in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0302"> <h6 class="title">Pathological mobility</h6> <p>At six and 12 months, data were extractable from three RCTs totaling 180 teeth. In two of the trials, there was no pathological mobility in any of the participants at either time point. For the remaining trial, the six‐ and 12‐month results showed no statistically significant difference in pathological mobility with Vitapex compared with ZOE (six months: RR 0.33, 95% CI 0.01 to 7.84; 12 months: RR 1.00, 95% CI 0.07 to 15.18; <a href="./references#CD003220-fig-0147" title="">Analysis 21.5</a>). At 30 months, one trial, which randomised 86 teeth, assessed pathologic mobility, and there was no cases (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). </p> <p>One additional trial, which randomised 58 teeth, did not assess the outcome at a fixed time point but at a mean (range) follow‐up of 12 (10 to 16) months (<a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>). The RR was 0.14 (95% CI 0.01 to 2.41). </p> </section> <section id="CD003220-sec-0303"> <h6 class="title">Soft tissue pathology</h6> <p>Three trials, randomising 155 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>; <a href="./references#CD003220-bbs2-0078" title="TrairatvorakulC , ChunlasikaiwanS . Success of pulpectomy with zinc oxide‐eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry2008; Vol. 30, issue 4:303‐8. ">Trairatvorakul 2008</a>; <a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). There was no soft tissue pathology in any of the participants in either trial. At 30 months, one trial, which randomised 86 teeth, assessed soft tissue pathology, and there was no cases (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). </p> </section> <section id="CD003220-sec-0304"> <h6 class="title">Pathological radiolucency</h6> <p>One trial, which randomised 40 teeth, assessed pathological radiolucency (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). There was no pathological radiolucency in any of the participants regardless of the intervention, at any time point. </p> <p>One additional trial, which randomised 58 teeth, did not assess the outcome at a fixed time point but at a mean (range) follow‐up of 12 (10 to 16) months (RR 0.14, 95% CI 0.01 to 2.41) (<a href="./references#CD003220-bbs2-0053" title="MortazaviM , MesbahiM . Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry2004; Vol. 14, issue 6:417‐24. ">Mortazavi 2004</a>). </p> </section> <section id="CD003220-sec-0305"> <h6 class="title">Pathological root resorption</h6> <p>One trial provided data on pathological root radiolucency at 12 months (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). There were no cases in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0306"> <h6 class="title">Filling material anomaly</h6> <p>One trial, which randomised 40 teeth, assessed filling material anomaly (<a href="./references#CD003220-bbs2-0062" title="OzalpN , SaroğluI , SönmezH . Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry2005; Vol. 18, issue 6:347‐50. ">Ozalp 2005</a>). There was no statistically significant difference between groups at either six months (RR 3.00, 95% CI 0.13 to 69.52) or 12 months (RR 7.00, 95% CI 0.38 to 127.33). </p> </section> <section id="CD003220-sec-0307"> <h6 class="title">Unerupted succedaneous tooth anomaly (radiographically)</h6> <p>One trial, which randomised 86 teeth, assessed unerupted succedaneous tooth anomaly (radiographically) at six, 12 and 30 months (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). There was no cases in any of the participants regardless of the intervention. </p> </section> </section> <section id="CD003220-sec-0308"> <h5 class="title">Vitapex (calcium hydroxide (calcium hydroxide)/iodoform) versus 3Mix (ciprofloxacin + metronidazole + minocycline) </h5> <p>One trial, which randomised 50 teeth, assessed Vitapex versus 3Mix (ciprofloxacin + metronidazole + minocycline) based on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0056" title="NakornchaiS , BanditsingP , VisetratanaN . Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry2010;20(3):214‐21. [PUBMED: 20409203] ">Nakornchai 2010</a>). At 12 months, there was a statistically significant difference in favour of Vitapex for pathological radiolucency (RR 2.75, 95% CI 1.01 to 7.48). There was no other statistically significant difference for any other outcome at either six or 12 months (<a href="#CD003220-tbl-0041">Table 38</a>). </p> <div class="table" id="CD003220-tbl-0041"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 38.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (3Mix)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.07 to 15.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 (0.38 to 4.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 (0.80 to 4.19)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.07 to 15.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.27 to 8.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.75 (1.01 to 7.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide; 3Mix: ciprofloxacin + metronidazole + minocycline. </p> </div> </div> </section> <section id="CD003220-sec-0309"> <h5 class="title">Vitapex versus RC Fill</h5> <p>One trial, which randomised 86 teeth, assessed Vitapex versus RC Fill based on clinical failure, radiological failure, overall failure, pain, pathologic mobility, soft tissue pathology, and unerupted succedaneous tooth anomaly (radiographically) (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). At six, 12 and 30 months, there was no cases of clinical failure, pain, pathologic mobility, soft tissue pathology, and unerupted succedaneous tooth anomaly (radiographically) in any of the participants regardless of the intervention. For radiological/overall failure, there were no statistically significant differences at six (RR 1.67, 95% CI 0.42 to 6.54), 12 (RR 2.00, 95% CI 0.65 to 6.15) and 30 months (RR 1.80, 95% CI 0.66 to 4.93). </p> </section> <section id="CD003220-sec-0310"> <h5 class="title">Vitapex versus ZOE + calcium hydroxide + iodoform (unnamed product)</h5> <p>One trial, which randomised 109 teeth, assessed Vitapex versus ZOE+calcium hydroxide+iodoform (unnamed product) based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>). At 12 months, there was a statistically significant difference in favour of ZOE+calcium hydroxide + iodoform (unnamed product) for clinical failure and radiological failure (clinical failure: RR 21.79, 95% CI 1.32 to 360.78; radiological failure: RR 42.63, 95% CI 2.65 to 685.54). There was no other statistically significant difference at six months (<a href="#CD003220-tbl-0042">Table 39</a>). </p> <div class="table" id="CD003220-tbl-0042"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 39.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (MPRCF)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.79 (1.32, 360.78)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.63 (0.35, 125.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.63 (2.65, 685.54)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; MPRCF: ZOE (zinc oxide eugenol), calcium hydroxide, iodoform. </p> </div> </div> </section> <section id="CD003220-sec-0311"> <h5 class="title">Endoflas versus zinc oxide and eugenol (ZOE)</h5> <section id="CD003220-sec-0312"> <h6 class="title">Clinical failure</h6> <p>At six months, data were extractable from two trials, totaling 80 teeth. There was no statistically significant difference (RR 0.26, 95% CI 0.05 to 1.50; <a href="./references#CD003220-fig-0148" title="">Analysis 22.1</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed clinical failure (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 1.00, 95% CI 0.07 to 14.55). </p> </section> <section id="CD003220-sec-0313"> <h6 class="title">Radiological failure</h6> <p>At six months, data were extractable from two trials, totaling 80 teeth. There was no statistically significant difference (RR 0.26, 95% CI 0.05 to 1.50; <a href="./references#CD003220-fig-0149" title="">Analysis 22.2</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed radiological failure (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 1.00, 95% CI 0.07 to 14.55). </p> </section> <section id="CD003220-sec-0314"> <h6 class="title">Pain</h6> <p>At six months, data were extractable from two trials, totaling 80 teeth. There was no statistically significant differences (RR 0.26, 95% CI 0.05 to 1.50; <a href="./references#CD003220-fig-0150" title="">Analysis 22.3</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed pain (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 1.00, 95% CI 0.07 to 14.55). </p> </section> <section id="CD003220-sec-0315"> <h6 class="title">Pathologic mobility</h6> <p>At six months, data were extractable from two trials, totaling 80 teeth. There was no statistically significant difference (RR 0.16, 95% CI 0.02 to 1.25; <a href="./references#CD003220-fig-0151" title="">Analysis 22.4</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed pathologic mobility (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58). </p> </section> <section id="CD003220-sec-0316"> <h6 class="title">Soft tissue pathology</h6> <p>At six months, data were extractable from two trials, totaling 80 teeth. There was no cases for one trial; for the remaining trial, there was no statistically significant difference (RR 3.00, 95% CI 0.13 to 68.26) (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 3.00, 95% CI 0.13 to 68.26). </p> </section> <section id="CD003220-sec-0317"> <h6 class="title">Adjacent tissue inflammation</h6> <p>There were no adjacent tissue inflammation in any of the participants regardless of the intervention. </p> </section> <section id="CD003220-sec-0318"> <h6 class="title">Pathologic radiolucency</h6> <p>At six months, data were extractable from two trials, totaling 80 teeth. There was no statistically significant difference (RR 0.64, 95% CI 0.11 to 3.63; <a href="./references#CD003220-fig-0152" title="">Analysis 22.5</a>). </p> <p>At 12 months, one trial, which randomised 30 teeth, assessed soft tissue pathology (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 3.00, 95% CI 0.13 to 68.26). </p> </section> <section id="CD003220-sec-0319"> <h6 class="title">Pathologic root resorption</h6> <p>At six and 12 months, one trial, which randomised 30 teeth, assessed pathologic root resorption (<a href="./references#CD003220-bbs2-0077" title="SubramaniamP , GilhotraK . Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars ‐ a comparative clinical study. Journal of Clinical Pediatric Dentistry2011;35(4):365‐9. [PUBMED: 22046693] ">Subramaniam 2011</a>). There was no statistically significant difference (RR 0.33, 95% CI 0.01 to 7.58). </p> </section> <section id="CD003220-sec-0320"> <h6 class="title">Filling material anomaly</h6> <p>One trial, which randomised 50 teeth, assessed filling material anomaly at six months (<a href="./references#CD003220-bbs2-0069" title="RewalN , ThakurA S , SachdevV , MahajanN . Comparison of endoflas and zinc oxide eugenol as root canal filling materials in primary dentition. Journal of Indian Society of Pedodontics and Preventive Dentistry2014;32(4):317‐21. ">Rewal 2014</a>). There was no statistically significant difference (RR 0.65, 95% CI 0.29 to 1.42). </p> </section> </section> <section id="CD003220-sec-0321"> <h5 class="title">Endoflas versus RC Fill</h5> <p>One trial, which randomised 66 teeth, assessed Endoflas versus RC Fill based on pain, pathological radiolucency, pathological root resorption and filling material anomaly (<a href="./references#CD003220-bbs2-0068" title="RamarK , MungaraJ . Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in‐vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2010;28(1):25‐9. [PUBMED: 20215668] ">Ramar 2010</a>). There was no statistically significant difference for any outcome at six months. For pain, the RR was 0.35 (95% CI 0.01 to 8.38); for pathological radiolucency and filling material anomaly, the RR was 0.10 (95% CI 0.01 to 1.68); for pathological root resorption, the RR was 0.85 (95% CI 0.25 to 2.88). </p> </section> <section id="CD003220-sec-0322"> <h5 class="title">Endoflas‐CF versus ZOE</h5> <p>One trial, which randomised 32 teeth, assessed Endoflas‐CF versus ZOE based on clinical failure and radiologic failure (pathologic radiolucency) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). There were no statistically significant differences for clinical failure at six (RR 0.33, 95% CI 0.01 to 7.92) and 12 months (RR 1.00, 95% CI 0.16 to 6.25), and for radiological failure (pathologic radiolucency) at six and 12 months (RR 1.00, 95% CI 0.24 to 4.23). </p> </section> <section id="CD003220-sec-0323"> <h5 class="title">Endoflas‐CF versus zinc oxide and propolis (ZOP)</h5> <p>One trial, which randomised 32 teeth, assessed Endoflas‐CF versus ZOP based on clinical failure and radiologic failure (pathologic radiolucency) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). There was no clinical failure at six months; there were no statistically significant differences for clinical failure at 12 months (RR 2.00, 95% CI 0.20 to 19.91), and for radiological failure (pathologic radiolucency) at six (RR 1.00, 95% CI 0.24 to 4.23) and 12 months (RR 0.60, 95% CI 0.17 to 2.10). </p> </section> <section id="CD003220-sec-0324"> <h5 class="title">ZOE versus ozonated sesame oil‐zinc oxide (ZO)</h5> <p>One trial, which randomised 60 teeth, assessed ZOE versus ozonated sesame oil‐ZO based on clinical failure, radiological failure, overall failure, pathologic radiolucency at 12 months (<a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>). For clinical failure, there was no statistically significant difference (RR 3.00, 95% CI 0.13 to 70.83). For radiological/overall failure (pathologic radiolucency), there was a statistically significant difference (RR 4.50, 95% CI 1.03 to 19.62). </p> </section> <section id="CD003220-sec-0325"> <h5 class="title">ZOE versus RC Fill</h5> <p>One trial, which randomised 86 teeth, assessed ZOE versus RC Fill based on clinical failure, radiological failure, overall failure, pain, pathologic mobility, soft tissue pathology, and unerupted succedaneous tooth anomaly (radiographically) (<a href="./references#CD003220-bbs2-0066" title="PramilaR , MuthuM S , DeepaG , FarzanJ M , RodriguesS J . Pulpectomies in primary mandibular molars: a comparison of outcomes using three root filling materials. International Endodontic Journal2016;49(5):413‐21. ">Pramila 2016</a>). At six, 12 and 30 months, there was no cases of clinical failure, pain, pathologic mobility, soft tissue pathology, and unerupted succedaneous tooth anomaly (radiographically) in any of the participants regardless of the intervention. For radiological/overall failure, there were no statistically significant differences at six (RR 0.14, 95% CI 0.01 to 2.68), 12 (RR 0.11, 95% CI 0.01 to 2.00) and 30 months (RR 0.09, 95% CI 0.01 to 1.59). </p> </section> <section id="CD003220-sec-0326"> <h5 class="title">ZOE versus zinc oxide and propolis (ZOP)</h5> <p>One trial, which randomised 32 teeth, assessed ZOE versus ZOP based on clinical failure and radiologic failure (pathologic radiolucency) (<a href="./references#CD003220-bbs2-0006" title="Al‐OstwaniAO , Al‐MonaqelBM , Al‐TinawiMK . A clinical and radiographic study of four different root canal fillings in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry2016;34:55‐9. ">Al‐Ostwani 2016</a>). There were no statistically significant differences for clinical failure at six (RR 3.00, 95% CI 0.13 to 68.57) and 12 months (RR 2.00, 95% CI 0.20 to 19.91), and for radiological failure (pathologic radiolucency) at six (RR 1.00, 95% CI 0.24 to 4.23) and 12 months (RR 0.60, 95% CI 0.17 to 2.10). </p> </section> <section id="CD003220-sec-0327"> <h5 class="title">ZOE versus ZOE + calcium hydroxide + iodoform (unnamed product)</h5> <p>One trial, which randomised 104 teeth, provided data on clinical failure, radiological failure and filling material anomaly at six and 12 months (<a href="./references#CD003220-bbs2-0017" title="ChenXX , LinBC , ZhongJ , GeLH . Degradation evaluation and success of pulpectomy with a modified primary root canal filling in primary molars. Beijing Da Xue Xue Bao Yi Xue Ban2015;47(3):529‐35. ">Chen 2015</a>). There were no clinical or radiological failures in any of the participants regardless of the intervention. For filling material anomaly, there was no statistically significant difference at six months (RR 1.73, 95% CI 0.95 to 3.17), and a statistically significant difference at 12 months (RR 3.12, 95% CI 1.35 to 7.22). </p> </section> <section id="CD003220-sec-0328"> <h5 class="title">Ciprofloxacin + metronidazole + minocycline (3Mix) versus ciprofloxacin + ornidazole + minocycline </h5> <p>One trial, which randomised 40 teeth, assessed 3Mix versus ciprofloxacin+ornidazole+minocycline based on clinical failure, pain, pathological mobility, soft tissue pathology and pathological radiolucency (i.e. radiological failure) (<a href="./references#CD003220-bbs2-0064" title="PinkyC , ShashibhushanKK , SubbareddyVV . Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2011;29(2):121‐7. [PUBMED: 21911950] ">Pinky 2011</a>). There was no clinical failure, pain, pathological mobility, soft tissue pathology in any of the participants regardless of the time point. There was no pathological radiolucency at six months in any of the participants, and there was no statistically significant difference at 12 months (RR 5.00, 95% CI 0.26 to 98.00). </p> </section> <section id="CD003220-sec-0329"> <h5 class="title">MTA versus IRM</h5> <p>One trial, which randomised 50 teeth, assessed MTA versus IRM based on clinical failure, radiological failure, overall failure, pain, pathological mobility, soft tissue pathology (<a href="./references#CD003220-bbs2-0010" title="ArikanV , SonmezH , SariS . Comparison of two base materials regarding their effect on root canal treatment success in primary molars with furcation lesions. BioMed Research International2016;2016:1429286. ">Arikan 2016</a>). At six and 12 months, there was no clinical failure, pain, pathological mobility and soft tissue pathology. For radiological/overall failure, there was no statistically significant difference at six (RR 0.20, 95% CI 0.01 to 3.97) or 12 months (RR 0.50, 95% CI 0.10 to 2.49). </p> </section> <section id="CD003220-sec-0330"> <h5 class="title">MTA versus gutta‐percha/AH‐Plus</h5> <p>One trial, which randomised 20 teeth, assessed MTA versus gutta‐percha/AH‐Plus based on clinical failure, radiological failure, overall failure, pain, pathologic mobility, soft tissue pathology and pathologic radiolucency (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>). At six months, there was no failure. At 12 and 24 months, there were no cases of pain and pathologic mobility. At 12 months, there was no statistically significant difference for clinical failure/soft tissue pathology (RR 0.20, 95 CI 0.01 to 3.70), radiological failure/pathologic radiolucency and overall failure (RR 0.25, 95 CI 0.03 to 1.86). At 24 months, there was no statistically significant difference for clinical failure/soft tissue pathology (RR 0.14, 95 CI 0.01 to 2.45); at 24 months, there was a statistically significant difference for radiological failure/pathologic radiolucency and overall failure (RR 0.14, 95 CI 0.02 to 0.96). </p> </section> </section> <section id="CD003220-sec-0331"> <h4 class="title">Pulpotomy versus pulpectomy</h4> <p>Four trials compared pulpotomy with pulpectomy. Two trials were at high risk of bias, and, for two other trials, the risk of bias was unclear. We judged no trials comparing pulpotomy versus pulpectomy to be at low risk of bias. </p> <section id="CD003220-sec-0332"> <h5 class="title">Formocresol pulpotomy versus calcium hydroxide pulpectomy</h5> <p>One trial, which randomised 51 teeth, assessed formocresol pulpotomy versus calcium hydroxide pulpectomy (<a href="./references#CD003220-bbs2-0018" title="CoserRM , GondimJO , Aparecida GiroEM . Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48‐month radiographic study. Quintessence International2008;39(7):549‐57. ">Coser 2008</a>). There were no data provided for any outcomes. </p> </section> <section id="CD003220-sec-0333"> <h5 class="title">Ferric sulphate/zinc oxide and eugenol (ZOE) pulpotomy versus Sedanol (ZOE) pulpectomy</h5> <p>One trial, which randomised 291 teeth, assessed ferric sulphate pulpotomy versus Sedanol pulpectomy based on radiological failure, pain, soft tissue pathology, pathological radiolucency, pathological root resorption and pulp canal obliteration (<a href="./references#CD003220-bbs2-0014" title="CasasMJ , KennyDJ , JohnstonDH , JuddPL . Long‐term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2004;26(1):44‐8. CasasMJ , LayugMA , KennyDJ , JohnstonDH , JuddPL . Two‐year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry2003;25(2):97‐102. [PUBMED: 12723832] ">Casas 2004</a>). There were statistically significant differences for pathological root resorption (RR 21.04, 95% CI 1.28 to 346.39) and pulp canal obliteration (RR 27.05, 95% CI 1.66 to 441.49) at 24 months. There was no statistically significant difference for any other outcome (<a href="#CD003220-tbl-0043">Table 40</a>). </p> <div class="table" id="CD003220-tbl-0043"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 40.</span> <span class="table-title">Pulpotomy (FS) versus pulpectomy (Sedanol)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.80 (0.07 to 43.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.21 (0.22 to 80.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.25 to 1.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.04 (1.28 to 346.39)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.05 (1.66 to 441.49)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulphate; Sedanol=ZOE: zinc oxide and eugenol. </p> </div> </div> </section> <section id="CD003220-sec-0334"> <h5 class="title">Ferric sulphate/MTA pulpotomy versus ZOE pulpectomy</h5> <p>One trial, which randomised 172 teeth, assessed ferric sulphate/MTA pulpotomy versus ZOE pulpectomy based on clinical failure and radiological failure (<a href="./references#CD003220-bbs2-0057" title="NguyenT D , JuddP L , BarrettE J , SidhuN , CasasM J . Comparison of ferric sulfate combined mineral trioxide aggregate pulpotomy and zinc oxide eugenol pulpectomy of primary maxillary incisors: an 18‐month randomized, controlled trial. Pediatric Dentistry2017;39(1):34‐8. ">Nguyen 2017</a>). There were no statistically significant differences for clinical failure at 12 (RR 3.61, 95% CI 0.18 to 74.16) and 18 months (RR 2.16, 95% CI 0.23 to 20.35), and for radiological failure at 12 (RR 0.36, 95% CI 0.09 to 1.39) and 18 months (RR 0.84, 95% CI 0.29 to 2.39). </p> </section> <section id="CD003220-sec-0335"> <h5 class="title">3Mix (ciprofloxacin + metronidazole + minocycline) pulpotomy versus 3Mix pulpectomy</h5> <p>One trial, which randomised 60 teeth, assessed 3Mix pulpotomy versus 3Mix pulpectomy based on clinical failure, pain, pathological mobility, soft tissue pathology and pathological radiolucency (i.e. radiological failure) (<a href="./references#CD003220-bbs2-0065" title="PrabhakarAR , SrideviE , RajuOS , SatishV . Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry2008;26(5):5‐10. ">Prabhakar 2008</a>). There was a statistically significant difference at six months for pathological radiolucency (RR 23.00, 95% CI 1.42 to 373.46), that was not maintained at 12 months. There was no statistically significant difference for the other outcomes at any time point (<a href="#CD003220-tbl-0044">Table 41</a>). </p> <div class="table" id="CD003220-tbl-0044"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 41.</span> <span class="table-title">Pulpotomy (3Mix) versus pulpectomy (3Mix)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25, 99.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25, 99.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.00 (1.42, 373.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.00 (0.64, 190.53)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack events</p> <p>Abbreviations ‐ CI: confidence interval; 3Mix: ciprofloxacin + metronidazole + minocycline.</p> </div> </div> </section> </section> <section id="CD003220-sec-0336"> <h4 class="title">Direct pulp capping versus direct pulp capping</h4> <p>Seven trials compared direct pulp capping using different medicaments. Six trials were at unclear risk of bias and one trial was at high risk of bias. </p> <section id="CD003220-sec-0337"> <h5 class="title">Calcium hydroxide versus formocresol</h5> <p>One trial, which randomised 120 teeth, assessed calcium hydroxide versus formocresol based on clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a>). There was a statistically significant difference for clinical failure (RR 3.83, 95% CI 1.68 to 8.74), radiological failure (RR 3.11, 95% CI 1.61 to 6.02) and pathological radiolucency (RR 5.00, 95% CI 1.14 to 21.86) at 24 months. There was no statistically significant difference for any other outcome or time point (<a href="#CD003220-tbl-0045">Table 42</a>). </p> <div class="table" id="CD003220-tbl-0045"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 42.</span> <span class="table-title">Direct pulp capping (CH) versus direct pulp capping (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.83 (1.68 to 8.74)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.11 (1.61 to 6.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.37 to 132.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.00 (0.50 to 163.59)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.89 to 18.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.37 to 132.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5 (0.50 to 12.39)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8 (0.64 to 5.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.46 to 34.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (1.14 to 21.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.33 (0.96 to 11.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.87 to 4.60)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval; FC: formocresol.</p> </div> </div> </section> <section id="CD003220-sec-0338"> <h5 class="title">Acetone‐based total‐etch adhesive versus calcium hydroxide</h5> <p>One trial, which randomised 40 teeth, assessed acetone‐based total‐etch adhesive versus calcium hydroxide based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no clinical failure, radiological failure, pain, pathological radiolucency or pathological root resorption in any of the participants regardless of the time point. </p> </section> <section id="CD003220-sec-0339"> <h5 class="title">Non‐rinse conditioner + acetone‐based total‐etch adhesive versus calcium hydroxide</h5> <p>One trial, which randomised 40 teeth, assessed non‐rinse conditioner + acetone‐based total‐etch adhesive versus calcium hydroxide based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no clinical failure, pain or pathological root resorption in any of the participants regardless of the delay. There was no radiological failure or pathological radiolucency in any of the participants regardless of the intervention at six months. For radiological failure and pathological radiolucency at 12 and 24 months, the RR was 3.00 (95% CI 0.13 to 69.52). </p> </section> <section id="CD003220-sec-0340"> <h5 class="title">Total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive versus calcium hydroxide </h5> <p>One trial, which randomised 40 teeth, assessed total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive versus calcium hydroxide based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0046">Table 43</a>). </p> <div class="table" id="CD003220-tbl-0046"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 43.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval</p> </div> </div> </section> <section id="CD003220-sec-0341"> <h5 class="title">Self etch adhesive system + acetone‐based total‐etch adhesive versus calcium hydroxide</h5> <p>One trial, which randomised 40 teeth, assessed self etch adhesive system + acetone‐based total‐etch adhesive versus calcium hydroxide based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0047">Table 44</a>). </p> <div class="table" id="CD003220-tbl-0047"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 44.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval</p> </div> </div> </section> <section id="CD003220-sec-0342"> <h5 class="title">Enamel matrix derivative (EMD) versus calcium hydroxide</h5> <p>One trial, which randomised 90 teeth, assessed EMD versus calcium hydroxide based on overall failure, pain, soft tissue pathology, pathological mobility and pathological root resorption (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>). For overall failure, the RR was 1.00 (95% CI 0.06 to 15.50) at six and 12 months. There was no pain, soft tissue pathology, pathological mobility or pathological root resorption in any of the participants regardless of the time point. </p> </section> <section id="CD003220-sec-0343"> <h5 class="title">MTA versus calcium hydroxide</h5> <p>One trial, which randomised 50 teeth, assessed MTA versus calcium hydroxide based on clinical failure, radiological failure and pain (<a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>). There were no clinical and radiological failures or pain in any of the participants regardless of the time point. </p> </section> <section id="CD003220-sec-0344"> <h5 class="title">Non‐rinse conditioner + acetone‐based total‐etch adhesive versus acetone‐based total‐etch adhesive </h5> <p>One trial, which randomised 40 teeth, assessed non‐rinse conditioner + acetone‐based total‐etch adhesive versus acetone‐based total‐etch adhesive based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no clinical failure, pain or pathological root resorption in any of the participants. There was no radiological failure or pathological radiolucency in any of the participants at six months. For radiological failure and pathological radiolucency, the RR was 3.00 (95% CI 0.13 to 69.52) at 12 and 24 months. </p> </section> <section id="CD003220-sec-0345"> <h5 class="title">Total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive versus acetone‐based total‐etch adhesive </h5> <p>One trial, which randomised 40 teeth, assessed total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive versus acetone‐based total‐etch adhesive based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0048">Table 45</a>). </p> <div class="table" id="CD003220-tbl-0048"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 45.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0346"> <h5 class="title">Self‐etch adhesive system + acetone‐based total‐etch adhesive versus acetone‐based total‐etch adhesive </h5> <p>One trial, which randomised 40 teeth, assessed self‐etch adhesive system + acetone‐based total‐etch adhesive versus acetone‐based total‐etch adhesive based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0049">Table 46</a>). </p> <div class="table" id="CD003220-tbl-0049"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 46.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI) </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval</p> </div> </div> </section> <section id="CD003220-sec-0347"> <h5 class="title">Total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive versus non‐rinse conditioner + acetone‐based total‐etch adhesive </h5> <p>One trial, which randomised 40 teeth, assessed total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive versus non‐rinse conditioner + acetone‐based total‐etch adhesive based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0050">Table 47</a>). </p> <div class="table" id="CD003220-tbl-0050"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 47.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (non‐rinse conditioner + acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0348"> <h5 class="title">Self‐etch adhesive system + acetone‐based total‐etch adhesive versus non‐rinse conditioner + acetone‐based total‐etch adhesive </h5> <p>One trial, which randomised 40 teeth, assessed self‐etch adhesive system + acetone‐based total‐etch adhesive versus non‐rinse conditioner + acetone‐based total‐etch adhesive based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0051">Table 48</a>). </p> <div class="table" id="CD003220-tbl-0051"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 48.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (non‐rinse conditioner + acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI) </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0349"> <h5 class="title">Self‐etch adhesive system + acetone‐based total‐etch adhesive versus total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive </h5> <p>One trial, which randomised 40 teeth, assessed self‐etch adhesive system + acetone‐based total‐etch adhesive versus total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive based on clinical failure, radiological failure, pain, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a>). There was no statistically significant difference for any outcome at six, 12 or 24 months (<a href="#CD003220-tbl-0052">Table 49</a>). </p> <div class="table" id="CD003220-tbl-0052"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 49.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </div> </section> <section id="CD003220-sec-0350"> <h5 class="title">Calcium‐enriched mixture (CEM) cement versus MTA</h5> <p>One trial, which randomised 42 teeth, assessed CEM cement versus MTA based on clinical failure, radiological failure, pain, soft tissue pathology, pathological radiolucency and pathological root resorption at six months, and overall failure at 20 month (<a href="./references#CD003220-bbs2-0027" title="Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Direct pulp‐capping with calcium enriched mixture in primary molar teeth: a randomized clinical trial. Iranian Endodontic Journal2010;5(1):27‐30. Fallahinejad GhajariM , Asgharian JeddiT , IriS , AsgaryS . Treatment outcomes of direct pulp‐capping after 20 months: a randomized controlled trial. Iranian Endodontic Journal2013;8(4):149‐52. ">Fallahinejad Ghajari 2013</a>). At six months, there was no pain, radiological failure, pathological radiolucency and pathological root resorption in any participants regardless of the intervention. There were no statistically significant differences for clinical failure and soft tissue pathology (RR 3.00, 95% CI 0.13 to 69.70). At 20 months, there was no statistically significant difference for overall failure (RR 1.00, 95% CI 0.07 to 14.95). </p> </section> <section id="CD003220-sec-0351"> <h5 class="title">MTA versus 3Mix</h5> <p>One trial, which randomised 160 teeth, assessed MTA versus 3Mix based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathologic radiolucency, pathologic root resorption at 12 months (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). There was a statistically significant difference for clinical and overall failure (RR 0.17, 95% CI 0.04 to 0.70), pain and soft tissue pathology (RR 0.08, 95% CI 0.01 to 0.61). There was no radiological failure. </p> </section> <section id="CD003220-sec-0352"> <h5 class="title">MTA versus 3Mixtatin</h5> <p>One trial, which randomised 160 teeth, assessed MTA versus 3Mixtatin based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathologic radiolucency, pathologic root resorption at 12 months (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). There were no statistically significant differences for clinical and overall failure (RR 0.67, 95% CI 0.12 to 3.78), pain (RR 0.33, 95% CI 0.04 to 3.07) and soft tissue pathology (RR 3.00, 95% CI 0.13 to 71.51). There was no radiological failure. </p> </section> <section id="CD003220-sec-0353"> <h5 class="title">MTA versus simvastatin</h5> <p>One trial, which randomised 160 teeth, assessed MTA versus simvastatin based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathologic radiolucency, pathologic root resorption at 12 months (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). There was a statistically significant difference for clinical and overall failure (RR 0.17, 95% CI 0.04 to 0.70), pain and soft tissue pathology (RR 0.08, 95% CI 0.01 to 0.61). There was no radiological failure. </p> </section> <section id="CD003220-sec-0354"> <h5 class="title">3Mix versus 3Mixtatin</h5> <p>One trial, which randomised 160 teeth, assessed 3Mix versus 3Mixtatin based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathologic radiolucency, pathologic root resorption at 12 months (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). There were statistically significant differences for clinical, overall failure, pain (RR 4.00, 95% CI 1.22 to 13.11), and soft tissue pathology (RR 25.00, 95% CI 1.53 to 408.39). There was no radiological failure. </p> </section> <section id="CD003220-sec-0355"> <h5 class="title">3Mix versus simvastatin</h5> <p>One trial, which randomised 160 teeth, assessed 3Mix versus simvastatin based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathologic radiolucency, pathologic root resorption at 12 months (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). There were no statistically significant differences for clinical, overall failure, pain and soft tissue pathology (RR 1.00, 95% CI 0.51 to 1.95). There was no radiological failure. </p> </section> <section id="CD003220-sec-0356"> <h5 class="title">3Mixtatin versus simvastatin</h5> <p>One trial, which randomised 160 teeth, assessed 3Mixtatin versus simvastatin based on clinical failure, radiological failure, overall failure, pain, soft tissue pathology, pathologic radiolucency, pathologic root resorption at 12 months (<a href="./references#CD003220-bbs2-0008" title="Asl AminabadiN , SatrabS , NajafpourE , SamieiM , JamaliZ , ShiraziS . A randomized trial of direct pulp capping in primary molars using MTA compared to 3Mixtatin: a novel pulp capping biomaterial. International Journal of Paediatric Dentistry2016;26(4):281‐90. ">Aminabadi 2016</a>). There was a statistically significant difference for clinical, overall failure and pain (RR 0.25, 95% CI 0.08 to 0.82), and soft tissue pathology (RR 0.04, 95% CI 0.00 to 0.65). There was no radiological failure. </p> </section> <section id="CD003220-sec-0357"> <h5 class="title">Calcium hydroxide cement (Dycal) versus calcium sulphate hemihydrate (DentoGen)</h5> <p>One trial, which randomised 40 teeth, assessed Dycal versus DentoGen based on clinical failure, radiological failure, pain, soft tissue pathology, pathological mobility, pathological radiolucency and pathological root resorption (<a href="./references#CD003220-bbs2-0081" title="UlusoyAT , BayrakS , BodrumluEH . Clinical and radiological evaluation of calcium sulfate as direct pulp capping material in primary teeth. European Journal of Paediatric Dentistry2014;15(2):127‐31. [PUBMED: 25102461] ">Ulusoy 2014a</a>). There was no statistically significant difference for any outcome at six or 12 months (<a href="#CD003220-tbl-0053">Table 50</a>). </p> <div class="table" id="CD003220-tbl-0053"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 50.</span> <span class="table-title">Direct pulp capping (Dycal) versus direct pulp capping (Dentogen)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI) </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38, 127.32)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.49, 32.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.34, 26.45)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67 (0.46, 6.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6, 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6, 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.20, 20.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6, 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.20, 20.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.34, 26.45)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.34, 5.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.20, 20.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.34, 5.21)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </div> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003220-sec-0358" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003220-sec-0358"></div> <section id="CD003220-sec-0359"> <h3 class="title" id="CD003220-sec-0359">Summary of main results</h3> <p>For this systematic review of pulp interventions for treatment of extensive decay in primary teeth of children, we included 87 randomised controlled trials (RCTs). These trials examined 125 different comparisons: 75 comparisons among different medicaments for pulpotomy (reported in 53 trials), 25 comparisons among different medicaments for pulpectomy (15 trials), four comparisons between pulpotomy and pulpectomy (4 trials), and 21 comparisons among different medicaments for direct pulp capping (7 trials). The risk of bias for all individual studies was assessed as either high or unclear. </p> <section id="CD003220-sec-0360"> <h4 class="title">Pulpotomy</h4> <p>The majority of the evidence with regards to pulpotomy versus pulpotomy came from trials of mineral trioxide aggregate (MTA) compared with formocresol (FC). MTA reduced both clinical and radiological failures with a statistically significant difference at 12 months for clinical failure and at six, 12 and 24 months for radiological failure (<i>moderate‐quality evidence</i>). MTA also showed favourable results for all secondary outcomes, especially pathological root resorption with around four times fewer cases at 24 months than when formocresol was used (effect size 0.25); pathological radiolucency was less than half as frequent with MTA than with formocresol at 12 months (effect size 0.43). MTA induced statistically significantly more pulp canal obliteration at 24 months and dentin bridge formation at six months. </p> <p>MTA also showed favourable results compared with calcium hydroxide for all outcomes measured, with statistically significant differences at six, 12 and 24 months for radiological failure, pathological radiolucency and root resorption, at 12 and 24 months for clinical failure, soft tissue pathology and pathological mobility, and at 24 months for overall failure (<i>moderate‐ to low‐quality evidence</i>). The largest effect sizes concerned pathological radiolucency, pathological root resorption and pathological mobility with over 10 times fewer cases when MTA was used (effect sizes at 24 months respectively 0.08, 0.08 and 0.09). MTA induced statistically significantly more pulp canal obliteration at six and 24 months (about double), but also five times more dentin bridge formation at six months (the effect size was 0.2 at 6 months and 0.8 at 12 and 24 months, which seems to indicate that there is 25% more dentin bridge formation with MTA. Dentin bridge formation was faster with MTA). </p> <p>Calcium hydroxide was compared with formocresol. There was a statistically significant difference in favour of formocresol for clinical failure at six and 12 months, radiological failure at six, 12 and 24 months, overall failure at 24 months, pain and soft tissue pathology at 12 months, and pathological root resorption at six, 12 and 24 months (<i>moderate‐quality evidence</i>). There was a statistically significant difference in favour of calcium hydroxide for dentin bridge formation at six and 12 months. </p> <p>Calcium hydroxide was also compared with ferric sulphate. There was a statistically significant difference in favour of ferric sulphate for radiological and overall failure at 24 months (<i>low‐quality evidence</i>). </p> <p>Compared with ferric sulphate, MTA had statistically significantly fewer radiological and overall failures and pathological radiolucency and root resorption at six months. (This difference was not significant at 12 and 24 months) (<i>low‐ to very low‐quality evidence</i>). </p> <p>For all other comparisons of medicaments used during pulpotomies, despite the statistically significant difference for seven comparisons, each including only one trial (<a href="./references#CD003220-bbs2-0044" title="KalraM , GargN , RallanM , PathivadaL , YeluriR . Comparative evaluation of fresh aloe barbadensis plant extract and mineral trioxide aggregate as pulpotomy agents in primary molars: a 12‐month follow‐up study. Contemporary Clinical Dentistry2017;8(1):106‐11. ">Kalra 2017</a>; <a href="./references#CD003220-bbs2-0070" title="SabbariniJ , MohamedA , WahbaN , El‐MeligyO , DeanJ . Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics2008; Vol. 34, issue 3:284‐7. ">Sabbarini 2008</a><a href="#CD003220-tbl-0009">Table 6</a>; <a href="#CD003220-tbl-0010">Table 7</a>; <a href="#CD003220-tbl-0018">Table 15</a>; <a href="#CD003220-tbl-0019">Table 16</a>; <a href="#CD003220-tbl-0020">Table 17</a>; <a href="#CD003220-tbl-0033">Table 30</a>), the small number of studies and the inconsistency in results limits any interpretation. </p> <p>Overall, MTA pulpotomy was superior to formocresol and ferric sulphate; all three treatments may be superior to calcium hydroxide pulpotomy. Although the evidence was weak for other medicaments, MTA seemed to stand out as the best treatment option for pulpotomy in primary teeth for the moment. </p> <p>A challenge is that MTA is an expensive product with a relatively short setting time. The total treatment cost is incompatible with prices set by social welfare systems in many countries. However, MTA cost is reducing rapidly in Europe. Very few trials compared MTA with Biodentine, lasers, EMD or Ankaferd Blood Stopper for pulpotomy in primary teeth. Large, long‐term, well‐designed trials comparing these therapies in terms of efficacy and cost‐effectiveness would be useful. Research should also be encouraged to find a calcium silicate or inorganic material that is as effective as MTA for primary tooth pulpotomy, but with a shorter setting time. </p> <p>Formocresol is a compound consisting of 48.5% formaldehyde, 48.5% cresol and 3% glycerine. Buckley's solution, introduced in 1904, is a diluted form of formocresol containing 19% formaldehyde, 35% cresol and 17.5% glycerine. Disinfecting agents used commonly for hospital floors and surfaces include sodium hypochlorite, chlorhexidine, ethanol, formaldehyde, glutaraldehyde, hydrogen peroxide, iodoform and calcium hydroxide (<a href="./references#CD003220-bbs2-0163" title="FerreiraFB , TorresSA , RosaOP , FerreiraCM , GarciaRB , MarcucciMC , et al. Antimicrobial effect of propolis and other substances against selected endodontic pathogens. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics2007;104(5):709‐16. [PUBMED: 17964476] ">Ferreira 2007</a>; <a href="./references#CD003220-bbs2-0182" title="SassoneLM , FidelRA , FidelSR , DiasM , HirataRJ . Antimicrobial activity of different concentrations of NaOCl and chlorhexidine using a contact test. Brazilian Dental Journal2003;14(2):99‐102. [PUBMED: 12964652] ">Sassone 2003</a>). However, formaldehyde is a carcinogen (of the second category according to modified 67/548/CEE) and mutagenic agent (of the third category according to modified 67/548/CEE) (<a href="./references#CD003220-bbs2-0176" title="MilnesAR . Persuasive evidence that formocresol use in pediatric dentistry is safe. Journal of the Canadian Dental Association2006;72(3):247‐8. [PUBMED: 16696891] ">Milnes 2006</a>). Moreover, cresols are toxic if ingested or there is cutaneous contact and can cause severe skin burns and eye lesions. Formocresol should therefore not be applied without a dental dam. Researchers started to say that formocresol should not be used at the beginning of the 1980s (<a href="./references#CD003220-bbs2-0172" title="LewisB . The obsolescence of formocresol. British Dental Journal2009;207(11):525‐8. [PUBMED: 20010749] ">Lewis 2009</a>); the American Association of Endodontists and the American Academy of Pediatric Dentistry advocate not using formocresol. We think the use of formocresol should be banned in children, and journals should not accept any publication of a trial including formocresol treatments in children. We think MTA should now be used as the 'gold standard' medicament in primary teeth pulpotomy trials. </p> <p>Although the evidence is insufficient and a proper network meta‐analysis would be needed, calcium hydroxide and calcium hydroxide iodoform may be ineffective medicaments that should not be applied after pulpotomy of a primary molar. It seems that ZOE, electrosurgery, buffered glutaraldehyde and probably ferric sulphate may have medium to low efficacy. Ferric sulphate has proved to be less effective than MTA and may be less effective than formocresol (except for pain). Ferric sulphate may also be less effective than NaOCl. If MTA, laser, Biodentine or EMD cannot be applied to the pulp stumps, applying NaOCl may be the safest and cheapest option, although the efficacy of such a treatment clearly seems to be limited. </p> <p>For the time being, the evidence supports applying MTA on the pulp stumps after pulpotomy in primary teeth. Where MTA is not accessible, research is needed to confirm if Biodentine, EMD, laser treatment or Ankaferd Blood Stopper are acceptable second choices, and if, where none of these treatments can be used, application of NaOCl would be the safest option. </p> </section> <section id="CD003220-sec-0361"> <h4 class="title">Pulpectomy</h4> <p>For comparisons of medicaments used during pulpectomies, ZOE had statistically significantly fewer clinical and radiological failures at six and 12 months than calcium hydroxide iodoform (Vitapex) (low‐quality evidence). For all other comparisons of medicaments used during pulpectomies, despite the statistically significant difference for four comparisons, each including only one trial (<a href="./references#CD003220-bbs2-0012" title="BezginT , OzgulBM , ArikanV , SariS . Root canal filling in primary molars without successors: Mineral trioxide aggregate versus gutta‐percha/AH‐Plus. Australian Endodontic Journal2016;42:73‐81. ">Bezgin 2016</a>; <a href="./references#CD003220-bbs2-0016" title="ChandraSP , ChandrasekharR , UloopiKS , VinayC , KumarNM . Success of root fillings with zinc oxide‐ozonated oil in primary molars: preliminary results. European Archives of Paediatric Dentistry2014;15(3):191‐5. ">Chandra 2014</a>; <a href="#CD003220-tbl-0041">Table 38</a>; <a href="#CD003220-tbl-0042">Table 39</a>), the small number of studies and the inconsistency in results limited interpretation. ZOE‐calcium hydroxide‐I (Endoflas) and 3Mix have been insufficiently evaluated and trials comparing ZOE, ZOE‐calcium hydroxide‐I, 3Mix (and maybe Metapex) should be conducted. </p> <p>Thus, until further trials compare ZOE‐calcium hydroxide‐I and 3Mix, ZOE may be the best choice for filling the root canals after pulpectomy in primary teeth. ZOE seems to be an effective medicament; it is cheap and reasonably safe (<a href="./references#CD003220-bbs2-0181" title="SarramiN , PembertonMN , ThornhillMH , TheakerED . Adverse reactions associated with the use of eugenol in dentistry. British Dental Journal2002;193(5):257‐9. [PUBMED: 12353045] ">Sarrami 2002</a>) for use in children. </p> </section> <section id="CD003220-sec-0362"> <h4 class="title">Pulpotomy versus pulpectomy</h4> <p>The evidence comparing pulpotomy and pulpectomy was limited as the four available trials each assessed a different combinations of medicament and pulpotomy/pulpectomy. Two of the trials found in favour of the pulpectomy arm for some secondary outcomes (<a href="#CD003220-tbl-0043">Table 40</a>; <a href="#CD003220-tbl-0044">Table 41</a>); however, we think this is due to the fact that the teeth included in both these trials presented root pulp irreversible inflammation or infection; actually, inclusion criteria in both these trials concerned teeth with furcal radiolucency, spontaneous pain, tenderness to percussion, abnormal mobility or an abscess or fistula. Such teeth should not be treated by pulpotomy. Pulpectomy and extraction are the two options in such cases. Researchers and clinicians should refer to the AAPD guideline on pulp therapy when conceiving a trial or choosing the appropriate pulp treatment (<a href="./references#CD003220-bbs2-0165" title="Clinical Affairs Committee ‐ Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. American Academy of Pediatric Dentistry2014:244‐52. ">Guideline Pulp Therapy 2014</a>; <a href="./references#CD003220-bbs2-0166" title="Clinical Affairs Committee ‐ Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. Pediatric Dentistry2016;38(6):280‐8. [PUBMED: 27931467] ">Guideline Pulp Therapy 2016</a>). </p> </section> <section id="CD003220-sec-0363"> <h4 class="title">Direct pulp capping</h4> <p>The evidence comparing different medicaments for use in direct pulp capping was limited as there was only one trial for each comparison. <a href="./references#CD003220-bbs2-0021" title="DemirT , CehreliZC . Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2‐year results. American Journal of Dentistry2007;20(3):182‐8. ">Demir 2007</a> compared different adhesive resins with each other and against calcium hydroxide, and did not find evidence that one medicament was superior to another. <a href="./references#CD003220-bbs2-0007" title="AminabadiNA , FarahaniRM , OskoueiSG . Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow‐up. Journal of Clinical Pediatric Dentistry2010;34(4):317‐21. [PUBMED: 20831133] ">Aminabadi 2010</a> favoured formocresol over calcium hydroxide; MTA over 3Mix or simvastatin; and 3Mixtatin over 3Mix or simvastatin (low‐quality evidence). Calcium silicates such as MTA and Biodentine seem to be promising materials; however, no failure was identified in Tuna's trial comparing calcium hydroxide and MTA (<a href="./references#CD003220-bbs2-0079" title="TunaD , OlmezA . Clinical long‐term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal2008; Vol. 41, issue 4:273‐8. ">Tuna 2008</a>). As for pulpotomy, EMD may also be an alternative medicament for direct pulp capping in primary teeth; one trial compared EMD with calcium hydroxide and identified only two failures (one from each group) from 90 teeth evaluated over 12 months (<a href="./references#CD003220-bbs2-0034" title="Garrocho‐RangelA , FloresH , Silva‐HerzogD , Hernandez‐SierraF , MandevilleP , Pozos‐GuillenAJ . Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(5):733‐8. ">Garrocho‐Rangel 2009</a>). </p> <p>Due to the toxicity of formocresol, conducting a large long‐term, well‐designed trial comparing MTA, Biodentine, EMD and DentoGen could help practitioners choose the right medicament to apply on a pulp exposure in a primary tooth. </p> </section> </section> <section id="CD003220-sec-0364"> <h3 class="title" id="CD003220-sec-0364">Overall completeness and applicability of evidence</h3> <section id="CD003220-sec-0365"> <h4 class="title">Overall completeness</h4> <p>Many trials have evaluated medicaments that can be used after pulpotomy of a deciduous molar. However, few trials have evaluated direct pulp capping medicaments. Several recent studies have added to the evidence comparing medicaments that can be applied to root canals after pulpectomy, but data are still scarce. </p> <p>Some studies have compared the pulpotomy and pulpectomy treatments but no study has compared dental pulp capping and pulpotomy. However, AAPD recommendations already stipulate the conditions when direct pulp capping, pulpotomy or pulpectomy should be performed; moreover, these recommendations say direct pulp capping of a carious pulp exposure in a primary tooth is not recommended (<a href="./references#CD003220-bbs2-0165" title="Clinical Affairs Committee ‐ Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. American Academy of Pediatric Dentistry2014:244‐52. ">Guideline Pulp Therapy 2014</a>; <a href="./references#CD003220-bbs2-0166" title="Clinical Affairs Committee ‐ Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. Pediatric Dentistry2016;38(6):280‐8. [PUBMED: 27931467] ">Guideline Pulp Therapy 2016</a>). It therefore seems there is no need for new trials comparing direct pulp capping and pulpotomy or pulpotomy and pulpectomy. </p> </section> <section id="CD003220-sec-0366"> <h4 class="title">Applicability of evidence</h4> <p>Many countries ‐ rich or poor, north or south ‐ contributed data to our review, so results should be valid in all countries and regions. </p> <p>In terms of context, all included trials were conducted in dental departments of hospitals. The context of a private practice is quite different and practice‐based studies, conducted in private practices, would enhance the external validity of data on pulp treatments in primary teeth. However, operators of included studies were of different types: either paediatric dentists, general practitioners, undergraduate or postgraduate students. Our results therefore do apply to all types of practitioners. </p> </section> </section> <section id="CD003220-sec-0367"> <h3 class="title" id="CD003220-sec-0367">Quality of the evidence</h3> <p>The major limitation of our review is inherent to shortcomings across and within primary studies. The efficacy of pulp treatment techniques may be measured in various ways, commonly by both clinical and radiological dimensions. We found substantial diversity in reported outcomes, with 78 outcomes pertaining to primary teeth (39 clinical and 39 radiological outcomes). A success or failure composite outcome was often used but was defined by various component outcomes across trials. Consensus is lacking regarding the most relevant outcomes, especially for the definition of success or failure. Most investigators used their own criteria. In our review, the median number of component outcomes defining success or failure for each trial was nine (quartile 1 to quartile 3: 5 to 10, minimum to maximum 1 to 20). Moreover, all these outcomes were frequently assessed at different times within and across trials. Because of heterogeneous selection and measurement of outcomes across trials, performing meta‐analyses may be difficult, if not impossible. However, this variety did not always result in substantial statistical heterogeneity on meta‐analysis. The number of children included in most studies was very small. Power was thus a problem both at the study level and at the review level. Until further trials are conducted, a network meta‐analysis may help unravel the efficacy hierarchy that exists among pulpotomy materials. </p> <p>The overall risk of bias of included studies was either high or unclear. Trial reporting often did not allow for assessment of all risk of bias domains because many methodological elements were not mentioned. Operative treatment cannot be blinded and the risk of bias could not be low. There is no solution to this problem. However, no included study would be at low risk if this risk of bias domain was not taken into account, which means the methodology of clinical trials evaluating pulp treatments in primary teeth can still be enhanced. </p> <p>We assessed the quality of evidence regarding pulp treatments for extensive decay in primary teeth as moderate to very low (according to GRADE recommendations), depending on the comparison and main outcome (clinical or radiographic). The risk of bias was high or unclear in all studies, the small size of the studies often resulted in imprecision and methodological differences sometimes resulted in substantial inconsistency. However, some comparisons had a large (RR &lt; 0.5 or &gt; 2) to very large (RR &lt; 0.2 or &gt; 5) magnitude of effect, which may compensate for the methodological shortcomings or the heterogeneity. We could not assess the potential for publication bias. </p> <p>In this review, the quality of the evidence seemed slightly better for radiographic outcomes: the risk of bias was rated as low, unclear and high in 51%, 44% and 5% of the included trials, respectively, for the clinical outcomes, compared to 59%, 39% and 2%, respectively, for the radiographic outcomes. </p> <p>We assessed 32% of the pulpotomy trials to be at high risk of bias, compared with 13% of the pulpectomy trials and 14% of the direct pulp capping trials. The pulpotomy evidence may be in larger quantity but of lower quality than the pulpectomy and direct pulp capping evidence. However, it is difficult to be sure as all other trials were at unclear risk of bias. </p> <p>We assessed 50% of the pulpotomy versus pulpectomy trials to be at high risk of bias, which is not surprising because the methodology of these trials was poor overall (in particular, inclusion criteria do not comply with AAPD guidelines). </p> <p>The heterogeneity of the results was very often low (0% to 40%) and sometimes moderate to substantial (40% to 68%) in pulpotomy trials. It was low to very substantial (up to 82%) in pulpectomy trials. Direct pulp capping comparisons all involved only one trial so heterogeneity could not be assessed. </p> <p>Imprecision was a common reason for downgrading the quality of the evidence because included trials were mostly small and yielded large confidence intervals if too few trials had been conducted. </p> </section> <section id="CD003220-sec-0368"> <h3 class="title" id="CD003220-sec-0368">Potential biases in the review process</h3> <p>Our search strategy was extensive and we contacted authors to query data. However, we cannot exclude the possibility of selective reporting of trials or outcomes. The small numbers of trials in comparisons preclude the assessment of small‐study biases through funnel plots and asymmetry tests. Regarding selective outcome reporting, we did not have access to most trial protocols. However, we found important differences between outcomes defined in the methods and results sections. In all 87 reports, at least one outcome defined in the methods section was not reported in the results section or vice versa. However, the large number of cases creates support for overall conclusions. </p> </section> <section id="CD003220-sec-0369"> <h3 class="title" id="CD003220-sec-0369">Agreements and disagreements with other studies or reviews</h3> <section id="CD003220-sec-0370"> <h4 class="title">Pulpotomy</h4> <p>A few systematic reviews have compared pulpotomy medicaments.</p> <p>One systematic review compared MTA, calcium hydroxide, ferric sulphate and electrosurgery; based on 30 trials, it concluded the superiority of MTA (<a href="./references#CD003220-bbs2-0188" title="Stringhini JuniorE , VitcelME , OliveiraLB . Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol. European Archives of Paediatric Dentistry2015;16(4):303‐12. [PUBMED: 25833280] ">Stringhini 2015a</a>). One systematic review compared MTA, formocresol, ferric sulphate and calcium hydroxide; based on 18 RCTs and 10 clinical trials; results suggested that MTA was superior to formocresol, ferric sulphate and calcium hydroxide in all time periods up to exfoliation (<a href="./references#CD003220-bbs2-0177" title="NgFK , MesserLB . Mineral trioxide aggregate as a pulpotomy medicament: an evidence‐based assessment. European Archives of Paediatric Dentistry2008;9(2):58‐73. [PUBMED: 18534173] ">Ng 2008</a>). One systematic review compared MTA and ferric sulphate; based on four trials, the 24‐month data were in favour of MTA (<a href="./references#CD003220-bbs2-0158" title="AsgaryS , ShirvaniA , FazlyabM . MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta‐analysis. Journal of Clinical Pediatric Dentistry2014;39(1):1‐8. [PUBMED: 25631717] ">Asgary 2014b</a>). One systematic review compared MTA and calcium hydroxide; based on four trials, risk ratios were in favour of MTA after six, 12 and 24 months (<a href="./references#CD003220-bbs2-0185" title="ShirvaniA , HassanizadehR , AsgaryS . Mineral trioxide aggregate vs. calcium hydroxide in primary molar pulpotomy: a systematic review. Iranian Endodontic Journal2014;9(2):83‐8. [PUBMED: 24688575] ">Shirvani 2014b</a>). The results of these four systematic reviews are in agreement with our results. </p> <p>Four systematic reviews compared MTA and formocresol. One was based on five trials (377 teeth) and did not identify any significant difference in success between medicaments (<a href="./references#CD003220-bbs2-0175" title="MarghalaniAA , OmarS , ChenJW . Clinical and radiographic success of mineral trioxide aggregate compared with formocresol as a pulpotomy treatment in primary molars: a systematic review and meta‐analysis. Journal of the American Dental Association (1939)2014;145(7):714‐21. [PUBMED: 24982277] ">Marghalani 2014a</a>). One was based on six trials and its results showed a clinical and a radiographic risk ratio statistically significantly in favour of MTA (<a href="./references#CD003220-bbs2-0179" title="PengL , YeL , TanH , ZhouX . Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta‐analysis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics2006;102(6):e40‐4. [PUBMED: 17138165] ">Peng 2006</a>). One was based on eight trials and concluded that overall clinical and radiographic success rates were in favour of MTA (<a href="./references#CD003220-bbs2-0162" title="Fallahinejad GhajariM , MirkarimiM , VatanpourM , Kharrazi FardMJ . Comparison of pulpotomy with formocresol and MTA in primary molars: a systematic review and meta‐analysis. Iranian Endodontic Journal2008;3(3):45‐9. [PUBMED: 24146670] ">Fallahinejad 2008</a>).One was based on 19 trials (1585 participants) and the resulting risk ratios were 0.26, 0.37 and 0.41 after six, 12 and 24 months, respectively, always in favour of MTA (<a href="./references#CD003220-bbs2-0186" title="ShirvaniA , AsgaryS . Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta‐analysis of randomized clinical trials. Clinical Oral Investigations2014;18(4):1023‐30. [PUBMED: 24452827] ">Shirvani 2014c</a>). Our results, based on 14 trials (1048 teeth), are very much in line with the latter as the risk ratios we observed were 0.23, 0.48 and 0.50, respectively. Overall, MTA is a more effective medicament than formocresol for the pulpotomy of primary molars. </p> <p>One network meta‐analysis was published (<a href="./references#CD003220-bbs2-0173" title="LinPY , ChenHS , WangYH , TuYK . Primary molar pulpotomy: a systematic review and network meta‐analysis. Journal of Dentistry2014;42(9):1060‐77. [PUBMED: 24513112] ">Lin 2014</a>). The results favoured MTA, ferric sulphate and formocresol over laser and calcium hydroxide. Considering the effect estimates and funnel plot of clinical and radiographic outcomes after 18 to 24 months, the medicaments followed the mentioned order in terms of success, with MTA being the most successful medicament and calcium hydroxide being the least successful. Concerning these two medicaments, our results are in agreement with this network meta‐analysis. However, our results are not completely in agreement with this publication for ferric sulphate, formocresol and laser. Our results were based on 53 trials while this network meta‐analysis was based on 37 studies (3 of which we excluded because they did not meet our inclusion criteria), 22 of which were included in the final network meta‐analysis. Thus, our effect estimates are much larger than those found in this review. Overall, our pair‐wise effect estimates favour the same medicament as in this review. A network meta‐analysis based on our results would certainly help in confirming the relative efficacy of medicaments such as ferric sulphate, laser or NaOCl. </p> <p>Furthermore, one systematic review compared formocresol and ferric sulphate; based on four RCTs, four controlled clinical trials and three retrospective studies; its results did not show any statistically significant risk ratio between medicaments (<a href="./references#CD003220-bbs2-0180" title="PengL , YeL , GuoX , TanH , ZhouX , WangC , et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta‐analysis. International Endodontic Journal2007;40(10):751‐7. [PUBMED: 17714467] ">Peng 2007</a>). Another systematic review comparing formocresol and ferric sulphate found clinical data statistically significantly in favour of ferric sulphate and radiographic data that did not statistically significantly differ between medicaments (<a href="./references#CD003220-bbs2-0174" title="LohA , O'HoyP , TranX , CharlesR , HughesA , KuboK , et al. Evidence‐based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatric Dentistry2004;26(5):401‐9. [PUBMED: 15460294] ">Loh 2004</a>). As in our review, their clinical data seemed to be in favour of ferric sulphate while their radiographic data seemed to be in favour of formocresol. </p> </section> <section id="CD003220-sec-0371"> <h4 class="title">Pulpectomy</h4> <p>We found no other systematic review comparing the different medicaments that can be used to fill the root canals of pulpectomised primary molars. </p> </section> <section id="CD003220-sec-0372"> <h4 class="title">Direct pulp capping</h4> <p>We found no other systematic review comparing the different medicaments that can be applied on the pulp stumps for direct pulp capping of primary molars. </p> </section> <section id="CD003220-sec-0373"> <h4 class="title">Comparison of pulp treatments</h4> <p>A recent systematic review supported indirect pulp therapy and pulpotomy (with either MTA or formocresol) over direct pulp capping as the latter showed similar failure rates but the quality of the evidence was lower (<a href="./references#CD003220-bbs2-0160" title="CollJ , SealeNS , VargasK , ChiDL , MarghalaniAA , GrahamL . Protocol for a systematic review and meta‐analysis of vital pulp therapy for children with deep caries in the primary dentition. Pediatric Dentistry2015;37(5):418‐21. [PUBMED: 26531083] ">Coll 2015</a>; <a href="./references#CD003220-bbs2-0161" title="CollJA , SealeNS , VargasK , MarghalaniAA , Al ShamaliS , GrahamL . Primary tooth vital pulp therapy: a systematic review and meta‐analysis. Pediatric Dentistry2017;39(1):16‐123. [PUBMED: 28292337] ">Coll 2017</a>). Our review did not evaluate indirect pulp capping. However, we found no randomised trial comparing pulpotomy and direct pulp capping. This recent systematic review was based on some of the trials included in this review, which compare medicaments for a given pulp treatment. We think the context and methodology varies too much across trials to conclude as to the superiority of pulpotomy or direct pulp capping: trials comparing these would be useful. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003220-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD003220-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD003220-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 3 Overall failure." data-id="CD003220-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 4 Pain." data-id="CD003220-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 4 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 5 Soft tissue pathology." data-id="CD003220-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 5 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 6 Pathological mobility." data-id="CD003220-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 6 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 7 Pathological radiolucency." data-id="CD003220-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 7 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 8 Pathological root resorption." data-id="CD003220-fig-0010" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 8 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 9 Pulp canal obliteration." data-id="CD003220-fig-0011" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 9 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 10 Dentin bridge formation." data-id="CD003220-fig-0012" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 10 Dentin bridge formation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 11 Physiological root resorption." data-id="CD003220-fig-0013" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy, Outcome 11 Physiological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0014" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0015" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0016" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0017" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 5 Pathological radiolucency." data-id="CD003220-fig-0018" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 5 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 6 Pathological root resorption." data-id="CD003220-fig-0019" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 6 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 7 Pulp canal obliteration." data-id="CD003220-fig-0020" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy, Outcome 7 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0021" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0022" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0023" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0024" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 5 Pathological mobility." data-id="CD003220-fig-0025" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 5 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 6 Pathological radiolucency." data-id="CD003220-fig-0026" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 6 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 7 Pathological root resorption." data-id="CD003220-fig-0027" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 7 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 8 Pulp canal obliteration." data-id="CD003220-fig-0028" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 8 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0029" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0030" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 3 Overall failure." data-id="CD003220-fig-0031" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 4 Pain." data-id="CD003220-fig-0032" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 4 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 5 Soft tissue pathology." data-id="CD003220-fig-0033" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 5 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 6 Pathologic mobility." data-id="CD003220-fig-0034" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 6 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 7 Pathologic radiolucency." data-id="CD003220-fig-0035" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 7 Pathologic radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 8 Pathological root resorption." data-id="CD003220-fig-0036" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 8 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 9 Pulp canal obliteration." data-id="CD003220-fig-0037" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy, Outcome 9 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0038" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0039" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 3 Overall failure." data-id="CD003220-fig-0040" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 4 Pain." data-id="CD003220-fig-0041" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 4 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 5 Soft tissue pathology." data-id="CD003220-fig-0042" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 5 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 6 Pathological mobility." data-id="CD003220-fig-0043" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 6 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 7 Pathological radiolucency." data-id="CD003220-fig-0044" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 7 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 8 Pathological root resorption." data-id="CD003220-fig-0045" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 8 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 9 Pulp canal obliteration." data-id="CD003220-fig-0046" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 9 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 10 Dentin bridge formation." data-id="CD003220-fig-0047" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy, Outcome 10 Dentin bridge formation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0048" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0049" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0050" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0051" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 5 Pathologic mobility." data-id="CD003220-fig-0052" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 5 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 6 Pathological radiolucency." data-id="CD003220-fig-0053" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 6 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 7 Pathological root resorption." data-id="CD003220-fig-0054" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 7 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 8 Pulp canal obliteration." data-id="CD003220-fig-0055" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 8 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 9 Dentin bridge formation." data-id="CD003220-fig-0056" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy, Outcome 9 Dentin bridge formation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0057" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0058" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0059" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0060" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 5 Pathologic mobility." data-id="CD003220-fig-0061" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 5 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 6 Pathological radiolucency." data-id="CD003220-fig-0062" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 6 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 7 Pathological root resorption." data-id="CD003220-fig-0063" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy, Outcome 7 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0064" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0065" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 3 Overall failure." data-id="CD003220-fig-0066" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 4 Pain." data-id="CD003220-fig-0067" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 4 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 5 Soft tissue pathology." data-id="CD003220-fig-0068" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 5 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 6 Pathological mobility." data-id="CD003220-fig-0069" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 6 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 7 Pathological radiolucency." data-id="CD003220-fig-0070" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 7 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 8 Pathological root resorption." data-id="CD003220-fig-0071" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 8 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 9 Pulp canal obliteration." data-id="CD003220-fig-0072" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 9 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-008-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-008-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 10 Dentin bridge formation." data-id="CD003220-fig-0073" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8 Calcium hydroxide pulpotomy versus formocresol pulpotomy, Outcome 10 Dentin bridge formation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-008-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0074" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0075" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 3 Overall failure." data-id="CD003220-fig-0076" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 4 Pathological root resorption." data-id="CD003220-fig-0077" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy, Outcome 4 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0078" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0079" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 3 Overall failure." data-id="CD003220-fig-0080" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 4 Pain." data-id="CD003220-fig-0081" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 4 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 5 Pathological radiolucency." data-id="CD003220-fig-0082" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 5 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 6 Pathological root resorption." data-id="CD003220-fig-0083" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 6 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-010-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-010-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 7 Pulp canal obliteration." data-id="CD003220-fig-0084" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10 Ferric sulphate pulpotomy versus formocresol pulpotomy, Outcome 7 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-010-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0085" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0086" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0087" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0088" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 5 Adjacent tissue inflammation." data-id="CD003220-fig-0089" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 5 Adjacent tissue inflammation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 6 Pathologic mobility." data-id="CD003220-fig-0090" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 6 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 7 Pathologic radiolucency." data-id="CD003220-fig-0091" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 7 Pathologic radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-011-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-011-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 8 Pathologic root resorption." data-id="CD003220-fig-0092" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11 Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 8 Pathologic root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-011-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0093" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0094" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0095" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 4 Pathological radiolucency." data-id="CD003220-fig-0096" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 4 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-012-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-012-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 5 Pathological root resorption." data-id="CD003220-fig-0097" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 5 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-012-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0098" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0099" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0100" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-013-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-013-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 4 Pathological mobility." data-id="CD003220-fig-0101" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 4 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-013-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-013-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 5 Pathological root resorption." data-id="CD003220-fig-0102" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 5 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-013-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-013-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 6 Pulp canal obliteration." data-id="CD003220-fig-0103" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.6</div> <div class="figure-caption"> <p>Comparison 13 Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy, Outcome 6 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-013-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0104" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0105" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0106" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0107" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 5 Pathologic mobility." data-id="CD003220-fig-0108" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.5</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 5 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 6 Pathologic radiolucency." data-id="CD003220-fig-0109" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.6</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 6 Pathologic radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-014-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-014-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 7 Pathologic root resorption." data-id="CD003220-fig-0110" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.7</div> <div class="figure-caption"> <p>Comparison 14 Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy, Outcome 7 Pathologic root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-014-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0111" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0112" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0113" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 3 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 4 Pathological mobility." data-id="CD003220-fig-0114" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 4 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 5 Pathological radiolucency." data-id="CD003220-fig-0115" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.5</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 5 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 6 Pathological root resorption." data-id="CD003220-fig-0116" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.6</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 6 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-015-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-015-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 7 Pulp canal obliteration." data-id="CD003220-fig-0117" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.7</div> <div class="figure-caption"> <p>Comparison 15 Diode laser pulpotomy versus electrosurgery pulpotomy, Outcome 7 Pulp canal obliteration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-015-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0118" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0119" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 3 Pain." data-id="CD003220-fig-0120" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0121" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.4</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 5 Pathologic mobility." data-id="CD003220-fig-0122" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.5</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 5 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 6 Pathologic radiolucency." data-id="CD003220-fig-0123" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.6</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 6 Pathologic radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-016-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-016-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 7 Pathologic root resorption." data-id="CD003220-fig-0124" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.7</div> <div class="figure-caption"> <p>Comparison 16 Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy, Outcome 7 Pathologic root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-016-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0125" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 2 Pain." data-id="CD003220-fig-0126" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 2 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 3 Soft tissue pathology." data-id="CD003220-fig-0127" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 3 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-017-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-017-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 4 Pathologic mobility." data-id="CD003220-fig-0128" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17 Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy, Outcome 4 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-017-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 1 Radiological failure." data-id="CD003220-fig-0129" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 1 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 2 Pain." data-id="CD003220-fig-0130" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 2 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 3 Pathological mobility." data-id="CD003220-fig-0131" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 3 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 4 Pathological radiolucency." data-id="CD003220-fig-0132" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 4 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-018-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-018-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 5 Pathological radiolucency." data-id="CD003220-fig-0133" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.5</div> <div class="figure-caption"> <p>Comparison 18 Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 5 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-018-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Metapex versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0134" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Metapex versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Metapex versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0135" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Metapex versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 1 Clincal failure." data-id="CD003220-fig-0136" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 1 Clincal failure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0137" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 3 Pain." data-id="CD003220-fig-0138" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 3 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 4 Soft tissue pathology." data-id="CD003220-fig-0139" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 4 Soft tissue pathology. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 5 Pathologic mobility." data-id="CD003220-fig-0140" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 5 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 6 Pathological radiolucency." data-id="CD003220-fig-0141" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.6</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 6 Pathological radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-020-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-020-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 7 Pathological root resorption." data-id="CD003220-fig-0142" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.7</div> <div class="figure-caption"> <p>Comparison 20 Metapex pulpectomy versus Endoflas pulpectomy, Outcome 7 Pathological root resorption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-020-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0143" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0144" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 3 Overall failure." data-id="CD003220-fig-0145" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 3 Overall failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-021-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-021-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 4 Pain." data-id="CD003220-fig-0146" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.4</div> <div class="figure-caption"> <p>Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 4 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-021-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-021-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 5 Pathological mobility." data-id="CD003220-fig-0147" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.5</div> <div class="figure-caption"> <p>Comparison 21 Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy, Outcome 5 Pathological mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-021-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 1 Clinical failure." data-id="CD003220-fig-0148" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 1 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-022-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-022-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 2 Radiological failure." data-id="CD003220-fig-0149" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 2 Radiological failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-022-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-022-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 3 Pain." data-id="CD003220-fig-0150" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-022-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-022-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 4 Pathologic mobility." data-id="CD003220-fig-0151" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.4</div> <div class="figure-caption"> <p>Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 4 Pathologic mobility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003220-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/urn:x-wiley:14651858:media:CD003220:CD003220-CMP-022-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_t/tCD003220-CMP-022-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 5 Pathologic radiolucency." data-id="CD003220-fig-0152" src="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.5</div> <div class="figure-caption"> <p>Comparison 22 Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy, Outcome 5 Pathologic radiolucency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/media/CDSR/CD003220/image_n/nCD003220-CMP-022-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003220-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pulpotomy compared with pulpotomy using alternative medicament/technique for extensive decay in primary teeth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Pulpotomy compared with pulpotomy using alternative medicament/technique for extensive decay in primary teeth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> children with extensive decay in primary teeth </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> pulpotomy with one type of medicament </p> <p><b>Comparison:</b> pulpotomy using alternative medicament or different technique </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Experimental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>MTA versus formocresol</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure</b> </p> <p><b>(12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>28 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>8.6 per 1000 (2.8 per 1000 to 26.0 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.31 (0.10 to 0.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740</p> <p>(12 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure rate less than 3% across both the MTA and formocresol treatment groups. Seven of the 12 studies had no failures at 12 months. </p> <p>No evidence of a difference in clinical failure at 6 months or 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure</b> </p> <p><b>(12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>50 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>20.5 per 1000 (9.5 per 1000 to 44.5 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.41 (0.19 to 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740 (12 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure rate 5% across formocresol treatment groups and 2.1% across MTA treatment groups. Five of the 12 studies had no failures at 12 months. </p> <p>Results similar at 6 and 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>MTA versus calcium hydroxide</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>14 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>2.2 per 1000 (0.02 per 1000 to 9.8 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.16 (0.04 to 0.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 24 months.</p> <p>No evidence of a difference in clinical failure at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure</b> </p> <p><b>(12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>351 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>42.1 per 1000 (14 per 1000 to 126.4 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.12 (0.04 to 0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 and 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Calcium hydroxide versus formocresol</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>115 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>215 per 1000 (140.3 per 1000 to 332.4 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.87 (1.22 to 2.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>332 (6 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 months</p> <p>No evidence of a difference in clinical failure at 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>253 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>470.6 per 1000 (359.3 per 1000 to 617.3 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.86 (1.42 to 2.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>332 (6 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 and 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Other comparisons assessed in more than one trial that had treatment failures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was<b>low</b> for 4 comparisons<sup>3</sup>: laser versus ferric sulphate; Biodentine versus MTA; ferric sulphate versus formocresol; electrosurgery versus ferric sulphate; calcium hydroxide versus ferric sulphate. </p> <p>The quality of the evidence was <b>very low</b> for 5 comparisons: NaOCl versus ferric sulphate<sup>4</sup>; laser versus electrosurgery<sup>4</sup>; MTA versus ferric sulphate<sup>5</sup>; ABS versus ferric sulphate<sup>6</sup>; EMD versus formocresol<sup>7</sup>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was<b>low</b> for 8 comparisons: NaOCl versus ferric sulphate<sup>2</sup>; MTA versus ferric sulphate<sup>3</sup>; Biodentine versus MTA<sup>3</sup>; ferric sulphate versus formocresol<sup>3</sup>; laser versus ferric sulphate<sup>3</sup>; electrosurgery versus ferric sulphate<sup>3</sup>; ABS versus ferric sulphate<sup>3</sup>; laser versus electrosurgery<sup>3</sup>; calcium hydroxide versus ferric sulphate (favouring ferric sulphate)<sup>3</sup>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Downgraded 1 level due to high risk of bias<br/> <sup>2.</sup> Downgraded 1 level due to high risk of bias and 1 level due to substantial inconsistency<br/> <sup>3.</sup> Downgraded 1 level due to high risk of bias and 1 level due to imprecision<br/> <sup>4.</sup> Downgraded 1 level due to high risk of bias and 2 levels due to imprecision<br/> <sup>5.</sup> Downgraded 1 level due to high risk of bias, 1 level due to moderate inconsistency and 1 level due to imprecision<br/> <sup>6.</sup> Downgraded 1 level due to high risk of bias and 2 levels due to very serious imprecision<br/> <sup>7.</sup> Downgraded 1 level due to high risk of bias, 1 level due to substantial inconsistency and 1 level due to imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Pulpotomy compared with pulpotomy using alternative medicament/technique for extensive decay in primary teeth</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003220-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Pulpectomy compared with pulpectomy using alternative medicament for extensive decay in primary teeth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Pulpectomy compared with pulpectomy using alternative medicament for extensive decay in primary teeth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> children with extensive decay in primary teeth </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> pulpectomy with 1 type of medicament </p> <p><b>Comparison:</b> pulpectomy using alternative medicament </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Experimental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Endoflas versus ZOE</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (6 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>128 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>33.3 per 1000 (6.4 per 1000 to 192 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.26 (0.05 to 1.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>One trial assessed failure at 12 months: RR 1.00, 95% 0.07 to 14.55</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (6 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>128 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>33.3 per 1000 (6.4 per 1000 to 192 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.26 (0.05 to 1.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Metapex versus ZOE</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>97 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>68.9 per 1000 (14.6 per 1000 to 323 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.71 (0.15 to 3.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>129 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>129 per 1000 (40 per 1000 to 421.8 per 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.00 (0.31 to 3.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results similar at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Other comparisons assessed in more than one trial that had treatment failures</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was rated as <b>low</b> for 1 comparison: Vitapex versus ZOE (favouring ZOE)<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was rated as <b>low</b> for 2 comparisons: Vitapex versus ZOE<sup>2</sup> (favouring ZOE); calcium hydroxide versus ZOE<sup>3</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Downgraded 1 level due to imprecision<br/> <sup>2.</sup> Downgraded 2 levels due to very substantial inconsistency<br/> <sup>3.</sup> Downgraded 1 level due to substantial inconsistency and 1 level due to imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Pulpectomy compared with pulpectomy using alternative medicament for extensive decay in primary teeth</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003220-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Direct pulp capping compared with direct pulp capping using alternative medicament for extensive decay in primary teeth</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Direct pulp capping compared with direct pulp capping using alternative medicament for extensive decay in primary teeth</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> children with extensive decay in primary teeth </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> direct pulp capping with 1 type of medicament </p> <p><b>Comparison:</b> direct pulp capping using alternative medicament </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Experimental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Seven trials evaluated 22 comparisons of different medicaments for direct pulp capping. Each comparison was assessed by a single trial. </p> <p>There were no clinical or radiological failures in two comparisons: acetone‐based total‐etch adhesive versus calcium hydroxide; MTA versus calcium hydroxide. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was assessed as <b>low</b> for 5 comparisons<sup>1</sup>: calcium hydroxide versus formocresol (favouring formocrescol), MTA versus 3Mix and MTA versus simvastatin (favouring MTA), 3Mix versus 3Mixtatin and 3Mixtatin versus simvastatin (favouring 3Mixtatin). </p> <p>The quality of the evidence was rated as <b>very low</b> for all other comparisons.<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiological failure (at six, 12 and 24 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>The quality of the evidence was rated as <b>low</b> for 1 comparison: calcium hydroxide versus formocresol<sup>1</sup> (favouring formocresol). </p> <p>The quality of the evidence was rated as <b>very low</b> for all other comparisons.<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Downgraded 1 level due to risk of bias and 1 level due to imprecision<br/> <sup>2.</sup> Downgraded 1 level due to risk of bias and 2 levels due to severe imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Direct pulp capping compared with direct pulp capping using alternative medicament for extensive decay in primary teeth</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Pulpotomy (FS + MTA) versus pulpotomy (MTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.46 (0.17 to 70.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.75 (0.82 to 9.29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (0.51 to 1.33)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulphate; MTA: mineral trioxide aggregate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Pulpotomy (FS + MTA) versus pulpotomy (MTA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pulpotomy (CEM cement) versus pulpotomy (MTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CEM: calcium‐enriched mixture; CI: confidence interval; MTA: mineral trioxide aggregate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pulpotomy (CEM cement) versus pulpotomy (MTA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.63)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 2.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 2.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologicroot resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.63)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 2.99)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; NaOCl: sodium hypochlorite </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (NaOCl)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (CH+NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09 (0.01, 1.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologicroot resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 (0.15, 1.29)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; CH: calcium hydroxyde; NaOCl; sodium hypochlorite </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (CH+NaOCl)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0008"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Pulpotomy (MTA + NaOCl) versus pulpotomy (CH + NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.02, 1.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04, 3.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.27, 1.65)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite; CH: calcium hydroxyde. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Pulpotomy (MTA + NaOCl) versus pulpotomy (CH + NaOCl)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0009"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (2% buffered glutaraldehyde)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06 (0.00, 0.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.00, 1.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06 (0.00, 0.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03 (0.00, 0.55)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05 (0.00, 0.78)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01, 1.98)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (2% buffered glutaraldehyde)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0010"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.03 to 1.59)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 (0.01 to 0.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 (0.02 to 0.93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.00 to 1.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.0 (0.64 to 188.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Physiological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; ZOE: zinc oxide and eugenol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (ZOE)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0011"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Pulpotomy (diode laser + MTA) versus pulpotomy (FC + ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.48 to 33.42)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.40 to 9.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.33 to 26.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.27 to 8.25)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol; MTA: mineral trioxide aggregate; ZOE: zinc oxide and eugenol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Pulpotomy (diode laser + MTA) versus pulpotomy (FC + ZOE)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0012"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (EMD)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 (0.06, 1.28)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14 (0.01, 2.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.91)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 (0.08, 1.93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.02)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; EMD: enamel matrix derivative </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (EMD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0013"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Pulpotomy (Tempophore) versus pulpotomy (MTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.21 (0.14, 75.68)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.64 (0.54, 171.09)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.69 (0.57, 12.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.21 (0.14, 75.68)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.15 (0.43, 10.79)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.44 (0.83, 50.11)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.30 (1.00, 18.47)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.76 (0.85, 16.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.61 (0.78, 3.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Dentine bridge formation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01, 2.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.07 (0.00, 1.19)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviation: CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Pulpotomy (Tempophore) versus pulpotomy (MTA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0014"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (MTA + NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.21, 2.13)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>* due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Pulpotomy (MTA) versus pulpotomy (MTA + NaOCl)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0015"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Pulpotomy (ProRoot MTA) versus pulpotomy (OrthoMTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.06, 15.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01, 4.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 71.82)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.06, 15.52)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation: CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Pulpotomy (ProRoot MTA) versus pulpotomy (OrthoMTA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0016"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Pulpotomy (ProRoot MTA) versus pulpotomy (RetroMTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.01, 8.32)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation: CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title">Pulpotomy (ProRoot MTA) versus pulpotomy (RetroMTA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0017"> <div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Pulpotomy (OrthoMTA) versus pulpotomy (RetroMTA)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.13 (0.13, 74.85)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70 (0.12, 3.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.13 (0.13, 74.85)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.07, 16.19)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.09 (0.20, 22.24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01, 2.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.04, 3.22)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation: CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 14.</span> <span class="table-title">Pulpotomy (OrthoMTA) versus pulpotomy (RetroMTA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0018"> <div class="table-heading"><span class="table-label">Table 15.</span> <span class="table-title">Pulpotomy (CH) versus pulpotomy (PC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 96.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.07 to 270.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.00 (1.34 to 328.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 96.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 96.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable *</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.07 to 270.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.00 (1.34 to 328.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.00 (0.80, 212.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.07 to 270.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.00 (1.34 to 328.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dentine bridge formation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.11 to 2.33)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxide; PC: Portland cement.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 15.</span> <span class="table-title">Pulpotomy (CH) versus pulpotomy (PC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0019"> <div class="table-heading"><span class="table-label">Table 16.</span> <span class="table-title">Pulpotomy (CH) versus pulpotomy (MTA + NaOCl)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.62, 40.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.00 (1.06, 60.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.00 (0.89, 251.77)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.00 (1.02, 282.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.52, 3.39)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxyde; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 16.</span> <span class="table-title">Pulpotomy (CH) versus pulpotomy (MTA + NaOCl)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0020"> <div class="table-heading"><span class="table-label">Table 17.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.01 to 7.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.60 to 14.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 (0.11 to 3.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56 (0.14 to 2.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.11 to 0.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56 (0.14 to 2.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.11 to 0.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.01 to 7.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 (0.11 to 3.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.60 to 14.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 (0.11 to 3.56)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; CH: calcium hydroxide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 17.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0021"> <div class="table-heading"><span class="table-label">Table 18.</span> <span class="table-title">Pulpotomy (CH/iodoform) versus pulpotomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.41 (0.77 to 2.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.82 to 1.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.89 to 2.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.17 (0.87 to 1.59)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.72 (0.45 to 6.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 (0.33 to 3.23)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.55 (0.28 to 8.65)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 (0.22 to 4.74)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.15 (0.26 to 103.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.72 (0.45 to 6.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29 (0.38 to 4.37)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>CI: confidence interval; CH: calcium hydroxide.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 18.</span> <span class="table-title">Pulpotomy (CH/iodoform) versus pulpotomy (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0022"> <div class="table-heading"><span class="table-label">Table 19.</span> <span class="table-title">Pulpotomy (CH + NaOCl) versus pulpotomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09 (0.01, 1.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63 (0.23, 1.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.43 (0.12, 1.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 (0.11, 1.28)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.50, 2.53)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxide; NaOCl: sodium hypochlorite.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 19.</span> <span class="table-title">Pulpotomy (CH + NaOCl) versus pulpotomy (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0023"> <div class="table-heading"><span class="table-label">Table 20.</span> <span class="table-title">Pulpotomy (FS) versus pulpotomy (buffered glutaraldehyde)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.06, 1.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.07, 1.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (0.30, 1.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14 (0.69, 1.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20 (0.61, 2.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01, 1.98)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulfate.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 20.</span> <span class="table-title">Pulpotomy (FS) versus pulpotomy (buffered glutaraldehyde)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0024"> <div class="table-heading"><span class="table-label">Table 21.</span> <span class="table-title">Pulpotomy (FS) versus pulpotomy (ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20 (0.42 to 3.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.26 to 1.40)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 (0.11 to 1.25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17 (0.02 to 1.29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Physiological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.27 to 8.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulphate; ZOE: zinc oxide and eugenol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 21.</span> <span class="table-title">Pulpotomy (FS) versus pulpotomy (ZOE)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0025"> <div class="table-heading"><span class="table-label">Table 22.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (FS)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.19 (0.13 to 76.37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.31 (0.26 to 107.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.13 to 1.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 (0.19 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.13 to 1.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 (0.19 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01 to 2.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71 (0.12 to 4.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53 (0.05 to 5.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.16 to 7.25)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; FS: ferric sulphate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 22.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (FS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0026"> <div class="table-heading"><span class="table-label">Table 23.</span> <span class="table-title">Pulpotomy (FS + MTA) versus pulpotomy (FS)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.01 to 6.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.01 to 6.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01 to 3.09)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adjacent tissue inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 (0.01 to 6.08)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 (0.01 to 6.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.31 to 1.19)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.39 (0.78 to 2.49)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>CI: confidence interval; FS: ferric sulphate; MTA: mineral trioxide aggregate</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 23.</span> <span class="table-title">Pulpotomy (FS + MTA) versus pulpotomy (FS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0027"> <div class="table-heading"><span class="table-label">Table 24.</span> <span class="table-title">Pulpotomy (PC) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19, 21.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 (0.23, 2.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19, 21.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07, 15.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19, 21.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 71.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.22, 4.62)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.27)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations ‐ CI: confidence interval; PC: Portland cement; FC: formocresol</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 24.</span> <span class="table-title">Pulpotomy (PC) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0028"> <div class="table-heading"><span class="table-label">Table 25.</span> <span class="table-title">Pulpotomy (PC) versus pulpotomy (EMD)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.12, 3.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 (0.18, 1.78)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.12, 3.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07, 15.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.15, 6.71)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.27)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.16, 2.32)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.05, 5.27)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; PC: Portland cement; EMD: enamel matrix derivative</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 25.</span> <span class="table-title">Pulpotomy (PC) versus pulpotomy (EMD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0029"> <div class="table-heading"><span class="table-label">Table 26.</span> <span class="table-title">Pulpotomy (glutaraldehyde + CH) versus pulpotomy (glutaraldehyde + ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90 (0.32 to 26.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11 (0.46 to 2.67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.39 to 2.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.15 to 6.44)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval; ZOE: zinc oxide and eugenol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 26.</span> <span class="table-title">Pulpotomy (glutaraldehyde + CH) versus pulpotomy (glutaraldehyde + ZOE)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0030"> <div class="table-heading"><span class="table-label">Table 27.</span> <span class="table-title">Pulpotomy (electrofulguration + CH) versus pulpotomy (electrofulguration + ZOE)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (0.26, 2.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.47, 1.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.47, 1.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (0.26, 2.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.43, 2.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (0.28, 2.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.16, 6.80)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; CH: calcium hydroxide; ZOE: zinc oxide eugenol</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 27.</span> <span class="table-title">Pulpotomy (electrofulguration + CH) versus pulpotomy (electrofulguration + ZOE)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0031"> <div class="table-heading"><span class="table-label">Table 28.</span> <span class="table-title">Pulpotomy (electrosurgery) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 71.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.62 to 40.64)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 71.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 100.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 100.54)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 28.</span> <span class="table-title">Pulpotomy (electrosurgery) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0032"> <div class="table-heading"><span class="table-label">Table 29.</span> <span class="table-title">Pulpotomy (Biodentine) versus pulpotomy (Tempophore)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 (0.07, 16.36)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.11, 2.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.16 (0.21, 22.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.11, 2.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36 (0.08, 1.62)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31 (0.07, 1.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.39 (0.61, 3.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 (0.60, 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dentine bridge formation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.85 (0.69, 203.86)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 29.</span> <span class="table-title">Pulpotomy (Biodentine) versus pulpotomy (Tempophore)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0033"> <div class="table-heading"><span class="table-label">Table 30.</span> <span class="table-title">Pulpotomy (CH/iodoform) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.41 (2.30 to 117.26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.11 (3.04 to 27.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.06 (3.44 to 168.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.11 (3.04 to 27.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.47 (0.67 to 44.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.47 (0.67 to 44.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.64 (0.41 to 142.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.64 (0.41 to 142.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19 (0.21 to 22.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19 (0.21 to 22.99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.00 (0.69 to 208.77)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.47 (0.67 to 44.34)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval; FC: formocresol</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 30.</span> <span class="table-title">Pulpotomy (CH/iodoform) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0033">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0034"> <div class="table-heading"><span class="table-label">Table 31.</span> <span class="table-title">Pulpotomy (ZOE) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (0.29 to 2.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 99.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67 (0.71 to 3.89)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25 to 99.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.67 (0.80 to 8.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.00 (0.78 to 46.29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Physiological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.19 to 20.67)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol; ZOE: zinc oxide and eugenol</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 31.</span> <span class="table-title">Pulpotomy (ZOE) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0034">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0035"> <div class="table-heading"><span class="table-label">Table 32.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.19 (0.13 to 76.37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.13 (0.20 to 22.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 (0.28 to 9.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.28 to 4.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Overall failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 (0.28 to 9.13)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.28 to 4.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (0.01 to 8.49)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 (0.01 to 4.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.16 to 7.25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.19 (0.13 to 76.37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.16 to 7.25)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; FC: formocresol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 32.</span> <span class="table-title">Pulpotomy (Er:YAG laser) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0035">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0036"> <div class="table-heading"><span class="table-label">Table 33.</span> <span class="table-title">Pulpotomy (diode laser) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67 (0.43, 6.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.75, 5.33)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; FC: formocresol.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 33.</span> <span class="table-title">Pulpotomy (diode laser) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0036">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0037"> <div class="table-heading"><span class="table-label">Table 34.</span> <span class="table-title">Pulpotomy (ABS) versus pulpotomy (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.13, 3.44)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01, 7.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.16, 6.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67 (0.13, 3.44)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 34.</span> <span class="table-title">Pulpotomy (ABS) versus pulpotomy (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0037">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0038"> <div class="table-heading"><span class="table-label">Table 35.</span> <span class="table-title">Pulpectomy (Sealapex) versus pulpectomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.10 to 2.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 (0.10 to 2.43)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26 to 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Filling material anomaly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Sealapex: eugenol‐free CH; CH: calcium hydroxide.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 35.</span> <span class="table-title">Pulpectomy (Sealapex) versus pulpectomy (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0038">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0039"> <div class="table-heading"><span class="table-label">Table 36.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.01 to 1.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Filling material anomaly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 36.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0039">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0040"> <div class="table-heading"><span class="table-label">Table 37.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (Sealapex)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Filling material anomaly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide; Sealapex: eugenol‐free CH. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 37.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (Sealapex)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0040">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0041"> <div class="table-heading"><span class="table-label">Table 38.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (3Mix)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.07 to 15.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 (0.38 to 4.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 (0.80 to 4.19)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 70.30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.07 to 15.12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.27 to 8.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.75 (1.01 to 7.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.01 to 3.97)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide; 3Mix: ciprofloxacin + metronidazole + minocycline. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 38.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (3Mix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0041">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0042"> <div class="table-heading"><span class="table-label">Table 39.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (MPRCF)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.79 (1.32, 360.78)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.63 (0.35, 125.41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.63 (2.65, 685.54)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; MPRCF: ZOE (zinc oxide eugenol), calcium hydroxide, iodoform. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 39.</span> <span class="table-title">Pulpectomy (Vitapex) versus pulpectomy (MPRCF)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0042">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0043"> <div class="table-heading"><span class="table-label">Table 40.</span> <span class="table-title">Pulpotomy (FS) versus pulpectomy (Sedanol)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.80 (0.07 to 43.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.21 (0.22 to 80.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.25 to 1.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.04 (1.28 to 346.39)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pulp canal obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.05 (1.66 to 441.49)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations ‐ CI: confidence interval; FS: ferric sulphate; Sedanol=ZOE: zinc oxide and eugenol. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 40.</span> <span class="table-title">Pulpotomy (FS) versus pulpectomy (Sedanol)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0043">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0044"> <div class="table-heading"><span class="table-label">Table 41.</span> <span class="table-title">Pulpotomy (3Mix) versus pulpectomy (3Mix)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25, 99.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.25, 99.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 70.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.00 (1.42, 373.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.00 (0.64, 190.53)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack events</p> <p>Abbreviations ‐ CI: confidence interval; 3Mix: ciprofloxacin + metronidazole + minocycline.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 41.</span> <span class="table-title">Pulpotomy (3Mix) versus pulpectomy (3Mix)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0044">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0045"> <div class="table-heading"><span class="table-label">Table 42.</span> <span class="table-title">Direct pulp capping (CH) versus direct pulp capping (FC)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.83 (1.68 to 8.74)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.11 (1.61 to 6.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.37 to 132.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.00 (0.50 to 163.59)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.89 to 18.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.37 to 132.66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5 (0.50 to 12.39)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8 (0.64 to 5.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.46 to 34.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (1.14 to 21.86)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.33 (0.96 to 11.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.87 to 4.60)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval; FC: formocresol.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 42.</span> <span class="table-title">Direct pulp capping (CH) versus direct pulp capping (FC)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0045">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0046"> <div class="table-heading"><span class="table-label">Table 43.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 43.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0046">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0047"> <div class="table-heading"><span class="table-label">Table 44.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (CH)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CH: calcium hydroxide; CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 44.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (CH)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0047">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0048"> <div class="table-heading"><span class="table-label">Table 45.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 and 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 45.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (acetone‐based total‐etch adhesive)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0048">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0049"> <div class="table-heading"><span class="table-label">Table 46.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI) </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 46.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (acetone‐based total‐etch adhesive)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0049">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0050"> <div class="table-heading"><span class="table-label">Table 47.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (non‐rinse conditioner + acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38 to 127.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviations ‐ CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 47.</span> <span class="table-title">Direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive) versus direct pulp capping (non‐rinse conditioner + acetone‐based total‐etch adhesive)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0050">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0051"> <div class="table-heading"><span class="table-label">Table 48.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (non‐rinse conditioner + acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI) </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 48.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (non‐rinse conditioner + acetone‐based total‐etch adhesive)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0051">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0052"> <div class="table-heading"><span class="table-label">Table 49.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.01 to 7.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13 to 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathological radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.07 to 14.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.04 to 2.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6, 12 and 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 49.</span> <span class="table-title">Direct pulp capping (self etch adhesive system + acetone‐based total‐etch adhesive) versus direct pulp capping (total‐etching with 36% phosphoric acid + acetone‐based total‐etch adhesive)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0052">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003220-tbl-0053"> <div class="table-heading"><span class="table-label">Table 50.</span> <span class="table-title">Direct pulp capping (Dycal) versus direct pulp capping (Dentogen)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point (months) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No. of studies </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk ratio (95% CI) </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Clinical failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.00 (0.38, 127.32)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00 (0.49, 32.72)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Radiological failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.34, 26.45)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67 (0.46, 6.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6, 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.13, 69.52)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Soft tissue pathology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6, 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.20, 20.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pathologic mobility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6, 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.20, 20.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic radiolucency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0.34, 26.45)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.34, 5.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pathologic root resorption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1, 3, 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.00 (0.26, 98.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 (0.20, 20.33)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.33 (0.34, 5.21)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*due to lack of events</p> <p>Abbreviation ‐ CI: confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 50.</span> <span class="table-title">Direct pulp capping (Dycal) versus direct pulp capping (Dentogen)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/full#CD003220-tbl-0053">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0054"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.07, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>740</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.10, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.18, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>922</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.17, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>740</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.19, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.22, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.04, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.17, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.25, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.14, 3.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.05, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.27, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>652</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.19, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>460</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.25, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.18, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.07, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.08, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.00, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.81, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [1.07, 3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Dentin bridge formation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>18.16 [3.63, 90.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.76, 47.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.76, 47.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Physiological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.81]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus full strength or 1:5 diluted formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0054">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0055"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.09, 5.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.12, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.05, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.08, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.06, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.16, 2.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.11, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.76 [0.79, 206.70]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus full strength formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0055">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0056"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.02, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.18, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.17, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.20, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.31, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 70.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.30, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.13, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.23, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.24, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.05, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.10, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.00, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.44, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.99, 3.89]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus 1:5 diluted formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0056">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0057"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.20, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.15, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.25, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.15, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.32, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathologic radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.01, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.12, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 70.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.47, 5.27]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus ferric sulphate (FS) pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0057">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0058"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.04, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.12, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.02, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.04, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.08, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.10, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.18, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.09, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.02, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.06, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.04, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.03, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.02, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.03, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.77 [1.56, 38.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.01 [0.97, 4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [1.01, 4.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Dentin bridge formation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.05, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.37, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.37, 1.74]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus calcium hydroxide pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0058">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0059"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.10, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.49, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.60, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.71, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dentin bridge formation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.13, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.61, 3.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.61, 3.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Mineral trioxide aggregate (MTA) pulpotomy versus Portland cement pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0059">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0060"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.42, 6.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.16, 3.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.40 [0.65, 8.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.22, 5.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.26, 98.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.26, 98.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.26, 98.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.46 [0.15, 81.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.19, 6.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.22, 24.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.30, 4.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0060">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0061"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Calcium hydroxide pulpotomy versus formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [1.17, 3.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.22, 2.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [0.78, 6.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.48 [3.86, 62.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [1.42, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.63 [1.73, 7.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [0.80, 7.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [1.35, 6.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.18 [0.35, 29.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.30 [1.15, 34.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.14 [0.63, 42.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.77 [1.23, 37.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.64 [0.51, 13.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.18, 8.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.40, 3.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.0 [0.53, 153.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.78 [0.64, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [0.67, 5.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.24 [0.79, 13.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.87 [2.33, 60.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.25 [2.04, 19.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.59 [1.33, 15.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [0.47, 33.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.68 [0.91, 7.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Dentin bridge formation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.0 [1.81, 93.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.0 [1.95, 100.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Calcium hydroxide pulpotomy versus formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0061">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0062"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.4 [0.14, 81.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.37, 31.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.44 [0.90, 13.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.53, 3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [1.04, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.53, 3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [1.04, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.05, 6.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.29 [0.60, 8.66]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Calcium hydroxide pulpotomy versus ferric sulphate pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0062">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0063"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Ferric sulphate pulpotomy versus formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.15, 6.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.45, 4.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.40, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.32, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.73, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.71, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.12, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.51, 2.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.74, 3.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.8 [0.40, 8.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.2 [0.51, 9.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [0.53, 5.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.50, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.54, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.28, 5.54]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Ferric sulphate pulpotomy versus formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0063">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0064"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.39 [0.22, 87.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.22, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.17, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 6.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adjacent tissue inflammation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathologic radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.06, 13.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.07, 4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pathologic root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.18, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.15, 1.01]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Sodium hypochlorite (NaOCl) pulpotomy versus ferric sulfate (FS) pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0064">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0065"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.04, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.38, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.44, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.03, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.29, 7.73]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Diode laser pulpotomy versus ferric sulfate (FS) pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0065">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0066"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.13, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.38, 4.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.13, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.2 [0.54, 8.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Electrosurgery pulpotomy versus ferric sulfate (FS) pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0066">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0067"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.37, 4.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.16, 6.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.34, 2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.15, 6.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.27, 8.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathologic radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathologic root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.26, 96.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.31, 3.23]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0067">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0068"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Diode laser pulpotomy versus electrosurgery pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.19, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 3.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.19, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pulp canal obliteration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Diode laser pulpotomy versus electrosurgery pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0068">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0069"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.33, 5.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.52, 6.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathologic radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathologic root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.33, 5.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.52, 6.59]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Sodium hypochlorite (NaOCl) pulpotomy versus 1:5 diluted formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0069">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0070"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.08, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.26, 96.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Enamel matrix derivative (EMD) pulpotomy versus formocresol pulpotomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0070">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0071"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.50, 12.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.26, 8.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Calcium hydroxide pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0071">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0072"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Metapex versus zinc oxide eugenol (ZOE) pulpectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.08, 4.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.15, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.31, 3.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.31, 3.27]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Metapex versus zinc oxide eugenol (ZOE) pulpectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0072">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0073"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Metapex pulpectomy versus Endoflas pulpectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clincal failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.79, 5.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Soft tissue pathology <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pathological radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.79, 5.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pathological root resorption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Metapex pulpectomy versus Endoflas pulpectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0073">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0074"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.75 [1.21, 18.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.36 [0.86, 6.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.56 [2.58, 16.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [0.63, 5.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.89, 7.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathological mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 15.18]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Vitapex pulpectomy versus zinc oxide and eugenol (ZOE) pulpectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0074">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003220-tbl-0075"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.05, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Radiological failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.05, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.05, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pathologic mobility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.02, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pathologic radiolucency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.11, 3.63]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003220.pub3/references#CD003220-tbl-0075">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003220.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003220-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003220-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003220-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD003220-note-0063">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD003220-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD003220-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD003220-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD003220-note-0001">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003220\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003220\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003220\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003220\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003220\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003220.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003220.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003220.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003220.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003220.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726467796"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003220.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726467800"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003220.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e945868499368',t:'MTc0MDcyNjQ2OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 